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ABSTRACT
The Effect of C8-Arylguanine Adducts on B/Z-DNA Equilibrium:
Implications in Aryl Hydrazine Carcinogenesis
Vorasit Vongsutilers
Aryl hydrazines and related compounds have been shown to be carcinogenic but
the mechanism is still unclear. C8-Arylguanine adducts, formed from oxidative
metabolites of aryl hydrazines, are suspected to be the cause of carcinogenesis. Z-DNA
formation facilitated by the aryl adduct are among the potential mechanisms and has been
investigated in this study. Z-DNA may be involved in carcinogenesis as several studies
have indicated that Z-DNA may play an important role in gene expression and to induce
mutagenic genetic deletions. C8-Arylguanine adducts may cause carcinogenesis by
promoting the formation of Z-DNA which in turn disturbing gene regulation and leading
to mutagenesis. To investigate this hypothesis, we have set out to 1) study the effect of
aryl adducts formed from carcinogenic aryl hydrazines on B/Z-DNA equilibrium and 2)
seek the relevancy between Z-DNA formation and aryl hydrazine carcinogenesis.
Here, alternating CG decamers containing C8-arylguanine modifications
(d(CGCGCG*CGCG)2, G* = C8-tolyl, C8-carboxyphenyl, C8-methoxymethylphenyl, or
C8-hydroxymethylphenyl guanine), were prepared through Suzuki coupling and
phosphoramidite chemistry. The effect of the aryl adducts on the B/Z-DNA equilibrium
were determined by CD and NMR analysis. The experimental results supported by
computational study have suggested that all of the aryl modifications examined facilitate
B-Z transition by destabilizing the B conformation and/or stabilizing the Z conformation
relative to the corresponding unmodified oligonucleotide. Among the aryl adducts, C8carboxyphenyl adduct has been shown to be best at facilitating B-Z transition followed
by C8-phenyl, C8-methoxymethylphenyl, C8-hydroxymethylphenyl, and C8-tolyl
respectively. The effect of aryl adducts on B-Z transition is generally correlated with the
reported V79 mutagenicity of the aryl hydrazines precursors. This preliminary study has
suggested that Z-DNA may be involved or plays a role in aryl hydrazine carcinogenesis.
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CHAPTER 1
INTRODUCTION
1.1 Carcinogenicity of Aryl Hydrazines and Related Compound
Aryl hydrazines and related compounds can be found in a variety of sources
including natural products, pharmaceutical agents, synthetic chemicals used in industry,
and agricultural substances1 (Figure 1.1). Agaricus bisporus, the most produced
mushroom in the United States, contains Agaritine which was found to be carcinogenic in
mice after bioactivation2,3. Several medicines, such as isoniazid and hydralazine, contain
aryl hydrazines or related functional groups. Though they display a wide range of
carcinogenic activities, most of the aryl hydrazines that have been studied are
carcinogenic4. However, though the carcinogenicity of aryl hydrazines has being
investigated for more than thirty years, the mechanism(s) with respect to carcinogenesis
remains unclear and is still being investigated.

Figure 1.1 Structure of aryl hydrazines and related compounds found in everyday life
(1) agaritine from the button mushroom Agaricus bisporus, (2) antitubercular agent
isoniazid, and (3) antihypertensive hydralazine.
1

Oxidative metabolism of aryl hydrazines is believed to produce reactive
intermediates that are related to the carcinogenicity of aryl hydrazines. Metabolism of
aryl hydrazines by cytochrome P450 has been shown to lead to the production of the
reactive intermediate arenediazonium ions, as first demonstrated by trapping with 2naphthol5,6. In vivo, arenediazonium ions may react directly or, after reduction, to
reactive aryl radicals (Scheme 1.1).

Scheme 1.1 Metabolism of aryl hydrazine leads to formation of arenediazonium ion and
aryl radical.
Both arenediazonium ions and aryl radicals are reactive electrophiles and they can
react with DNA either directly or indirectly. Direct reaction of the aryl radical leads to
the formation of DNA adducts. Reaction with water or oxygen results in the formation of
reactive oxygen species (ROS) which may, in turn, react with DNA. ROS can be
produced by both chemical processes7 and during enzymatic metabolism of aryl
hydrazines, as shown for example, when methylphenyl hydrazines are incubated with
microsomes from C50 cells7,8.
Several ROS intermediates have been implicated in genetic alterations and
carcinogenesis through oxidative DNA damage9-11. 8-Hydroxyguanine, also known as 8oxoguanine, is one of the products resulting from ROS production and subsequesnt
reaction with DNA, ultimately leading to base mis-pairs as Cheng K.C. et al. have
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shown12. Generation of ROS, or the related reactive nitrogen specied (RNS) through
metabolism may be a part of mechanism behind aryl hydrazine carcinogenesis. However,
previous studies have not provided sufficient results to indicate a direct relationship
between aryl hydrazines carcinogenesis and ROS/RNS production. Runge-Morris et al.
suggested that hydrazine-mediated DNA damage is more likely to occur through organic
free radical (carbon-centered) than from ROS13. In turn, the importance of direct DNA
adducts formation has been increased, significantly, due to several studies that indicate
the possibility of DNA adducts can alter either local or global DNA conformation.
The C8 position of the purine bases has been shown to be a common target for
radical species such as aryl radicals formed from aryl hydrazines. As shown in Scheme
1.2, adenine can react with both the arenediazonium ion and aryl radicals to form a C8aryl adenine adduct while C8-aryl guanine adduct formation generally occurs by reaction
with the aryl radical directly14. Aryl radicals can react at the C8 position of purine bases
to form carbon centered radical intermediates. This intermediate, then, must undergo an
oxidation and loss of a proton to produce the neutral adduct. In the case of adenine,
reaction at C6-N can also occur which yields a triazene. The triazene is unstable and can
decompose, with the loss of nitrogen and the resulting aryl radical can react at C8.
Tautomerization then leads to the final C8-aryl purine adduct.

3

Scheme 1.2 Mechanisms of C8-arylpurine adduct formation: The upper scheme shows
C8-arylguanine adduct formation while the lower scheme shows C8-aryladenine adduct
formation.

DNA adducts have been extensively investigated for their potential to cause
cancer development. Miscoding15 and DNA strand breakage16 have been studied in
relation to C8-aryl purine adducts, however none of these processes has unequivocally
been related to aryl hydrazine carcinogenesis. Study of DNA adducts has often focused
on the relationship of the observed conformational changes and the resulting genetic
mutations. Of the many known C8 guanine adducts, the 2-aminofluorene17, bromine18,19,
and methyl20,21 adducts have all been shown to shift the B/Z equilibrium toward Z-DNA
in alternating purine-pyrimidine sequences, along with the phenyl22 adduct formed from
aryl hydrazines. The effects of C8-aryl adduct on Z-DNA and B-DNA were examined
throughout this study in order to evaluate the significance of the B-Z conversion in aryl
hydrazine carcinogenesis.
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1.2 Z-DNA: Structure and Biological Role
1.2.1 Structure and Chemistry of Z-DNA
Z-DNA was first identified by X-ray crystallography in 1979 by Wang et. al.23.
The X-ray crystal structure indicated that a self complementary CG hexamer was in a
non-canonical, left-handed double helix as shown in Figure 1.2. Although both B and ZDNA are anti-parallel, double stranded helices that are composed of Watson-Crick
hydrogen bonding base-pairs, their structures are very different. Unlike B-DNA in which
all of the bases are in anti conformation about the glycosidic bond, in Z-DNA the
pyrimidine bases are anti and the purines adopt the syn conformation (Figure 1.3). This
structural feature leads to a zigzag phosphate backbone of the left-handed DNA which, in
turn, gave rise to the name Z-DNA. Studies have shown that purine bases are more prone
to adopt the syn conformation than pyrimidine bases mainly due to the energy penalty
from van der Waals crowding24. Therefore, alternating purine-pyrimidine sequences are
the most prone to form Z-DNA. In addition, Z-DNA does not have as visually distinct
major groove and minor groove as seen in B-DNA. It does have a very narrow and deep
minor groove while; what is technically the major groove, is nearly flat or even convex.
The positions of the base-pairs, within the helix, are also significantly displaced from the
helical axis in Z-DNA relative to the B form. This reduces stacking interactions among
bases25 and lowers the stability of the left-handed DNA form. Under standard
physiological conditions B-DNA is typically lower in energy, though certain factors can
stabilize Z-DNA relative to B-DNA and thus facilitate B to Z conversion.
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Figure 1.2 Structure of B-DNA (left) and Z-DNA (right) of the duplex CG decamers

Figure 1.3 Structure of guanosine in B-DNA and Z-DNA. In B-DNA, the glycosidic
bond in is in anti conformation and the deoxyribose adopts the C2′ endo orientation. In
Z-DNA, the glycosidic bond is in syn and the deoxyribose contains is C3′ endo.
6

Several studies have investigated the factors affecting the stability of Z-DNA.
Alternating purine-pyrimidine sequences are more common to form Z-DNA due to the
previously described preferences for purines to adopt syn glycosidic bonds. Certain
chemical modifications like N7 guanine methylation26 or C5 cytosine methylation,27 help
stabilize Z-DNA and/or destabilize B-DNA and drive the B to Z conversion. A very
interesting target is the C8 position of guanine since several modifications including
methylation, bromination, and phenylation, have been shown to facilitate B-Z transition
via C8 guanine adduct formation. The addition of a group to the C8 of guanine or adenine
causes the syn conformation to be favored, at least at the nucleoside level, due to less
steric hindrance compared to anti conformation. In anti position, the C8-substituent
sterically interacts with the C2′-proton.
Organic and inorganic cations can stabilize Z-DNA and molecules with those
bearing multiple positive charges are even more efficient at stabilization of the Z-DNA
conformation than monovalent cations as has been shown in poly GC sequences28. The
reason for the stabilizating effect of cations is, in Z-DNA, the phosphate groups are closer
together than in B-DNA and under normal physiological conditions give rise to
electrostatic repulsion among the negatively charged phosphate backbone. Positive
charged species such as Na+, K+, Mg+, spermine, and spermidine diminish the
electrostatic effect by screening and thereby lower the energy level of Z-DNA.
In 1982, another factor that stabilizes Z-DNA was discovered. Negative
supercoiling, which occurs during transcription, has been shown to facilitate B to Z
conversion. This factor was originally detected with gel electrophoresis29 and a Z-DNA
antibody binding assay30. The level of negative supercoiling required to stabilized Z-
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DNA depends on the length of alternating purine-pyrimidine track. Generally longer
tracks of purine-pyrimidine repeats require a lower level of negative supercoiling to
stabilize the Z conformation25. The discovery of the stabilization effect that negative
supercoiling has on the Z-DNA conformation suggested possible biological roles for ZDNA since supercoiling tends to be interrelated with biological function (e.g.,
transcription). Further details regarding supercoiling and biological significant of Z-DNA
are discussed in the following section.

1.2.2 Biological Relevance of Z-DNA
Although many chemical aspects of left-handed DNA have been investigated and
elucidated, the biological role has not. A major impediment is the lack of data regarding
the formation of Z-DNA under physiological conditions, even after 30 years of research
following the discovery of Z-DNA. However, in the past decade several studies have
shown that Z-DNA may play significant roles in biological systems and investigations
into its biological functions are being revived. The evidence that suggested that negative
supercoiling stabilizes Z-DNA has redirected biologists to have renewed interest in ZDNA function31.
In 1987, study of DNA supercoiling during transcription by Liu L.F. and Wang
J.C. 32 showed the possible biological relevance of Z-DNA in gene transcription. The
study showed that, in the process of transcription, RNA polymerase actually plows
through DNA helices instead of rotating around DNA, as believed in the past. Because
the DNA has a fixed end, the movement of RNA polymerase complex unwinds the DNA
and generates a negative supercoil behind the moving polymerase. The left-handed Z-
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DNA form, then, may form to reduce the negative torsional strain caused by the unwound
DNA. The information from this study supports the ideas that Z-DNA may have a
biological function(s).
A computational study was conducted to map the potential Z-DNA forming
sequences in 137 human genes33. The result has shown that potential Z-DNA forming
sequences are located non-randomly near transcription initiation sites. Further evidence
from a more recent computational study in 200434 also suggests that Z-DNA coupled
transcription may be possible since the results show the distribution of Z-DNA forming
regions across chromosome 22 toward the transcription start sites. To gain more direct
evidence of Z-DNA associated with transcription, the level of Z-DNA during
transcription in permeabilized mammalian cell nuclei was detected by a Z-DNA antibody
binding assay35. This study has discovered that transcription is directly associated with
the binding of anti Z-DNA antibodies; inhibition of RNA transcription results in
decreasing Z-DNA antibody binding.
Specific gene expression, for example, of c-myc, has also been shown to correlate
with the formation of Z-DNA in permeabilized nuclei36. In 2001, Liu R. et al. proposed
one possible mechanism to explain how Z-DNA initiates transcription37. To activate the
colony stimulating factor-1 (CSF-1) promoter, the activity of the NFI-BAF complex
required the transition of B-DNA to Z-DNA. Binding of NFI to CSF-1 facilitates the
activation of the promoter by BAF which in turn initiates the unwinding of chromatin
structure. Negative supercoiling would then be increased and stabilized by the transition
of B to Z-DNA. This discovery has shown that Z-DNA could not form nucleosomes38.
Therefore, stabilization of Z-DNA, TG repeats in this case, by negative supercoiling
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further opens the chromatin structure and allows other transcription factors to engage and
to initiate transcription. Z-DNA formation is only transient and will relax back to B-DNA
after transcription ends. The evidence of Z-DNA coupled CSF-1 transcription has
demonstrated a significant biological role of Z-DNA.
In addition to Z-DNA coupled transcription, other studies have found the
occurrence of Z-DNA binding proteins. A screening technique to identify selective ZDNA binding proteins has been described by Herbert et al.39 It led to the isolation of
several specific Z-DNA binding proteins. One of the Z-DNA binding proteins that is
worthy of mention is double stranded RNA adenosine deaminase (ADAR1)40. ADAR1
binds to the double stranded part of RNA that forms in pre-mRNA31 and activates
deamination of adenosine to give inosine, interpreted as guanine by ribosome. The
activity of ADAR1 may regulate the expression of multiple proteins from single encoded
genes through the alteration of amino acid sequence of the encoded protein. Although the
in vivo experiment on Z-DNA binding domain of ADAR1 has been studied41 and the cocrystallization of Z-DNA and ADAR1 has been conducted42, a regulatory role of Z-DNA
on ADAR1 function is still not completely elucidated.

1.2.3 Z-DNA Induces Genetic Instability
From previous studies, the biological relevance of Z-DNA has been demonstrated
mainly in a transcription process. Since Z-DNA seems to have a biological role in gene
expression, it has been speculated that Z-DNA may play a role in carcinogenesis.
Considering the suggestion that Z-DNA may regulate transcription, over-stabilization of
the Z-DNA conformation may have negative consequences. As explained earlier that Z-
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DNA formation only occurs transiently, initiating transcription and over stabilized ZDNA may prolong Z-DNA formation and therefore, potentially over-expression of a
gene. In addition, increasing the stability of Z-DNA may affect the regulatory role of ZDNA on ADAR1 activity and can result in translation errors from improper guanine
substitution. Furthermore, Z-DNA prone sequences have been shown to be highly
recombinogenic and often result in genetic deletions43. In 1989, Spitzner, J. R. et al. 44
demonstrated that alternating purine-pyrimidine repeats were sensitive to strand breaking
by DNA topoisomerases. The study suggested that the Z-DNA forming sequence may be
a hot spot that is vulnerable to DNA damage. Recently, Wang G. et al45 have confirmed
that Z-DNA may cause genetic instability. They demonstrated Z-DNA is a genomic hot
spot that can induce genetic instability in both bacterial and mammalian cells. Thus, a ZDNA prone sequence induced double strand breaks close to the Z-DNA and result in
large scale deletions. The result from this study has again suggested the mutagenic
potential of Z-DNA. Considering that several C8 guanine adducts including C8-phenyl
adduct formed from phenyl hydrazine22 can stabilize the left-handed DNA, Z-DNA
stabilization may be related to aryl hydrazine carcinogenesis.

1.3 Effect of C8-Arylguanine Adduct on Aryl Hydrazine Carcinogenesis: The
Possibility of Z-DNA Mediated Carcinogenesis
Previous studies have shown a correlation between C8-arylguanine adduct
formation and carcinogenicity of the parent aryl hydrazines22,46. Thus, through
bioactivation of aryl hydrazines, arenediazonium ions and/or aryl radicals are produced
and lead to the formation of DNA aryl adducts. This process may be the cause of aryl
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hydrazine carcinogenesis. Several attempts have been made to determine how the DNA
aryl adduct facilitates cancer development. Kohda et al.15 has suggested that the C8phenyl guanine adduct may be mis-read by DNA polymerase and can cause miscoding
through G→T and G→C transversions. However, the C8-arylguanine adducts are not
efficiently read and when read, tend to be read correctly. Consequently, aryl hydrazine
carcinogenesis is likely caused by other mechanisms22.
Four different p-substituted arenediazonium ions (Figure 1.4) including MBD,
HMBD, MMBD, and CBD have been shown to be capable of inducing DNA damage
through DNA-DNA cross linking (except for MBD) and single strand breaks in Chinese
hamster lung fibroblast V79 cells46. It has been suggested that either the reactive azo
group of arenediazonium ions or, after reduction to an aryl radical (metabolically or
chemically), reaction with DNA occurs to form the C8-arylguanine adduct.
Subsequently, p-substituents (-CH2OH, -CH2OCH3, -COOH, CH3) may then react with
another base to form DNA cross linking47. The methyl functional group in MBD does not
bear any leaving groups and, therefore, no reactions with other bases are possible and no
DNA cross links form. The mechanism of DNA single strand breaks caused by reaction
of the arenediazonium ions or aryl radicals is still not clear and will require additional
research to elucidate the mechanism.

Figure 1.4 Structures of carcinogenic arenediazonium ions a) MBD, b) HMBD, c)
MMBD, and d) CBD.
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Studies of carcinogenic polycyclic aromatic hydrocarbons have demonstrated that
the C8-aryl modified guanosine formation through the oxidation of benzo[α]pyrene can
result in the loss of the pendant sugar residue48. Identification of depurination in both in
vitro and in vivo studies49,50 have been conducted and the results suggest that the C8benzo[α]pyrene adduct formation facilitates the depurination of the modified guanine.
Furthermore, the formation of apurinic sites has been correlated with the mutagenic level
of benzo[α]pyrenes49. Depurination is a common occurance in cells and is usually taken
care by DNA repair enzymes51,52. However, an excessive exposure to certain types of
chemicals, for example carcinogens, may overwhelm the DNA repair enzymes. In this
case, the abasic sites may cause several types of DNA lesions and may lead to
mutagenesis51. DNA strand breaks can occur through the abasic sites since the aldehydic
lesions are vulnerable to oxidative strand scission53. Misincorporation by DNA
polymerase through depurination can occur as explained by Boiteux and Laval’s
observation54 that E. coli DNA polymerase preferentially incorporates dAMP over dGMP
opposite the abasic site. In addition, Dutta et al.55 have shown that the abasic sites can
generate interstrand cross links through the reaction of the aldehyde of the abasic site and
N2-amino group of guanine residue in the opposite strand.
Apurinic site formation has also been detected, albeit indirectly, by high pressure
liquid chromatography (HPLC) analysis as C8-aryl modified bases can be detected from
solutions resulting from calf thymus DNA or C50 cells treated with with MBD, HMBD,
or CBD7,14. As a result of C8-aryl purine adduct formation, the glycosidic bond is more
vulnerable to hydrolysis and the depurination rate is increased. This suggested that aryl
hydrazines may induce carcinogenesis via depurination of C8-aryl modified purine. This
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depurination, facilitated by C8-aryl adduct formation, may explain the previous result
that aryl hydrazines mediated DNA single strand breaks and DNA cross links in V79
cells. Nevertheless, further study needs to be conducted to explore this possibility.
Another possible mechanism that will be addressed throughout this dissertation is
Z-DNA mediated aryl hydrazine carcinogenesis. As described in the previous section,
several studies have suggested the biological role of Z-DNA in the transcription process.
Furthermore, there is mounting evidence that indicates the mutagenic potential of ZDNA. These results lead to the idea that Z-DNA “over” stabilization is likely to cause
genetic alteration by disturbing transcription balance and/or increasing vulnerability of
DNA to damage. Given the results from several studies that C8-guanine adducts can
promote the conversion of B- to Z-DNA by destabilizing B-DNA and/or stabilizing ZDNA, aryl hydrazine carcinogenesis through Z-DNA formation by C8-aryl adduct seems
to be possible.
Previously22 our group has shown that the C8-phenyl guanine adducts promote BZ conversion in CG8Ph (d(5′-CGCGCG*CGCG-3′)2, G* = C8-phenyl modified guanine).
The aryl modified DNA requires much lower NaCl concentrations to stabilize the Z
conformation compared with the unmodified DNA, indicating the stabilization effect of
C8-phenyl guanine adduct on Z-DNA. The result from this initial study confirmed the
possibility that B-Z transition may play a role in aryl hydrazine carcinogenesis and has
opened the opportunity of further explore the effect the C8-arylguanine adduct has on ZDNA stabilization or B-DNA destabilization. Given that Z-DNA is suspected to play a
significant role in cancer development, the C8-aryl adduct formed from the carcinogenic
aryl hydrazines should, in general, promote the Z-DNA formation. To prove this concept
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and to determine the correlation between Z-DNA formation and carcinogenesis, several
C8-arylguanines, modified DNA including CG8Tol, CG8HMPh, CG8MMPh, and CG8CPh (d(5′CGCGCG*CGCG-3′)2, G* = 8-p-tolyl, 8-p-hydroxymethylphenyl, 8-pmethoxymethylphenyl, or 8-p-carboxyphenyl guanine) were made. These modified
oligonucleotides are formed from the arenediazonium ions (MBD, HMBD, MMBD, and
CBD, respectively), via aryl radicals, and all have been shown to be mutagenic4,46. In this
study, the effects of each C8-aryl adduct on B/Z-DNA equilibrium was investigated.
The next chapter provides fundamental knowledge regarding methodologies and
experimental techniques that have been used in this research. The experimental results
are reported in Chapter 3 (DNA synthesis) and 4 (structural and conformational analysis).
The computational study of the modified DNA, conducted to help explain the
experimental results, is described in Chapter 5. Finally in Chapter 6, the effect of C8arylguanine adducts on B/Z-DNA equilibrium and the significance of Z-DNA in aryl
hydrazine carcinogenesis are discussed.
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CHAPTER 2
EXPERIMENTAL TECHNIQUES
2.1 Synthesis of CG Decamers Containing C8-Aryl Modified Guanine
Generally, most short length oligonucleotide sequences can be efficiently made
through use of an automated DNA synthesizer that utilizes phosphoramidite chemistry.
The DNA synthesizer uses nucleoside cyanoethyl phosphoramidites (dA CE-PA, dG CEPA, dT CE-PA, dC CE-PA, Figure 2.1) as the building blocks for the chemical synthesis
of oligonucleotides. However, in order to make CG decamer with C8-arylguanine adduct,
the modified C8-aryl-dG phosphoramidites (Figure 2.1) must be made as they are
commercially unavailable. In this section, an overview of the chemistry behind
automated DNA synthesis and the synthesis of C8-aryl-dG phosphoramidites will be
described.

Figure 2.1 Structures of the phosphoramidites used in DNA synthesis.
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2.1.1 Chemistry for Automated DNA synthesis56
Fundamentally, chemical synthesis of DNA works on the basis that the
oligonucleotide can be elongated by coupling the reactive 3′-phosphoramidite of one
nucleoside and the 5′-hydroxyl of the existing oligonucleotide. The synthesis occurs on
the controlled pore glass (CPG) solid phase column with the first 3′ base attached to the
column through an ester linkage57. All phosphoramidites, reactants, and solvents are
flushed through the synthesis column with the oligonucleotide being extended from the 3′
end toward the 5′ end. Each base extension cycle is composed of four steps (Scheme 2.1)
including detritylation of 5′-hydroxyl, base coupling, capping of unextended DNA, and
oxidation. The reaction cycle repeats, for each base addition, until the DNA sequence is
completed.

Scheme 2.1 The DNA synthesis cycle is including Detritylation, Coupling, Capping,
and Oxidation. (B = A, G, C, T)
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Detritylation deprotects the 5′-hydroxyl of the nucleoside bound to the solid phase
and renders it a nucleophile for coupling in the next reaction (AÆB). Trichloroacetic acid
(TCA) in CH2Cl2, a protic acid, is used as a deprotecting agent as the DMTr group is acid
labile. The protonation on the 5′-hydroxyl leads to DMTr cation loss and the detritylation
can be driven to completion by removal of DMTr cations.
After removal of excess TCA in detritylation step, the phosphoramidite is
activated by tetrazole which transfers a proton to the nitrogen of the diisopropyl group on
the 3′-phosphorous making the protonated amine a better leaving group. The nucleophilic
tetrazole then attacks the phosphorous to form a tetrazolyl phosphoramidite. The molar
excess of tetrazole ensures that most of the phosphoramidite is activated. The solid
supported end 5′-hydroxyl reacts with the 3′-tetrazolyl phosphoramidite to form the
internucleotide phosphite linkage (BÆC). As a result, the oligonucleotide is extended.
The coupling reaction between nucleotides may not proceed completely leaving
some of the oligonucleotide attached to the solid support unextended. To prevent the
unreacted oligonucleotide from being extended and giving rise to undesirable
oligonucleotide sequences, unreacted material is capped. Acetic anhydride and
methylimidazole are used as a capping reagent and are delivered to the synthesis column
simultaneously. The two reagents react and give a reactive acetylating agent which, in
turn, reacts with the 5′-hydroxyl of the unextended oligonucleotide to inactivate the
moiety from further reaction (CÆD).
The last step is to oxidize the freshly formed internucleotide trivalent phosphite to
pentavalent phosphodiester. Iodine in an aqueous pyridine-tetrahydrofuran (THF)
solution is used as a mild oxidizing agent. The iodine-pyridine complex forms a di-iodo
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adduct with the phosphate that is subsequently hydrolyzed by water to form the
internucleotide phosphodiester linkage.
To maximize DNA synthesis yield, each step of the synthesis cycle is followed by
an acetonitrile (ACN) and argon flush to make sure that no reagents from the previous
reaction remain to interfere with the next cycle. Following the oxidation of the final base,
the DMTr protected 5′-hydroxyl group of the completed sequence can be detritylated.
After the completion of the DNA synthesis the amine protecting groups and the solid
support linkage are removed by incubating the synthesis column in a basic ammonium
hydroxide solution for 15 hrs at 55°C. The crude oligonucleotide can be purified if
necessary.

2.1.2 Synthesis of C8-Arylguanine Phosphoramidites
To incorporate C8-arylguanine adduct to the CG decamer, the modified C8-aryl
dG phosphoramidites are required. The phosphoramidite used in the DNA synthesis
contains several required functional groups including a diisopropylamino cyanoethyl
phosphorous on 3′-hydroxyl, a DMTr on 5′-hydroxyl, and a protecting group of the
exocyclic amine of nucleoside base. In case of the C8-aryl modified guanosine
phosphoramidite, the purine ring has an additional aryl substituent at C8. Several
reactions need to be performed in order to add these functional groups to prepare the aryl
modified phosphoramidite. Our scheme starts with attachment of the aryl group to the C8
position of 2′-deoxyguanosine. Next the exocyclic amine is protected, followed by 5′hydroxyl and 3′-hydroxyl groups are functionalized, respectively.
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2.1.2.1 Synthesis of C8-Aryl dG Using the Suzuki Coupling
The 8-aryl-dG can be made through the chemical reaction between
arenediazonium ion and dG as described by Kohda K. et al.15 To make 8-phenyl-dG, the
BD solution was freshly made from the reaction between aniline and NaNO2. After
reacted with BD in basic condition for 24 hrs, dG was arylated and 8-aryl-dG was
collected from crystallization. Despite the success of making 8-phenyl-dG, using the
carcinogenic arenediazonium ions as the arylating agents is quite hazardous requiring
special handling. In addition, the reaction produces nitrogen which causes foaming, is
difficult to contain, and to filter after the reaction is complete. It is also not very efficient,
and provides relatively low yields (40%) in the case where the aryl group is phenyl.
Finally, while this reaction works with some substituted phenyl groups it is unlikely to
work with many substituted phenyl groups that are of interest. Improved methods that
provide a safer, more convenient protocol, higher product yields and simple purification
to isolate the product is preferred.
Palladium catalyzed cross coupling reactions have been successfully used for
carbon modification of nucleosides58,59. Among the cross coupling reactions, Suzuki
coupling between halonucleosides and arylboronic acids have been shown to be an
effective way to make aryl modified nucleosides60,61. In general, the Suzuki coupling is
the important carbon-carbon bond forming reaction that can be used to make biaryl
compounds through palladium catalysis of the reaction between arylboronic acids or
esters and aryl halides, sulfonates, or diazonium salts in basic condition62,63 as shown in
Scheme 2.2.
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Base, Pd catalyst

Ar-X

+

Ar′-B(OR)2

Ar-Ar′

X = I, Br, Cl, OTf, OTs, OMs, N2+BF4R = H or Alkyls
Scheme 2.2 The synthesis of biaryls from arylboronic acids or esters and electrophilic
aryl reactants by Suzuki coupling
The general mechanism64-66 of the coupling reaction is described in Scheme 2.3.
The reaction begins with the arylhalide (or other electrophilic aryl reactant) reacting with
the Pd(0) catalyst by oxidative addition to form an arylpalladium (II) halide. The
hydroxide (or other negatively charge bases such as alkoxide, carbonate, or phosphate
etc.) then attacks the boron atom in the arylboronic acid to give an aryl borate- ate
complex. In addition, the nucleophilic base also reacts with the arylpalladium (II) halide
to generate an arylpalladium (II) hydroxide. The aryl borate and the arylpalladium (II)
hydroxide then react and form a diarylpalladium (II) complex which eventually
undergoes a reduction-elimination reaction that leads to the formation of a biaryl product
and the regeneration of the Pd(0) catalyst.
Several factors affect the efficiency of the Suzuki coupling reaction62. Because the
reaction requires basic conditions, base selection is very important. Using different bases
can give different products from the coupling. Weaker bases such as triethylamine (TEA)
usually are less efficient with respect to product formation. The solvent system is also
crucial since it strongly determines the solubility and basicity of the base that used in the
coupling. In our case, making the modified nucleoside, that contains the hydrophilic
sugar moiety, requires an aqueous solvent system. This limits the range of bases that can
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be used to water soluble base. Generally, carbonate or hydroxide have been used and
seem to work well.

Scheme 2.3 The general mechanism of the Suzuki coupling reaction

The homogeneous mixture from water and water-miscible organic solvent such as
ACN or THF can be used to improve the solubility of the hydrophobic reactants. In case
this is necessary, the biphasic solvent mixture from organic solvent and water can be used
if the lipophilic part is needed. The palladium catalyst is probably the most important part
in the Suzuki coupling reaction. Pd(0) is the actual catalytic species but is usually
generated in situ by reduction of Pd(II). Once formed, the Pd(0) must be kept in solution
and, since it is sensitive to oxidation, the reaction is conducted under an inert gas such as
argon or nitrogen to prevent reaction with oxygen. In addition, using a suitable and
soluble palladium ligand is also essential to solubilize and stabilize Pd(0) in solution.
Shaughnessy et al.67 have developed an the efficient way to synthesize biaryl
compounds from an aqueous based Suzuki coupling using ACN as a co-solvent. The key
discovery was that sterically demanding water soluble ligands can be successfully used
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with palladium acetate (Pd(OAc)2) to catalyze the coupling reaction. The idea seemed to
be suitable for preparation of aryl modified nucleosides and has since been used to
synthesize C8-arylpurine, as was demonstrated by Western E.C, et al.61 in 2003. The
successful aqueous Suzuki coupling of 8-Bromo-2′-deoxyguanosine (8-BrdG) and several
arylboronic acids were reported in this study with the product yield in range of 70-90 %.
The reaction is conducted at 80°C with Na2CO3 as the base in deoxygenated aqueous
acetonitrile with Pd(OAc)2 as the catalyst in a presence of the palladium ligand TPPTS
(tris-(3-sulfonatophenyl)phosphine) ligand (Figure 2.4).
These studies provided a relatively efficient and convenient method to synthesize
8-aryl dG for the C8-arylguanine modified DNA synthesis. The protocols of making 8aryl dG used in this study were followed and/or further developed.

Scheme 2.4 The synthesis of C8-aryl dG using the Suzuki coupling

2.1.2.2 Synthesis of the TBS Protected p-Hydroxymethylphenylboronic acid
Most of the arylboronic acids needed here, including phenyl, p-tolyl, phydroxymethylphenyl, p-methoxymethylphenyl, and p-carboxyphenyl boronic acids, are
commercially available and have been successfully used directly to make the modified
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DNAs except for the p-hydroxymethylphenyl derivative. The 8-(phydroxymethylphenyl)-dG phosphoramidite has been synthesized, however using it in for
the modified DNA synthesis failed to unequivocally produce the desired DNA, as
suggested by mass spectral analysis. This synthesis failure may occur due to the
nucleophilic nature of the benzyl hydroxyl group that can interfere with the DNA
synthesis. In order to prevent the hydroxyl substituent from interfering with the DNA
synthesis, a protecting group was needed on the hydroxyl group. The t-butyldimethylsilyl
(TBS) protecting group has been used as a 2′-hydroxyl protection group of
ribonucleosides68 and is cleaved by exposure to concentrated ammonium hydroxide after
DNA synthesis along with other protecting groups. Therefore TBS was chosen for use as
the protecting group for the p-hydroxyl substituent.
The arylboronic acids can be made through the classical Grignard reaction62
between aryllithiums and trialkyl borates. The reaction generates arylboronic esters
which are hydrolyzed by acid to form the arylboronic acids69. From this reaction, one can
vary the p-substituent of aryllithiums to make various p-substitute arylboronic acids.
Zheng N. et al.70 has shown the efficient way to make the TBS protected phydroxymethylphenylboronic acid in a pilot scale by utilizing a Grignard reaction. The
synthesis protocol is shown in Scheme 2.5 starting with the protection of the hydroxyl of
4-bromobenzyl alcohol by using TBS-Cl to give the TBS protected product. The
protected p-hydroxymethylphenylbromide is then reacted with t-buthyl lithium to form
the TBS protected p-hydroxymethylphenyl lithium which is then treated with triisopropylborate to form the TBS protected p-hydroxymethylphenylboronic ester. After
acid hydrolysis, the TBS protected p-hydroxymethylphenylboronic acid was isolated.
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This final product was then used to prepare the modified guanine phosphoramidite which
was successfully used to synthesize the hydroxymethylphenyl guanine adduct containing
DNA. This arylboronic acid synthesis protocol is potentially useful for making other
substituted arylboronic acids that may require protecting groups.

Scheme 2.5 The synthesis of 4-(TBS-O-methyl)-phenylboronic acid

2.1.2.3 Syntheses of Protected C8-Aryl dG and Phosphoramidites
Methods to prepare the C8 modified dG phosphoramidites for the oligonucleotide
synthesis15,71,72 have been published. The routes typically begin with C8-arylation of dG
and are then followed by several reactions to prepare the modified dG phosphoramidite
monomers for use in automated DNA synthesis as shown in Scheme 2.5.
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Scheme 2.6 The synthesis of the phosphoramidite monomer. The reaction conditions are
including A) N’N-Dimethylformamide dimethyl acetal, MeOH; B) DMTr-Cl, pyridine,
TEA; C) 2-Cyanoethydiisopropylchlorophosphoramidite, CH2Cl2, TEA.

Various amine protecting groups including benzoyl, isobutyryl, and N,Ndimethylformamidine can be used to protect the N2 position of the aryl modified dG. The
latter group has been shown to improve the stability of the nucleosides73 toward acid and
was used here for the synthesis of the C8-aryl dG phosphoramidites. To attach the N2(N,N-dimethylformamidine) protecting group, N,N-dimethylformamide dimethyl acetal
is reacted with the 8-aryl dG in dry methanol. The protecting group, which is a protected
amide, forms a formamidine with the N2 amino group of the 8-aryl dG. The reaction has
been found to be very sensitive to moisture. Water will hydrolyze the protected amide to
N,N-dimethylformamide (DMF) which is inactive for the amine protection reaction.
Generally, the methanol that used in the reaction must be dried over molecular sieves
under inert gases such as nitrogen or argon. The reaction proceeds to the completion
within 24 hrs, at room temperature, with product yields of approximately 90%. The
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amine protected 8-aryl dG may be purified using normal phase column chromatography.
However, the purification is usually unnecessary because the crude reaction product is
quite pure as found by NMR of the crude reaction product. Simply drying in vacuo has
proven to be sufficient to prepare the crude product for the next reaction.
After the protection of the N2 amine group, the 5′-hydroxy group of the 8-aryl dG
is protected using DMTr-Cl, as is the case for unmodified phosphoramidites used in
automated DNA synthesis. The reaction mechanism involves the nucleophilic attack
(SN1) of the 5′-hydroxyl group to the electrophilic tertiary carbon center of DMTr-Cl,
resulting in the formation of the DMTr protected 5′-hydroxyl nucleoside and HCl. Since
the nucleosides are sensitive to acid hydrolysis, the reaction is conducted in pyridine, a
basic solvent, and in a presence of TEA to neutralize the acid generated and maximize the
product yield. The reaction can be monitored by normal phase thin layer chromatography
(TLC) with visualization by phosphomolybdic acid. The reaction product appears as an
orange spot, likely due to cleavage of the DMTr protecting group from the product as the
DMTr group is very acid labile and gives DMTr-OH which is orange in color. Unlike the
previous protection step, the DMTr protection product requires purification. Several
chromatographic systems have been explored for purification of the DMTr protected
nucleosides73. A silica gel stationary phase was first used and was shown to cause
decomposition of the nucleoside due to the acidic nature of the stationary phase. In
contrast, Alumina, a basic stationary phase, has been found to be a more suitable system
and causes minimal product decomposition. A mixture of CH2Cl2 and methanol gradient
(0-10%) is used as the mobile phase and, after chromatography, the product yield is
usually in range between 40% and 60%.
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The attachment of a 2-cyanoethoxydiisopropylaminophosphoramidite at the 3′hydroxyl position of the 8-aryl dG is the final step of the phosphoramidite synthesis. 2Cyanoethyldiisopropylchlorophosphoramidite is used as the phosphatidylating agent. The
reaction also involves the nucleophilic substitution of the chlorine on phosphorous by a
3′-hydroxyl of the 8-aryl dG. The reaction is conducted in CH2Cl2 in a presence of TEA
to neutralize HCl that is generated during the course of the reaction. Due to high
reactivity of the phosphatidylating agent, most nucleophiles, including water, can
interfere with the reaction. Therefore, using dried, purified starting materials and solvent
is necessary to achieve the desired product and optimize the yield, as is conducting the
reaction under an inert atmosphere. The phosphoramidite is only partially purified by the
precipitation of TEA hydrochloride salts out of the reaction by the addition of a mixture
of benzene and THF. While further purification can be done by column chromatography,
this step has been found to be unnecessary and tends to lead to the product degradation.
After precipitation of salts, the solvents are removed in vacuo and the product dried over
phosphorus pentoxide in vacuo.
By following these synthesis protocols, the aryl adducts with different psubstituents on phenyl ring can be introduced to the C8 position of dG. The 8-aryl dG
phosphoramidites then were made and used for the modified CG decamer synthesis
through the DNA synthesizer.

2.2 Purification of CG Decamers Containing C8-Aryl Modified Guanine
A number of factors, including low quality of the starting materials and reagents,
degradation of the modified DNA during synthesis, machine malfunction, and other
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technical issues, can affect the efficiency of the modified oligonucleotide synthesis.
Although these unfavorable factors can be prevented or minimized, most of time they can
not be completely eliminated. This will decrease the efficiency of the synthesis cycle and
resulting in by-product generation. In order to get the sufficiently pure DNA that is pure
enough for NMR and CD experiments, the crude modified oligonucleotides require
purification.
Several HPLC techniques including ion-exchange chromatography and reversed
phase chromatography74 can be utilized to purify the modified oligonucleotides. The fast
protein liquid chromatography (FPLC) method is one of the HPLC methods that has been
widely used to isolate proteins in biochemistry and enzymology research and has also
been used to purify the synthesized DNA. Because of the anion exchange matrix
stationary phase that used in the preparation column, FPLC separates DNA mainly by the
differences in negative charge of the DNA molecules. The oligonucleotide structures
contain the phosphate backbones which carry negatively charges. Therefore, DNAs of
various lengths will contain a different number of negatively charges and will bind to the
anion exchange resin to a different degree. The longer DNA sequences that have more
negative charge adsorb to the cationic stationary phase more strongly and require a more
anionic mobile phase to elute them out of the column than shorter DNAs. In addition to
the charge separation, there is some dependence of elution time on the hydrophopic
nature of the DNAs with more hydrophobic sequences eluting more quickly.
The anion exchange matrix, diethylaminoethyl (DEME) modified resin, is
commonly used to isolate nucleic acids74 and have been successfully used to purify the
modified CG decamer in this study. The quarternary ammonium ion functional groups on
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DEME give them the anion exchanging capability. The counter ions, often OH-, maintain
electroneutrality of the stationary matrices. Once the oligonucleotides are loaded on to
the column, the multi-negatively charged molecules will replace the previous counter
ions with stronger electrostatic forces. A mobile phase that contains anions, in this case
Cl-, has been used extensively to elute the oligonucleotides and a gradient comprised of
sodium chloride and sodium hydroxide can effectively be used to separate the modified
oligonucleotides contained in the crude DNA synthesis mixture. Generally, the desired
product, the longest sequence in the synthesis process, is the last one that is eluted off of
the column since it bares the highest negative charge. The separation of the crude DNA
can be monitored by using an ultraviolet (UV) light detector at 260 nm where nucleic
acids generally have the highest absorbtivities.
After isolation by FPLC, the oligonucleotides still need to be isolated from the
sodium chloride and sodium hydroxide salts that were present in the eluant. Solid phase
extraction (SPE) using reversed phase C18 cartridge can be used to desalt the DNA
samples. Because of the partial hydrophobic parts of the DNA (the purine and pyrimidine
rings) the oligonucleotides can bind to the lipophilic hydrocarbon chain in the stationary
phase better than NaCl and NaOH. Therefore, the polar impurities can be eliminated by
washing the cartridge with water after the DNA samples were loaded. The DNA can be
eluted with an aqueous methanol mixture. After removing the solvent, the purity of the
modified oligonucleotides can be confirmed by FPLC analysis. A single peak in the
FPLC chromatogram is expected if the synthesized oligonucleotides are pure.
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2.3 Mass Spectrometry of CG Decamers Containing C8-Aryl Modified Guanine
Mass Spectrometry (MS) analysis has been commonly used to characterize
organic compounds and study molecular interaction of a wide variety of chemicals. This
method of analysis is based on the detection of weight to charge ratio of the ionized
molecules by measuring the response of their trajectories to electronic or/and magnetic
fields. Hence, in the process of detection, the analytes need to be ionized in vacuo and
move through an electronic field to the mass analyzer which separates the ionized
molecules by their mass to charge ratio (m/z). The detector will then detect the sorted
ionized molecules and convert the signal into a mass spectrum that is generally distinct
for each chemical.
The classical MS methods usually use electron (EI) or chemical ionization (CI) as
an ionization source75. The high energy electron beam used in EI to interact with the
analytes and generate the molecular ions (M+·) and daughter ions. Unlike EI-MS in which
electrons directly interact with the analyte molecules, CI-MS method uses an ionized
reagent gas such as protonated methane (CH5+), isobutene cation ((CH3)3C+), or
ammonium ion (NH4+) as the ionization reagent to generate protonated analytes (MH+).
However, due to the limitations of conventional techniques, it is difficult to convert
thermal labile and/or non-volatile macro molecules such as nucleic acids or proteins into
the ionized gaseous state without decomposition.
The development of soft ionization methods including electrospray ionization
(ESI) and desorption ionization have provided the opportunity to use MS as an analytical
tool for biological molecular research. ESI-MS analysis has been successfully used in for
the characterization and sequencing of biological polymers and can be used to probe
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molecular interaction76,77. Here, we have used ESI-MS to characterize the C8-aryl dG
monomers and the C8-arylguanine modified CG decamers.
The ESI-MS method produces the quasi-molecular ions78 by nebulizing a sample
solution, in which analytes are already in the ionic form, into an aerosol through a high
voltage chamber. The charged droplets containing the analytes that are generated are
subjected to the counterflow of a drying gas, generally nitrogen gas. This process helps to
accelerate solvent evaporation, decreases the size of the droplets, and increases the charge
density on the droplet surfaces which ultimately causes the droplets to burst or undergo a
“Coulomb explosion” due to their electrostatic repulsion. As a result, daughter droplets
are produced and further break down until the preformed ions are generated (Figure 2.2).
The preformed ions79 are the ionic analyte droplets that are small enough (ideally each
droplet contains only one molecule of analyte) so they can be desorbed into the gas phase
and pass through the capillary tube into the m/z analyzer. The ion adducts can be
incorporated into the preformed ions in cases where the analyte molecules are not well
dissociated or neutral. For instance, ammonium acetate buffer can be used as a source of
the ammonium ion adducts which give positive charges to the preformed droplets.

Figure 2.2 A diagram shows the ionization process in the positive ion mode ESI-MS to
generate the preformed ions
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Depending on the mode of detection, ESI-MS can be used to detect either
negatively charged ions in a negative ion mode or positively charged ions in a positive
ion mode. Fundamentally, the ionization state of the analyte molecule is mainly
dependent on the solvent system and the pKa of the analyte molecule. Volatile aqueous
organic solvent (methanol, ACN, isopropylalcohol, etc.) systems are commonly used in
ESI-MS. In addition, a limited amount of volatile acids or bases, such as formic acid,
acetic acid, trifluoroacetic acid, ammonium formate, ammonium acetate, ammonium
hydroxide, and TEA, may be used as buffers to adjust the optimum pH of the solvent
system. Non-volatile solvents or salts should be avoided since they may accumulate in
the system and cause machine malfunction. In general, acidic molecules from negative
ions in high pH solution while the basic molecules would be protonated and form positive
ions in low pH solution. If the analyte is in a neutral form at the working pH, the ion
adducts from buffer ions will largely determine the charge of the ions.
Multiple charge states of the ions are commonly observed during the ionization
process and depend on the structure of the analyte and the solvent system. This
phenomenon is actually advantageous for the analysis of the biological macromolecules
like peptides or oligonucleotides that have high molecular weight (MW). Because ESIMS detects m/z of the preformed ions, the higher charge state of the analyte the lower
m/z ratio compared to a lower charge state of the same analyte. Unlike the conventional
ionization methods, ESI can be used to analyze high MW compounds up to 100,000 mass
units due to its ability to generate ions with multiple charged. The mass spectra of the
biological molecules from ESI-MS are usually composed of a series of peaks from
several charge states (Mn- or Mn+, n is a charge state of the molecule). The MW of the
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analyte then can be determined from a mathematically approximation from the resulting
mass spectrum.
In the positive ion mode, the molecular mass (M) of the analyte can be
calculated80 from a grouping of m/z ratios of the ion series and n as described by the
following equations.

From

m/z1 = (M + n)/n

Equation 2.1

and

m/z2 = (M + n + 1)/(n + 1)

Equation 2.2

Therefore

n = (m/z2 -1)/(m/z1- m/z2)

Equation 2.3

By solving Equation 2.1 after calculating n from Equation 2.3, the molecular mass of the
analyte can be estimated. Similar to a positive ion mode, M can also be calculated in a
negative ion mode from the observe m/z and n as described below in the Equations 2.4 to
2.6.

From

m/z1 = (M - n)/n

Equation 2.4

and

m/z2 = (M - n - 1)/(n + 1)

Equation 2.5

Therefore

n = (m/z2 + 1)/(m/z1- m/z2)

Equation 2.6

The m/z ratios can be obtained from the mass spectrum of the analyte and used to
calculate n from the Equation 2.6. After replacing the calculated n in Equation 2.4, M of
the analyte then can be resolved. The calculation may need to be justified accordingly in
case that the ion adducts are present. Alternatively, the series of m/z of multiple charge
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states of the analyte, with or without the ion adducts, can be calculated based on the
expected MW of the analyte and compared to the observed m/z in order to characterize
the sample.
The negative ion mode seems to be a suitable detection method for the
oligonucleotides mass analysis because of the net negative charge of the DNA
phosphodieater backbone (pKa ~ 1)77 which are usually dissociated in a sample solution
at pH 7.4. Hence, without any buffer, an aqueous methanol solvent system for the
modified CG decamers analysis and the negative ion mode ESI-MS has been successfully
used to characterize the oligonucleotides. A series of charge states of the oligonucleotides
were observed and compared to the calculated value to verify the identity of the
synthesized oligonucleotides.

2.4 Circular Dichroism Spectrophotometry of CG Decamers Containing C8-Aryl
Modified Guanine
2.4.1. CD of B and Z DNA
CD spectroscopy is based on the fact that an optically active, asymmetrical
molecule intereacts with the right and left handed circular polarized lights differently.
When right and left circular polarized lights pass through absorbing optically active
matter, not only do they travel at different speeds, they also absorbed to a dissimilar
extent. The difference between the circular light absorptions (Δє = єL - єR) is called
circular dichroism81 which is detected in the CD spectrometer. When two circular
polarized light beams, with equal amplitudes and wavelengths, are superposed the result
is a linear polarized wave. In case of CD, the superposition of the right and left polarized
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light is no longer a linearly polarized wave. Instead, elliptically polarized light is
generated. The ellipticity that is caused by CD can be mathematically determined and is
usually presented in a CD spectrum. CD spectroscopy has been widely used to study
molecular conformation of the chiral compounds including peptides and nucleic acids in
several research areas due to the fact that different conformations of the same optically
active substance can be distinguished by the unique patterns of their CD spectra.
The structure of nucleic acids is composed of the aromatic purine/pyrimidine
bases that are connected through the internucleotide sugar-phosphate backbone. The
phosphate groups have high energy electronic transition at wavelengths shorter than 170
nm. Close to the absorption band of phosphates, deoxyribose sugars absorb light begin at
190 nm. The nucleotide bases, A, G, C, and T, are the chromophoric parts of DNA
because of the aromatic system of purine and pyrimidine bases. Since the nucleotide base
contains several π bonds, it is possible for them to have a large number of π→π*
transitions which result in a lower electronic transition energy begining at 300 nm81.
While the nucleotide bases are chromophoric, they are also symmetrical (plane of
symmetry) and are not optically active which, in turn, makes them CD inactive. The
deoxyribose sugar that attach to the base is chiral and gives the nucleoside molecule
asymmetry and CD activity. However, since the absorbing moiety (pyrimidine or purine)
is attached to the chiral component (deoxyribose) the effect of a chiral sugar on the CD is
greatly attenuated and therefore, the CD intensity of a nucleoside base is relatively low.
Several interactions including base-paring through hydrogen bonding, base stacking,
hydrophobic and electronic interactions give rise to a super asymmetric species, the
double helical structure of DNA which has high CD intensity. Due to the polymorphic
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nature of nucleic acids and numerous secondary structures of DNA, other than the
conventional B-DNA structure, can be adopted under specific conditions including the
conformation of interest here, Z-DNA. Due to the differences in interstrand and
intrastrand base-base interaction, B- and Z-DNA each have a unique ‘signature’ in the
CD spectrum that can be used to distinguish the two structures.
The B to Z transition of several oligonucleotides including unmodified and
modified poly (dCdG) have been investigated by using CD spectrophotometry28,82-84 due
to the fact that the repeated CG sequences can, relatively easily, assume the Z
conformation. In general the CD spectrum of B-DNA shows the positive ellipticity at
approximately 280 nm and 220 nm and a negative ellipticity at approximately 250 nm
(Figure 2.3). In contrast, the CD spectrum of Z-DNA shows a sharp negative ellipticity at
approximately 295 nm81. Based on the different CD patterns of B and Z-DNA, the
conversion of B to Z-DNA can be monitored as demonstrated by Pohl, F.M. and Jovin,
T.M. in 197282. The study has shown that the conformational change of poly (dCdG)
from B to Z can be achieved by stabilizing the Z conformation by increasing sodium
chloride concentration. The transition process is completely reversible since the Z-DNA
converts back to B-DNA after salt removal. At physiological pH with low salt
concentration, unmodified oligonucleotides preferentially adopt the B conformation. ZDNA formation can be observed at high salt concentration (more than 2M sodium
chloride for unmodified oligonucleotides). A reduction of the CD signal at approximately
295 nm (trough formation) and an increase of CD at approximately 270 nm can be used
to follow the transition of B to Z-DNA and to quantitate the conversion.

37

Figure 2.3 CD spectra of B-DNA (black) and Z-DNA (red) forms of the duplex CG
decamer

To evaluate the effect of the C8-arylguanine adduct on B-Z transition, a series of
CD spectra of the unmodified and aryl modified CG decamers in pH 7.4 phosphate buffer
solution with various concentrations of sodium chloride have been collected. The B to Z
conversion of the oligonucleotides can be observed from the transition of CD spectra as
explained previously. The CD spectra can be used to quantitate the amount of the Z and
B forms and thereby the effect of the C8-arylguanine adducts on Z-DNA stabilization
and/or B-DNA destabilization can be roughly estimated in response to increasing sodium
chloride concentration that needed for Z-DNA formation. The lower the concentration of
sodium chloride that is required to cause the B to Z transition of the modified
oligonucleotides, then, can be related to the higher stabilization effect of the C8arylguanine adduct on a Z conformation or destabilization effect on B conformation of
CG decamer. However, this method is only appropriate for preliminary comparison. A
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more quantitative method that has been used to evaluate the effect of the aryl adduct on
B-Z transition is discussed in the next section.

2.4.2. Z-DNA Quantitation
In order to compare the effect of the C8-arylguanine adduct on B- and Z-DNA
stability in a more quantitative fashion, molar fractions of B, Z and ssDNA ( fB, fZ, and fss
respectively) can be calculated from the CD spectra. By quantitating the amount of ZDNA in a sample, the Z-DNA stabilization effect of the aryl adducts can be inferred from
the amount of Z-DNA that forms in the solution. The mathematical estimation of fB, fZ,
and fss from CD spectra was reported previously by Xodo, L.E. et al.85 and was used in
this study. The calculation was based on the assumption that there is an equilibrium
amongst three conformations of the oligonucleotide under study (B, Z, and ss). Therefore,
at any given wavelength, the total molar ellipticity (Δє) of the oligonucleotide is equal to
the sum of the molar ellipticities of each conformation, weighted by the molar fraction of
each species (Equation 2.7). The CD at 295 nm has being selected here to use in the
calculation, mainly due to the strong CD intensity of the Z conformation relative to the B
form. The total molar fraction of all conformations equals the summation of fB, fZ, and fss,
and, therefore, equals 1 (Equation 2.8).

At 295 nm

Δє295 = ΔєB295*fB + ΔєZ295*fZ + Δєss295*fss

Equation 2.7

1 = fB + fZ + fss

Equation 2.8

However, in practice, the instrument provides the total ellipticity (є), not Δє. Therefore,
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to make the calculation possible Equation 2.7 has been modified as shown in Equation
2.9 as shown below.

At 295 nm

CD295 = (Δєss295*Css) + (ΔєB295*CB) + (ΔєZ295*CZ)

Equation 2.9

Where CD295 is the observed CD intensity at 295 nm and Css, CB, and Cz are the
concentrations of ssDNA, B-DNA, and Z-DNA in solution, respectively. To simplify the
calculation, the path length (b) which is constant at 1 mm for all experiments is left out of
the equation. The Δє of each conformation can be estimated by assuming under selected
conditions, most of the oligonucleotides can be driven into a single polymorphic form. At
temperature as high as 90°C most of dsDNA will be denatured and is in the ssDNA form,
thus the CD295 signal will be due to only the ssDNA (CD295 = Δєss295 *Css). Then, Δєss295
can be solved with the observed CD295 and Css which can be quantitated by UV. With low
salt concentration at room temperature, B-DNA is expected to be a sole conformation
present and ΔєB295 can be approximated from CD295 of the sample. By increasing a
sodium chloride concentration to 2M-4M and cooling the sample to 10°C, the Δє of ZDNA can also be estimated the same way as done for the B and ssDNA. With the
observed CD295 and the estimated molar ellipticities, Css, CB, and CZ are left to be solved.
Note that Css, CB, and CZ are measurable by UV only when a single conformation exists
in the sample under controlled conditions. Otherwise, they are considered as variables
that need to be mathematically calculated. To get CZ, both Css and CB must be determined
first.
The Css can be obtained by the following calculation. At the isosbestic point of
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dsDNA, the molar absorptivities (Δε) of B and Z-DNA are equal (ΔεB = ΔεZ = Δεds).

Therefore
And

ε270 = εds270*fds + εss270*fss

Equation 2.10

1 = fds + fss

Equation 2.11

Similar to CD, the observed UV absorbance (A) has being used in the calculation instead
of Δε. Hence, Equation 2.10 has been modified to give Equation 2.12.

At 270 nm

A270 = (εss270*Css) + (εds270*Cds)

Equation 2.12

Where A270 is the observed UV absorbance at 270 nm and Cds is a concentration of
dsDNA which equals to CB + CZ. The molar absorptivities of ss- and dsDNA can be
obtained the same way as the molar ellipticities. At 90°C, εss270 can be estimated while
εds270 is attained at low temperature. To further solve the calculation, the relationship
between the concentrations of ssDNA and dsDNA in the sample is must be established.
The equilibrium between ssDNA and dsDNA is varied based on a given condition,
however the amount of total DNA is constant. Considering that at low temperature where
DNA denaturation is minimized, we may assume the total concentration of
oligonucleotide (Ctotal) as double helix based on the UV measurement.

Therefore

Ctotal = (Css/2) + Cds

Equation 2.13

And

Cds = Ctotal – (Css/2)

Equation 2.14
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By replacing Cds in Equation 2.12 with Ctotal – (Css/2) (Equation 2.14) Css can be solved
from Equation 2.15 (derived below).

A270 = (εss270*Css) + (εds270*(Ctotal – (Css/2)))
A270 = (εss270*Css) + (εds270*Ctotal) – ((εds270/2)*Css)
A270 = ((εss270– (εds270/2))*Css) + (εds270*Ctotal)
A270 – (εds270*Ctotal) = (εss270– (εds270/2))*Css
Css = A270 – (εds270*Ctotal)
εss270 – (εds270/2)

Equation 2.15

Equation 2.9 can then be simplified to solve CB by replacing CZ with Cds-CB
(because Cds = CZ + CB). As a result, CB can be calculated from Equation 2.16 which is
derived as follows.

CD295 = (Δєss295*Css) + (ΔєB295*CB) + (ΔєZ295*(Cds - CB))
CD295 = (Δєss295*Css) + (ΔєB295*CB) + (ΔєZ295*Cds) – (ΔєZ295*CB)
CD295 = (Δєss295*Css) + (ΔєZ295*Cds) + (ΔєB295*CB) – (ΔєZ295*CB)
CD295 = (Δєss295*Css) + (ΔєZ295*Cds) + ((ΔєB295 - ΔєZ295)*CB)
CB = CD295 – (Δєss295*Css) – (ΔєZ295*Cds)
ΔєB295 - ΔєZ295

Equation 2.16

After CB is solved, CZ can then be estimated, and fB, fZ, ,and fss can be obtained
accordingly.
The molar fractions of the C8-arylguanine modified oligonucleotides in all three
conformations have being calculated based on the described method. Measurements were
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made on DNA samples with a wide range of salt concentrations and temperatures. The
resulting data from the CD experiments were used to generate a series of conformational
diagrams which are useful to evaluate and compare the Z-DNA stabilization and B-DNA
destabilization effects among various C8-arylguanine adducts. Then, comparing under
the same set of conditions, the molar fractions of Z form of the different synthetic
modified oligonucleotides can be used to compare the Z-DNA stabilizing effect (or may
be B-DNA destabilizing effect) of the DNA adducts, given that more stable Z-DNA
would have higher fZ which indicates a greater stabilization effect from the C8arylguanine adduct. CD spectroscopy has proven to be a useful technique to study the
conformation and stability of the modified oligonucleotides.

2.5 Nuclear Magnetic Resonance Spectrometry of CG Decamers Containing C8Aryl Modified Guanine
Nuclear magnetic resonance (NMR) is one the most important tools available for
obtaining structural information of molecules. NMR has been used in this study to
characterize synthetic nucleosides and also to determine the conformation of unmodified
and modified oligonucleotides. Although CD can provide information about the overall
conformation of an oligonucleotide, it cannot provide information regarding the local
conformation. To confirm the results from CD experiments and to obtain a better
understanding of the B-Z interconversion, several NMR experiments have been
conducted. The principles of the NMR experiment will be discussed briefly in this section
along with the NMR methods that have been used to study the B-Z equilibrium of the
modified oligonucleotides.
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2.5.1. Basic Theory of NMR86-88
All nuclei contain electrons that have the property of spin which may generate a
magnetic dipole along the nuclear axis. Fundamentally, NMR spectra of the nuclei that
have a non-zero spin number (I) , can be measured , especially nuclei that have I = ½
(e.g. 1H and 13C) due to their uniform spherical charge distribution. Based on quantum
mechanics, the spin number determines the number of possible orientations (2I +1) of
nuclei when an external magnetic field is applied. In the case of a nucleus with I=½, there
are two energy levels possible as shown in Figure 2.4.

Figure 2.4 Two energy levels of the nuclei with I = 1/2 in a magnetic field strength of B0

According to the Boltzmann distribution, the population of the lower energy state nuclei
(Nα) is slightly greater than the higher energy state population (Nβ). The energy gap (ΔE)
between the two states is determined by a magnetic field strength (B0) as shown in
Equation 2.17,

ΔE = (hγ/2π)B0
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Equation 2.17

where h is Plank’s constant and γ is a gyromagnetic ratio which is constant for each
atomic type of nuclei. In a static magnetic field, the populations of two energy states are
established and the application of RF can be used to cause a transition between the two
states. Given ΔE = hv, the relationship between the applied radio frequency (v) and B0
can be established as described in the Equation 2.18.

v = (γ/2π)B0

Equation 2.18

By applying a matching RF at a particular magnetic field strength, nuclei in the lower
energy state will absorb energy and rise to a higher energy level. The excited nuclei then
relax back to the original state by radiating the absorbed energy which can be detected
ultimately and recorded as the NMR spectrum.
The potential of NMR for structure determination was not recognized until the
chemical shift effect was discovered in 195387. The chemical shift effect arising from the
electron cloud associated with nuclei plays a very important role in the observed NMR
behaviour of other nearby nuclei. The electron spin of each nucleus generates its own
local magnetic field that alters the applied magnetic field (B0). Due to the shielding effect
of the nuclei’s electron cloud that alters the local B0, the effective frequency (veff) is
decreased as shown in Equation 2.19. A shielding constant (σ) is proportional to the
degree of shielding by a nuclei electron cloud. The higher veff means less shielding effect
from the electron cloud and the lower veff indicates more electron shielding effect.

veff = (γ/2π)B0(1-σ)
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Equation 2.19

Because the chemical environment can affect the electron density of nuclei, identical
nuclei that are in different environments will have distinctive shielding constants that can
be recorded by NMR instrumentation and used to differentiate them. As a result, a series
of absorption peaks, which represent nuclei in different environments, are observed in the
NMR spectrum. The chemical shifts that are assigned in NMR spectrum indicate the
absorption position of the nuclei in dissimilar environments compared to the reference
nuclei. For instance, a hydroxyl proton will have a different chemical shift as compared
to the protons from tetramethylsilane (TMS). The unit of chemical shift is in Hz which
can be converted to the ppm unit, typically used for reporting the NMR spectrum. It is
derived by dividing the observed frequency of nuclei by the operating frequency (MHz
range) of the NMR spectrometer. Usually, a simple one dimension (1D) NMR spectrum
shows a plot of the chemical shifts in ppm against the intensity of the absorption peaks of
different nuclei. Furthermore, the peak area represents the relative number of each type of
nuclei in a molecule.
In addition to chemical shift, spin coupling is an important phenomenon that
provides additional information regarding chemical structure. The coupling constant (J)
and multiplicity of the absorption peaks results from spin-spin coupling that can be used
to assist chemical shift assignment in order to characterize a molecular structure of
chemical, especially in 1H NMR. An absorption peak of a certain proton can be affected
by its magnetically active neighboring nuclei that typically are separated by two to three
bonds. In a magnetic field, the energy states of nuclei are established based on their spin
number. An NMR active nucleus can interact with nearby nuclei resulting in a
multiplicity of absorption peaks for the nucleus under consideration. For example, as
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shown in Figure 2.5, a triplet peak is observed for a proton that has two equivalent
neighboring protons since the neighboring nuclei have three energy states that produce
three different microfields. The coupling constant, which can be measured from the
multiplet, is the separation between the two coupled NMR peaks and can be used to
determine the relationship between protons (e.g., dihedral angle).

Figure 2.5 Triplet generated by neighbor CH2 microfields

A simple first order multiplicity can be used to predict the pattern of proton absorption
peaks based on the formula n + 1, where n is the number of adjacent protons with the
same coupling constant. A more general formula, 2nI +1, can be used to cover all nuclei
(i.e., spin > ½). However, if the coupling is non-first order (non-first order coupling is
observed when then Δν/J < 10) more complicated coupling patterns may be observed.
Overall, by gathering all of the pieces of information available from the NMR spectrum
of a compound, including the chemical shifts, coupling constants, and multiplicities of
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the absorption peaks, one may use the observed 1H NMR spectrum (and perhaps
additional spectra obtained on on nuclei other than protons) to assign both structure and
conformation.
Because many organic compounds are comprised mainly of a carbon skeleton, 13C
NMR spectrometry has also been used to characterize the organic chemicals. The basic
concept of 13C NMR is the same as 1H NMR. In practice, however, since the spin
couplings between 13C nuclei are very weak due to the low natural abundance of 13C
(1.11%), and therefore the likelihood of having two adjacent 13C atoms, necessary to
observe coupling, is low (12C (~98.89%) is NMR silent). Furthermore, 13C are typically
obtained with proton decoupling and 13C NMR spectra appear as a series of 13C
absorption singlets.
Generally, simple 1D spectra of 1H and 13C NMR may be sufficient to identify a
simple organic molecule. However, in the case of a more complicated molecule,
additional NMR experiments may be necessary. Two dimensional (2D) NMR provides
enhanced capability to elucidate the structure of organic compounds. The correlation
NMR experiments including COSY (correlation spectroscopy) and HETCOR
(heteronuclear correlation spectroscopy) have been used extensively in this study to
characterize the synthesized nucleosides. In addition to COSY, NOESY (nuclear
Overhauser effect correlation spectroscopy) has been used to study and assign the
structure of the modified CG decamers and the B-Z DNA equilibrium.
A proton-proton coupling correlation, 1H-1H COSY, is based on spin couplings
among protons and therefore reveals connectivity. The diagonal of the correlated
spectrum corresponds to the normal 1H NMR spectrum (typically displayed along both
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the vertical and horizontal axes). The off-diagonal elements of a COSY spectrum indicate
the couplings between protons. Since the magnitude of coupling constants falls off
rapidly, the appearance of COSY correlations typically indicates the protons are adjacent.
Similar to 1H-1H COSY, the 1H -13C COSY or HETCOR shows the correlation between
13

C and 1H spectra. The cross peaks indicate the couplings between carbons and protons

(and therefore attached protons) that may help identify unknown carbons or protons that
can not be assigned from normal 1D NMR or assigned only with difficulty. With COSY
and HETCOR, most protons and carbons of the nucleosides can be assigned.
Unlike COSY, 2D 1H-1H NOESY experiment utilizes the nuclear Overhauser
enhancement (nOe) to obtain spectra that are correlated based on a through space
interaction. To explain nOe, we consider two nuclei that are close in space and involved
in the relaxation process of each other. If a saturating RF were applied to equalize the
population of the two energy levels (Nα = Nβ) of one nuclei, the energy state dynamics of
another nuclei will be affected resulting in the enhancement of integrated signal of the
nuclei89. The complete mathematical explanation of nOe has been described by Solomon,
I, 195590. The nOe effect can be observed in 1D 13C NMR. As proton decoupling is
typically used, the absorption peak intensity of 13C can be increased significantly (up to
200 %)88. This is a major reason 13C spectra are acquired in the proton-decoupled mode.
Another implication of nOe, the one that is useful for our conformational study, is that
because of the nOe effect, NMR experiments can be designed and used to establish the
spatial relationship between nuclei (e.g., protons) based on the change in absorption
intensity. The nOe cross peaks in 2D NOESY spectra indicate the spatial separation
between protons (nearer than approximately 4-5 Å give rise to nOe enhanced peaks) and
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is due to spin polarization rather than spin coupling. Therefore, NOESY protons are near
in space, but may also be separated by many intervening bonds. The intensity of the cross
peak is dependent on the distance (r) between the interacting protons. In fact, the intensity
enhancement is proportional to the inverse sixth power of the distance between the two
nuclei (1/r-6)89. By using a combination of NMR experiments (1D, COSY, HETCOR,
NOESY, etc) the solution structure and conformation of macromolecules, such as nucleic
acids, can be determined.

2.5.2. NMR Studies on B-Z Transition of DNA
In 1979, Patel, D.J. et al.91 observed the conformational interconversion between
two forms for poly(dG-dC) by using NMR. The 1D 1H NMR was used to assign the
cluster of chemical shifts of H1′, H3′, H5′, H8 of dG, and H5, H6 of dC. The data showed
that the chemical shift of H1′ of dG increased at high salt concentration, suggesting that
the glycosidic torsion angle of the purine bases have changed dramatically. The
observation made by NMR was correlated to the conformational transition that had been
previously detected by CD. Considering that the chemical shift of H1′ of dG is sensitive
to glycosidic torsion angle, the NMR data were consistent with a conformation change of
B-DNA to “alternating B-DNA”, later has been identified as Z-DNA. Although the
conformational change could be surmised from the simple 1D 1H NMR of the
oligonucleotides, the structural details could not be determined from the 1D spectrum
which made full determination of the DNA conformational interconversion difficult to
investigate. Due to the fact that nucleic acids are composed of nucleotide monomers, they
contain many protons which have relatively similar chemical environments and hence
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similar chemical shifts. Therefore, 1D proton NMR of DNA contains a series of
absorption peaks that are not well resolved from one another and it is nearly impossible
to assign or distinguish each proton based solely on chemical shift. The 2D correlation
experiments, including COSY and NOESY, provided the possibility to assign all protons
of nucleic acids and resulted in a more complete picture of structure and conformation.
Hence, the 2D NMR experiments can be used to study the tertiary structure of nucleic
acids, B and Z-DNA in particular.
For example, the sequential resonance assignment92 based on NOESY and COSY
experiment has been applied to the non-exchangeable proton assignment of the right
handed helix of d(TGAGCGG) : d(CCGCTCA). The J-correlated spectroscopy based
COSY, was used first to assign the thymine H6 and 5-methyl, cytosine H6 and H5,
deoxyribose H1′, H2′, and H2′′ resonances (see Figure 2.6 for structure of bases and
nuclei number assignment). The off diagonal cross peaks in 2D nOe spectra link two
types of protons that are near in space (less than 4 A°) and have been used to help
identify the remaining adenine H8, guanine H8, H3′, H4′, H5′ and H5′′ protons.

Figure 2.6 Structures of purine and pyrimidine deoxyribose nucleosides.
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The nucleotides at 5′ or 3′-ends can serve as a starting point for the assignment due to
distinctive chemical shift of the terminal bases compared to the same type of base in the
middle of DNA strand (due to fraying of the ends). Then, the nearest neighbor
nucleotides93 can be targeted and assigned accordingly. Basically, one can start with a
terminal base assignment and then use nOe and/or J-correlated cross peaks to assign the
protons, sequentially, of the remaining bases until the entire sequence has been assigned.
The structural differences between Z-DNA and B-DNA stem from their distinct
sugar backbone conformation. In B-DNA, all deoxyriboses are in anti conformation
while Z-DNA has an alternating syn-anti backbone. These differences give rise to unique
NMR spectra, mainly,due to the effect of conformation on the chemical shifts of the H1’
protons and also the conformational requirements94-96. In the case of poly d(CG), the
most notable observation is that the Z conformation displays strong nOe cross peak
correlations between the guanine H8 and H1′95. This is due to the syn conformation of the
purine nucleotides that brings the H8 of guanine into close proximity of H1′ of the
intranucleoside deoxyribose residue (Figure 2.7). On the other hand, B-DNAs show only
weak or no nOe cross peaks between the guanine H8 and its own H1′. This effect extends
to C8 modified purines. For example, C8 methyl guanine containing DNA20,21,97 displays
strong nOe between methyl protons of the C8-methyl group and H1′.

52

Figure 2.7 Shown are the syn and anti conformations of dG and how the H8 and H1′
are in close proximity in the syn conformation but not in the anti conformation.

By using a combination of NMR experiments as described above, the chemical
shifts of protons of the unmodified CG and CG8Ph have been assigned for both the B and
Z conformation22. The structural information obtained from NMR is in complete
agreement with the CD data and has confirmed that the C8-phenyl adduct facilitate the BZ transition of CG decamers. The same NMR techniques have also been used in this
research to study the B-Z transition of the rest of the aryl modified CG decamers.
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CHAPTER 3
EXPERIMENTAL PROCEDURES AND RESULTS PART I: SYNTHESIS OF CG
DECAMERS CONTAINING C8-ARYL MODIFIED GUANINE

Our approach to the study of the effects of the C8-arylguanine adducts on B/ZDNA equilibrium, was to prepare aryl modified CG decamers. Z-DNA formation
generally requires an alternating purine-pyrimidine sequence. Thus, the modification
could be incorporated into either an alternating TG or CG sequence. As it is well known,
CG sequences are more prone to adopt the Z conformation98, we used this sequence here.
The aryl adducts selected for incorporation into this sequence were p-substituted (-H, CH3, -COO-, -CH2OCH3, and -CH2OH) and were selected because of the availability of
carcinogenic profiles of the arylhydrazines that lead to their formation. Each adduct was
introduced in the middle of the CG decamer sequence at C8 position of G6 base and since
the CG sequences are palindromes, duplexes contain two modified guanines.
In our previous work22, the C8 phenyl or C8-tolyl adducts, which are needed for
phosphoramidite synthesis and hence oligonucleotide synthesis, were prepared via a
Suzuki cross coupling between 8-BrdG and the corresponding aryl boronic acid. The C8aryl modified dG phosphoramidites were then prepared by the successive protection of
the N2 amine, the 5′-OH, and the 3′-OH groups. Finally, the unmodified CG, modified
oligonucleotides CG8Ph, and CG8Tol were prepared by automated DNA synthesis,
although the aryl modified bases were coupled by manual addition.
In the present case, the same basic methods were applied to prepare the modified
oligonucleotides CG8CPh, CG8MMPh, CG8HMPh as well as the synthesis of the corresponding
modified phosphoramidites (Scheme 3.1) with one notable exception. The p-
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hydroxymethyl substituent was found to interfere with DNA synthesis. Therefore, the phydroxymethyl was protected with TBS protecting group prior to Suzuki coupling to
avoid potential side reactions during oligonucleotide synthesis. The TBS group was used
to protect the hydroxymethyl group because it is stable toward all conditions used to
prepare the phosphoramidite as well as conditions used for automated DNA synthesis and
is removed under the same conditions used to remove all other protecting groups (i.e.,
concentrated ammonium hydroxide). Interestingly, although the p-carboxylate can be
considered to be nucleophilic, the substituent did not interfere with DNA synthesis, hence
no protection of the carboxyl group was necessary.

Scheme 3.1 Synthesis procedures of C8-arylguanine phosphoramidites a) Suzuki
coupling, b) N2 protection, c) 5′-OH protection, and d) 3′-OH phosphoramidation
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3.1 Synthesis of C8-Arylguanine Nucleosides and Phosphoramidites
3.1.1 General
All chemicals used were purchased from Aldrich (Milwaukee, WI) unless
otherwise noted. Both 4-carboxyphenylboronic acid (4-CPBA) and 4methoxymethylphenylboronic acid (4-MMPBA) were purchased from Frontier Scientific
(Logan, Utah).
With exception for the Suzuki coupling reaction, all other reactions require
anhydrous conditions. Therefore, organic solvents were dried and distilled prior to use as
follows. Methanol was dried over molecular sieves (3Å). Methylene chloride was dried
by distillation from phosphorus pentoxide. TEA, THF, and pyridine were dried and then
distilled from LAH. Benzene and toluene were dried by distillation from calcium hydride.
DMF was dried by distillation from barium oxide.
To identify and characterize the chemical structure of the synthesized nucleosides
(Structures are shown in Appendix B), NMR spectra were obtained on either Varian 300
or 600 spectrometers (Palo Alto, CA). 1H NMR and COSY were obtained for proton
assignment, while 13C NMR, HETCOR, and long range HETCOR were obtained to
assign carbon nuclei. ESI-MS of the nucleosides, measured in positive ion mode, were
recorded on a Finnigan LCQdeca (Waltham, MA). UV spectra were obtained on a
Beckman DU640 spectrophotometer (Somerset, NJ). NMR, UV, and ESI-MS spectra of
the modified nucleosides can be found in Appendix C.
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3.1.2 Synthesis

8-Bromo-2′-deoxyguanosine, C10H12O4N5Br (1): dG (2.86 g, 10.0 mmol) was
suspended in the mixture of acetonitrile (100 ml) and water (25 ml) and Nbromosuccinimide (freshly recrystallized, NBS, 2.67 g, 15.0 mmol) was then added to the
suspension and the formation of light orange precipitate was then observed. The reaction
mixture was allowed to stir for 30 min at room temperature. The precipitate was isolated
by filtration and then suspended in acetone (50 ml). The suspension was stirred for an
additional 2 h at room temperature, cooled at -20°C overnight, the precipitate collected
by filtration, and then dried in vacuo to yield 8-BrdG (2.81 g, 8.1 mmole, 81.2% yield).

1

H NMR (600 MHz, dmso-d6): δ ppm 10.78 (1H, s, NH), 6.47 (2H, s, NH2), 6.16 (1H, t,

J = 7.5 Hz, H-1′), 5.23 (1H, d, J = 4.2 Hz, 3′-OH), 4.83 (1H, t, J = 5.7 Hz, 5′-OH), 4.39
(1H, m, H-3′), 3.80 (1H, m, H-4′), 3.62 and 3.50 (2H, m, H-5′/5″), 3.16 (1H, m, H-2″)
and 2.10 (1H, m, H-2′). 13C NMR (150 MHz, dmso-d6): δ ppm 155.42, 153.31, 151.97,
120.50, 117.49, 87.89, 85.06, 71.02, 62.04, and 36.47.

4-(TBS-O-methyl)-phenyl bromide, C13H21OSiBr (2): 4-Bromobenzyl alcohol (756
mg, 4.0 mmol), TBSCl (1.30 mg, 8.0 mmol), and imidazole (605 mg, 8.8 mmol) were
dissolved in DMF (10 mL). The reaction mixture was allowed to stir at room temperature
for 24 hr under argon. The reaction mixture was then concentrated to dryness using
rotavap (vacuum pump). The crude product was extracted with hexane (30 mL), washed
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with water (3 x 30 mL), and the organic layer dried over sodium sulfate to yield 2 (1.08
g, 3.58 mmol, 89.6%) was then collected by filtration and brought to dryness in vacuo.

1

H NMR (600 MHz, dmso-d6): δ ppm 7.46 (2H, d, J = 8.4 Hz, aryl), 7.20 (2H, d, J = 9.0

Hz, aryl), 4.69 (2H, s, CH2), 0.95 (9H, s, t-butyl), and 0.11 (6H, s, dimethylsilyl). 13C
NMR (150 MHz, dmso-d6): δ ppm 140.70, 131.49, 127.94, 120.80, 64.55, 26.14, 18.60,
and -5.02.

4-(TBS-O-methyl)-phenyl boronic acid, C13H23O3BSi (3): The synthesis protocol has
been adapted based on the previous report by Zheng et al.70 Compound (2) (1 g, 3.3
mmol) was dissolved in THF (10 mL), toluene (2 mL), and triisopropyl borate (1.1 mL,
4.7 mmol). The mixture was sparged with nitrogen gas at -78°C (acetone/dry ice bath) for
30 min and then n-butyl lithium (1.5 M in hexane, 4mL) was gradually added to the
solution over 2 hr The reaction mixture was quenched with 2M HCl (3.5 mL) in an ice
bath and stirred for 30 min. Ethyl acetate (5.5 mL) was then added to the reaction flask
and mixed for an additional 30 min. The organic layer was collected, washed with the
mixture of 5% sodium bicarbonate solution (5 mL) and sodium chloride (450 mg), and
concentrated to dryness in vacuo. The crude product was suspended in ACN and the
precipitate was collected by filtration to yield the aryl boronic acid (3) (300 mg, 1.13
mmol, 33.7 %).

1

H NMR (600 MHz, dmso-d6): δ ppm 8.22 (2H, d, J = 8.4 Hz, aryl), 7.48 (2H, d, J = 7.8

Hz, aryl), 4.86 (2H, s, CH2), 0.99 (9H, s, t-butyl), and 0.15 (6H, s, dimethylsilyl). 13C
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NMR (150 MHz, dmso-d6): δ ppm 146.52, 135.90, 133.67, 125.66, 65.19, 26.18, 18.66,
and -4.98.

8-(4-Carboxyphenyl)-2′-deoxyguanosine, C17H17O6N5 (4): 4-CPBA (183 mg, 1.10
mmol), 8-BrdG (346 mg, 1.00 mmol), TPPTS (80 mg, 0.14 mmol), and Na2CO3 (292 mg,
2.75 mmol) were placed in round bottom flask and purged with argon for 10 min.
Pd(II)acetate (22 mg, 0.10 mmol) was then added to the flask and again purged with
argon for an additional 5 min. A mixture of acetonitrile and water (1:2, 10 mL) (sparged
with argon) was then added to the reaction flask and the reaction mixture then heated at
80ºC, under argon, and allowed to react until RP-TLC (C18, 1:1 water:methanol, UV
detection) indicated complete consumption of 8-BrdG. The reaction mixture was then
diluted with water (5 mL) and the pH was adjusted to 6 by the dropwise addition of 10 %
HCl. The precipitate was collected and dried in vacuo to yield the coupled product (320
mg, 0.83 mmol, 82.6% yield).

1

H NMR (600 MHz, dmso-d6): δ ppm 10.82 (1H, s, NH), 8.07 (2H, d, J = 7.8 Hz, aryl),

7.80 (2H, d, J = 8.4 Hz, aryl), 6.48 (2H, s, NH2), 6.10 (1H, t, J = 7.2 Hz, H-1′), 5.14 (1H,
brs, 3′-OH), 4.96 (1H, brs, 5′-OH), 4.34 (1H, m, H-3′), 3.80 (1H, m, H-4′), 3.66 and 3.55
(2H, m, H-5′/5″), 3.11 (1H, m, H-2″) and 2.05 (1H, ddd, J = 3.0, 6.6, 13.2 Hz, H-2′).13C
NMR (150 MHz, dmso-d6): δ ppm 166.88, 156.64, 153.20, 152.29, 146.11, 134.33,
131.36, 129.48, 129.24, 117.42, 87.85, 84.45, 71.00, 61.93, and 36.66. UV: ε227 = 13,745
cm-1M-1 and ε285 = 18,054 cm-1M-1. MS: m/z for MW 387.35, calculated MH+ 388.35,
found 388, 410 (M+Na)+, 426 (M+K)+, 775 (2M+H)+,and 797 (2M+Na)+.
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8-(4-Methoxymethylphenyl)-2′-deoxyguanosine, C18H21O5N5 (5): 4-MMPBA (183
mg, 1.10 mmol), 8-BrdG (346 mg, 1.00 mmol), TPPTS (80 mg, 0.14 mmol), and Na2CO3
(292 mg, 2.75 mmol) were placed in round bottom flask and purged with argon for 10
min. Pd(II)acetate (22 mg, 0.10 mmol) was then added to the flask and again purged with
argon for an additional 5 min. A mixture of acetonitrile and water (1:2, 10 mL) (sparged
with argon) was then added to the reaction flask and the reaction mixture then heated at
80ºC, under argon, and allowed to react until RP-TLC (C18, 1:1 water:methanol, UV
detection) indicated complete consumption of 8-BrdG. The reaction mixture was then
diluted with water (5 mL) and the pH was adjusted to 6 by the dropwise addition of 10 %
HCl. The precipitate was collected and dried in vacuo to yield the coupled product (260
mg, 0.67 mmol, 67.1% yield).

1

H NMR (600 MHz, dmso-d6): δ ppm 10.76 (1H, s, NH), 7.63 (2H, d, J = 8.4 Hz, aryl),

7.47 (2H, d, J = 7.8 Hz, aryl), 6.39 (2H, s, NH2), 6.07 (1H, dt, J = 1.8, 7.5 Hz, H-1′), 5.12
(1H, d, J = 4.2 Hz, 3′-OH), 4.97 (1H, t, J = 5.7 Hz, 5′-OH), 4.49 (2H, s, CH2), 4.33 (1H,
m, H-3′), 3.79 (1H, m, H-4′), 3.65 and 3.54 (2H, m, H-5′/5″), 3.34 (3H, s, OCH3 ), 3.15
(1H, m, H-2″) and 2.02 (1H, m, H-2′). 13C NMR (150 MHz, dmso-d6): δ ppm 156.63,
152.97, 151.95, 146.92, 139.69, 129.37, 129.05, 127.48, 117.13, 87.84, 84.58, 73.14,
71.15, 62.07, 57.71, and 36.55. UV: ε221 = 9,377 cm-1M-1 and ε282 = 15,552 cm-1M-1. MS:
m/z for MW 387.40, calculated MH+ 388.40, found 411 (M+Na)+ and 798 (2M+Na)+.

8-(4-(TBS-O-methyl)phenyl)-2′-deoxyguanosine, C23H33O5N5Si (6): Compound (3)
(293 mg, 1.10 mmol), 8-BrdG (346 mg, 1.00 mmol), TPPTS (80 mg, 0.14 mmol), and
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Na2CO3 (292 mg, 2.75 mmol) were placed in round bottom flask and purged, with argon,
for 10 min. Pd(II)acetate (22 mg, 0.10 mmol) was then added to the flask and again
purged with argon for an additional 5 min. A mixture of acetonitrile and water (1:1, 10
mL) (sparged with argon) was then added to the reaction flask and the reaction mixture
then heated at 80ºC, under argon, and allowed to react until RP-TLC (C18, 1:1
water:methanol, UV detection) indicated complete consumption of 8-BrdG. The reaction
mixture was then diluted with water (5 mL). Unlike the previous coupling reaction, the
pH of reaction mixture was not adjusted. The precipitate was collected, washed with
water and ethyl acetate respectively, and then dried in vacuo to yield the coupled product
(350 mg, 0.72 mmol, 71.8% yield).

1

H NMR (600 MHz, dmso-d6): δ ppm 10.78 (1H, s, NH), 7.62 (2H, d, J = 8.4 Hz, aryl),

7.46 (2H, d, J = 8.4 Hz, aryl), 6.39 (2H, s, NH2), 6.06 (1H, t, J = 7.5 Hz, H-1′), 5.12 (1H,
d, J = 3.6 Hz, 3′-OH), 4.96 (1H, m, 5′-OH), 4.80 (2H, s, CH2), 4.34 (1H, m, H-3′), 3.79
(1H, m, H-4′), 3.65 and 3.55 (2H, m, H-5′/5″), 3.16 (1H, m, H-2″), 2.02 (1H, m, H-2′),
0.93 (9H, s, t-butyl), and 0.11 (6H, s, dimethylsilyl). 13C NMR (150 MHz, dmso-d6): δ
ppm 156.71, 153.00, 151.91, 147.00, 142.54, 129.00, 128.86, 125.99, 117.13, 87.87,
84.65, 71.20, 63.90, 62.12, 36.56, 25.83, 18.01, and -5.33. UV: ε281 = 15,285 cm-1M-1.
MS: m/z for MW 487.63, calculated MH+ 488.63, found 488, 510 (M+Na)+, 526 (M+K)+,
975 (2M+H)+, and 997 (2M+Na)+.

N2-(N,N-Dimethylformamidine)-8-(4-carboxyphenyl)-2′-deoxyguanosine,
C20H22O6N6 (7): Compound (4) (387 mg, 1.00 mmol) was dissolved in methanol (10
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mL). N,N-dimethylformamide dimethyl acetal (0.67 mL, 5.00 mmol) was then added and
the reaction mixture was allowed to stand for 24 h, under argon, at room temperature.
The reaction mixture was then concentrated to dryness in vacuo to yield product (7) (423
mg, 0.95 mmole, 95.7 % yield).

1

H NMR (600 MHz, dmso-d6): δ ppm 8.53 (1H, s, HC=N), 8.02 (2H, d, J = 8.4 Hz, aryl),

7.64 (2H, d, J = 8.4 Hz, aryl), 6.14 (1H, t, J = 7.2 Hz, H-1′), 4.45 (1H, m, H-3′), 3.82 (1H,
m, H-4′), 3.68 and 3.58 (2H, m, H-5′/5″), 3.18 (1H, m, H-2″), 3.16 and 3.05 (3H each, s,
N(CH3)2), and 2.10 (1H, ddd, J = 3.0, 6.6, 13.2 Hz, H-2′).13C NMR (150 MHz, dmso-d6):
δ ppm 169.17, 158.12, 156.82, 150.75, 147.98, 138.74, 131.22, 129.13, 128.46, 120.21,
87.67, 84.71, 70.95, 61.94, 40.79, 37.08, 34.58, and 34.13. UV: ε231 = 17,153 cm-1M-1
and ε318 = 20,164 cm-1M-1. MS: m/z for MW 442.43, calculated MH+ 443.43, found 443,
465 (M+Na)+, 488 (M+2Na)+, 885 (2M+H)+, and 907 (2M+Na)+.

N2-(N,N-Dimethylformamidine)-8-(4-methoxymethylphenyl)-2′-deoxyguanosine,
C21H26O5N6 (8): Compound (5) (387 mg, 1.00 mmol) was dissolved in methanol (10
mL). N,N-dimethylformamide dimethyl acetal (0.67 mL, 5.00 mmol) was then added and
the reaction mixture was allowed to stand for 24 h, under argon, at room temperature.
The reaction mixture was concentrated down close to dryness using a Rotavap follow by
the addition of water (2 ml). After filtration, the precipitate was dried in vacuo to yield
product (8) (388 mg, 0.88 mmole, 87.6 % yield).

62

1

H NMR (600 MHz, dmso-d6): δ ppm 11.45 (1H, s, NH), 8.51 (1H, s, HC=N), 7.64 (2H,

d, J = 8.4 Hz, aryl), 7.49 (2H, d, J = 7.8 Hz, aryl), 6.12 (1H, t, J = 7.2 Hz, H-1′), 5.21
(1H, d, J = 4.2 Hz, 3′-OH), 4.88 (1H, dt, J = 1.8, 6.0 Hz, 5′-OH), 4.50 (2H, s, CH2), 4.44
(1H, m, H-3′), 3.82 (1H, m, H-4′), 3.68 and 3.57 (2H, m, H-5′/5″), 3.34 (3H, s, OCH3 ),
3.22 (1H, m, H-2″), 3.16 and 3.05 (3H each, s, N(CH3)2), and 2.08 (1H, m, H-2′).13C
NMR (150 MHz, dmso-d6): δ ppm 158.10, 157.48, 156.81, 150.67, 147.92, 139.86,
129.19, 129.08, 127.56, 120.17, 87.70, 84.81, 73.13, 71.03, 61.99, 57.72, 40.78, 37.03,
and 34.57. UV: ε229 = 14,602 cm-1M-1 and ε314 = 20,834 cm-1M-1. MS: m/z for MW
442.47, calculated MH+ 443.47, found 443, 466 (M+Na)+, and 908 (2M+Na)+.

N2-(N,N-Dimethylformamidine)-8-(4-(TBS-O-methyl)phenyl)-2′-deoxyguanosine,
C26H38O5N6Si (9): Compound (6) (488 mg, 1.00 mmol) was dissolved in methanol (10
mL). N,N-dimethylformamide dimethyl acetal (0.67 mL, 5.00 mmol) was then added and
the reaction mixture was allowed to stand for 24 h, under argon, at room temperature.
The reaction mixture was concentrated to near dryness using Rotavap follow by the
addition of water (2 ml). After filtration, the precipitate was dried in vacuo to yield
product (9) (419 mg, 0.77 mmole, 77.3 % yield).

1

H NMR (600 MHz, dmso-d6): δ ppm 11.42 (1H, s, NH), 8.51 (1H, s, HC=N), 7.63 (2H,

d, J = 7.8 Hz, aryl), 7.48 (2H, d, J = 7.8 Hz, aryl), 6.11 (1H, t, J = 7.2 Hz, H-1′), 5.20
(1H, d, J = 2.4 Hz, 3′-OH), 4.88 (1H, m, 5′-OH), 4.81 (2H, s, CH2), 4.44 (1H, m, H-3′),
3.82 (1H, m, H-4′), 3.67 and 3.57 (2H, m, H-5′/5″), 3.22 (1H, m, H-2″), 3.16 and 3.05
(3H each, s, N(CH3)2), 2.08 (1H, m, H-2′), 0.93 (9H, s, t-butyl), and 0.12 (6H, s,
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dimethylsilyl). 13C NMR (150 MHz, dmso-d6): δ ppm 158.07, 157.46, 156.77, 150.62,
148.01, 142.70, 129.02, 128.67, 126.03, 120.15, 87.70, 84.83, 71.04, 63.88, 62.01, 40.76,
37.03, 34.56, 25.82, 18.00, and -5.35. UV: ε229 = 21,603 cm-1M-1 and ε313 = 28,129 cm1

M-1. MS: m/z for MW 542.71, calculated MH+ 543.71, found 543, 565 (M+Na)+, 1085

(2M)+, and 1107 (2M+Na)+.

5′-O-(DMTr)-N2-(N,N-dimethylformamidine)-8-(4-carboxyphenyl)-2′deoxyguanosine, C41H40O8N6 (10): Compound (7) (442 mg, 1.00 mmol) and DMTr-Cl
(1 g, 2.80 mmol) were dissolved in pyridine (10 mL) and then TEA (430 µL, 3.08 mmol)
was added. The reaction mixture was stirred at room temperature, under argon, for 1 h.
The reaction was quenched by the addition of methanol (10 mL) and solvents then
removed in vacuo. The crude product was resuspended in methylene chloride (100 mL)
and stored at -20°C for 24 hr. The precipitate was collected and dried again in vacuo to
yield the DMTr protected product (10) (230 mg, 0.31 mmole, 30.9 % yield).

1

H NMR (600 MHz, dmso-d6): δ ppm 8.32 (1H, s, HC=N), 8.05 (2H, d, J = 7.8, aryl),

7.83 (2H, d, J = 8.4, aryl), 7.32-6.73 (13H, m, DMTr-H), 6.20 (1H, dd, J = 4.8, 7.8, H-1′),
4.57 (1H, m, H-3′), 3.93 (1H, m, H-4′), 3.71 and 3.70 (3H each, s, OCH3), 3.30 and 3.15
(2H, m, H-5′/5″), 3.21 (1H, m, H-2″), 3.03 and 2.98 (3H each, s, N(CH3)2), and 2.20 (1H,
m, H-2′). 13C NMR (150 MHz, dmso-d6): δ ppm 157.93, 157.86, 157.59, 157.50, 156.44,
150.54, 147.53, 144.92, 135.67, 135.58, 129.59, 129.41, 129.31, 128.95, 127.62, 127.56,
126.48, 120.28, 112.93, 112.90, 85.71, 85.18, 84.05, 70.82, 63.99, 54.93, 54.89, 40.74,
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37.44, 34.60, and 34.18. UV: ε233 = 43,258 cm-1M-1 and ε322 = 27,453 cm-1M-1. MS: m/z
for MW 744.80, calculated MH+ 745.80, found 745, 767 (M+Na)+, and 1511 (2M+Na)+.

5′-O-(DMTr)-N2-(N,N-dimethylformamidine)-8-(4-methoxymethylphenyl)-2′deoxyguanosine C42H44O7N6 (11): Compound (8) (442 mg, 1.00 mmol) and DMTr-Cl
(535 mg, 1.50 mmol) were dissolved in pyridine (10 mL) and then TEA (229 µL, 1.65
mmol) was added. The reaction mixture was stirred at room temperature, under argon,
and was monitored by normal phase TLC (aluminum oxide, 6 % methanol in methylene
chloride) until the complete consumption of (8) was observed. In addition, an ethanolic
solution of phosphomolybdic acid (10%) was used on the developed TLC plate to
visualize the production of (11). Upon completion of the reaction or after 4 hr, the
reaction was quenched by the addition of methanol (10 mL) and solvents removed in
vacuo. The crude product was then purified by low pressure column chromatography
(aluminum oxide, 0-10% methanol in methylene chloride) to yield the DMTr protected
product (11) (406 mg, 0.55 mmole, 54.5 % yield).

1

H NMR (600 MHz, dmso-d6): δ ppm 11.42 (1H, s, NH), 8.31 (1H, s, HC=N), 7.74 (2H,

d, J = 8.4, aryl), 7.46 (2H, d, J = 8.4, aryl), 7.33-6.73 (13H, m, DMTr-H), 6.17 (1H, dt, J
= 3.0, 6.6, H-1′), 5.28 (1H, d, J = 4.8 Hz, 3′-OH), 4.57 (1H, m, H-3′), 4.50 (2H, s, CH2),
3.92 (1H, m, H-4′), 3.71 and 3.70 (3H each, s, OCH3), 3.35 (3H, s, CH3), 3.30 and 3.15
(2H, m, H-5′/5″), 3.20 (1H, m, H-2″), 3.03 and 2.98 (3H each, s, N(CH3)2), and 2.18 (1H,
m, H-2′). 13C NMR (150 MHz, dmso-d6): δ ppm 157.94, 157.87, 157.52, 156.31, 150.41,
148.05, 144.94, 139.75, 135.70, 135.59, 129.61, 129.42, 129.12, 127.62, 127.57, 127.50,
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126.48, 120.07, 112.94, 112.91, 85.72, 85.18, 84.02, 73.14, 70.87, 64.04, 57.68, 54.94,
54.90, 40.72, 37.37, and 34.59. UV: ε231 = 35,034 cm-1M-1 and ε319 = 23,448 cm-1M-1.
MS: m/z for MW 744.85, calculated MH+ 745.85, found 746, 768 (M+Na)+, 784 (M+K)+,
and 1512 (2M+Na)+.

5′-O-(DMTr)-N2-(N,N-dimethylformamidine)-8-(4-(TBS-O-methyl)phenyl)-2′deoxyguanosine, C47H56O7N6Si (12): Compound (9) (442 mg, 1.00 mmol) and DMTrCl (535 mg, 1.50 mmol) were dissolved in pyridine (10 mL) and then TEA (229 µL, 1.65
mmol) was added. The reaction mixture was stirred at room temperature, under argon,
and was monitored by normal phase TLC (aluminum oxide, 6 % methanol in methylene
chloride) until the complete consumption of (9) was observed. An ethanolic solution of
phosphomolybdic acid (10%) was used on the developed TLC plate to visualize the
production of (12). Upon completion of the reaction or after 4 hr, the reaction was
quenched by the addition of methanol (10 mL) and solvents then removed in vacuo. The
crude product was then purified by low pressure column chromatography (aluminum
oxide, 0-10% methanol in methylene chloride) to yield the DMTr protected product (12)
(350 mg, 0.41 mmole, 41.4 % yield).

1

H NMR (600 MHz, dmso-d6): δ ppm 11.41 (1H, s, NH), 8.31 (1H, s, HC=N), 7.74 (2H,

d, J = 8.4, aryl), 7.46 (2H, d, J = 7.8, aryl), 7.33-6.73 (13H, m, DMTr-H), 6.17 (1H, m,
H-1′), 5.28 (1H, d, J = 4.8 Hz, 3′-OH), 4.81 (2H, s, CH2), 4.57 (1H, m, H-3′), 3.93 (1H,
m, H-4′), 3.71 and 3.70 (3H each, s, OCH3), 3.32 and 3.15 (2H, m, H-5′/5″), 3.21 (1H, m,
H-2″), 3.03 and 2.98 (3H each, s, N(CH3)2), 2.18 (1H, m, H-2′), 0.94 (9H, s, t-butyl), and
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0.12 (6H, s, dimethylsilyl). 13C NMR (150 MHz, dmso-d6): δ ppm 157.93, 157.86,
157.51, 156.27, 150.38, 148.16, 144.94, 142.61, 135.68, 135.59, 129.61, 129.41, 129.07,
128.93, 127.62, 127.56, 126.47, 125.97, 120.04, 113.09, 112.93, 112.89, 85.70, 85.17,
84.00, 70.86, 64.03, 63.89, 54.92, 54.89, 40.72, 37.37, 34.58, 25.81, 17.99, and -5.36.
UV: ε231 = 39,719 cm-1M-1 and ε316 = 22,703 cm-1M-1. MS: m/z for MW 845.08,
calculated MH+ 846.08, found 845, 867 (M+Na)+, and 1712 (2M+Na)+.

3′-O-[(2-Cyanoethoxy)(diisopropylamino)phosphino]-5′-O-(DMTr)-N2-(N,N
dimethylformamidine)-8-(4-carboxyphenyl)-2′-deoxyguanosine, C50H57O9N8P (13):
Compound (10) (0.25 mmol) was dissolved in methylene chloride (2.5 mL) and then
TEA (115 µL, 0.83 mmol) was added followed by 2-cyanoethyl
diisopropylchlorophosphoamidite (100 µL, 0.43 mmol). After stirring the reaction
mixture for 30 min at room temperature, another portion of 2-cyanoethyl
diisopropylchlorophosphoamidite (75 µL, 0.32 mmol) was added to the reaction mixture
and then stirred for an additional 30 min. The crude reaction was dried in vacuo. The
reaction mixture was resuspended in a mixture of benzene and THF (4:1, 3 mL), filtered
and the filtrate was concentrated to dryness in vacuo to yield the crude phosphoramidite
(13) that is ready to use for DNA synthesis.

3′-O-[(2-Cyanoethoxy)(diisopropylamino)phosphino]-5′-O-(DMTr)-N2-(N,N
dimethylformamidine)-8-(4-methoxymethylaryl)-2′-deoxyguanosine, C51H61O8N8P
(14): Compound (11) (0.25 mmol) was dissolved in methylene chloride (2.5 mL) and
then TEA (115 µL, 0.83 mmol) was added followed by 2-cyanoethyl
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diisopropylchlorophosphoamidite (100 µL, 0.43 mmol). After stirring the reaction
mixture for 30 min at room temperature, another portion of 2-cyanoethyl
diisopropylchlorophosphoamidite (75 µL, 0.32 mmol) was added to the reaction mixture
and then stirred for an additional 30 min. The crude reaction was dried in vacuo. The
reaction mixture was resuspended in a mixture of benzene and THF (4:1, 3 mL), filtered
and the filtrate was concentrated to dryness in vacuo to yield the crude phosphoramidite
(14) for DNA synthesis.

3′-O-[(2-Cyanoethoxy)(diisopropylamino)phosphino]-5′-O-(DMTr)-N2-(N,N
dimethylformamidine)-8-(4-(TBS-O-methyl)aryl)-2′-deoxyguanosine,
C56H73O8N8SiP (15): Compound (12) (0.25 mmol) was dissolved in methylene chloride
(2.5 mL) and then TEA (115 µL, 0.83 mmol) was added followed by 2-cyanoethyl
diisopropylchlorophosphoamidite (100 µL, 0.43 mmol). After stirring the reaction
mixture for 30 min at room temperature, another portion of 2-cyanoethyl
diisopropylchlorophosphoamidite (75 µL, 0.32 mmol) was added to the reaction mixture
and then stirred an for additional 30 min. The crude reaction was dried in vacuo. The
reaction mixture was resuspended in a mixture of benzene and THF (4:1, 3 mL), filtered
and the filtrate was concentrated to dryness in vacuo to yield the crude phosphoramidite
(15) that is ready to use for DNA synthesis.
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3.2 Synthesis of CG Decamers Containing C8-Aryl Modified Guanine
3.2.1 General
The oligonucleotides CG8CPh, CG8MMPh, and CG8HMPh were made on ABI 394
DNA synthesizer (Newark, CA). The reagents used for automated DNA synthesis,
including phosphoramidites (dG CE-PA and dC CE-PA), phosphoramidite diluent
(anhydrous ACN), activator (0.45M tetrazole in ACN), cap mix A (THF/pyridine/acetic
anhydride), cap mix B (16% 1-methylimidazole in THF), oxidizing solution (0.02M I2 in
THF/pyridine/water), deblocking mix (3% TCA in methelene chloride), and dG-CPG
synthesis column (1 μmol, 500Å pore size), were purchased from Glen Research
(Sterling, VA). In addition, the anhydrous acetonitrile used with the DNA synthesizer
was purchased from VWR (West Chester, PA).
To purify the synthesized oligonucleotides, the following FPLC system has been
used. Anion exchange columns (DEAE-5PW) were purchased from Tosoh Bioscience
(Montgomeryville, PA). Waters U6K loop injector, HPLC pump model 510 or 501, and
Waters 486 tunable absorbance detector (Milford, MA) were used for the
chromatography. Sep Pak C18 cartridges for solid phase extraction used to desalt the
DNA sample were bought from VWR (West Chester, PA). The amount of DNA in
synthesized samples were quantified by UV measurement at 260 nm on a Beckman
DU640 spectrophotometer (Somerset, NJ) and assumed that a 1 mL solution with an
absorbance of 1 OD at 260 nm contained 24 μg of oligonucleotide duplex. ESI-MS
spectra of the purified oligonucleotides, obtained in negative ion mode, were recorded on
a Finnigan LCQdeca (Waltham, MA).
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3.2.2 Synthesis
The modified oligonucleotides were made on an automated DNA synthesizer
through solid phase synthesis on 1 µmol scale column. Fresh reagents were used to
maximize the efficiency of the reactions. The base extensions started from the 3′ end
through the 5′ end of 5′-CGCGCG*CGC-3′ sequences while the dG phosphoramidite
from the dG-CPG synthesis column served as a first 3′-base. Generally, the synthesis
utilized the standard protocol (1.0 µM CE cycle) for automated DNA synthesis which
includes detritylation, coupling, capping and oxidation. The efficiency of each base
extension can be monitored from the trityl group (as the alcohol) that is cleaved just
before the addition of the next base. In order to make the aryl modified oligonucleotides,
the G6 coupling was performed manually with the C8-aryl modified guanine
phosphoramidites (compounds (13), (14), or (15) to yield CG8CPh, CG8MMPh, or CG8HMPh
respectively). Manual addition of the modified bases was required because these
phosphoramidites form gels in acetonitrile within minutes of initial dissolution. After
detritylation of C7 (the 3rd base from 3′end) the automated synthesis was stopped and the
synthesis column, sealed at both ends to minimize air and moisture exposure, was
removed from the DNA synthesizer. The C8-aryl modified dG phosphoramidite (25-30
mg or approximately 25 µmol) was dissolved immediately prior to use in anhydrous
ACN (100 µL) and transferred to the synthesis column through a 1 mL syringe. The
activator solution (100 µL) was then added to the synthesis column through another 1 mL
syringe. Both phosphoramidite solution and activator solution were mixed through the
synthesis column and the reaction mixture was allowed to stay in the column for 15 min.
After that, the reaction mixture was removed from the column and a fresh solution of the
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coupling reaction mixture was then added and allowed to stay in the column for an
additional 15 min to maximize the efficiency of modified base extension. After removing
the reaction mixture, the synthesis column was reattached to the DNA synthesizer. The
automated synthesis cycle was then resumed after programming to skip the G6 coupling
and pass to the capping step. The DNA synthesis was continued normally after the
manual coupling of C8-aryl G6 until the CG decamer sequence has been completely
extended.
Following the completion of DNA synthesis, the oligonucleotides were cleaved
off the synthesis column. Ammonium hydroxide (30%, 0.3 mL) was transferred by using
a syringe and allowed to stay on the column for 20 min. Two additional fresh fractions of
ammonium hydroxide were added to the synthesis column in the same fashion as the first
one to ensure complete removal of the oligonucleotides from the column. The
synthesized oligonucleotides, in ammonium hydroxide, were then collected from the
column, transferred to a centrifuge tube, and deprotected by heating at 55°C overnight.
After cooling to room temperature, the solution was brought to dryness in SpeedVac to
yield the crude C8-arylguanine modified CG decamer.

3.2.3 FPLC Purification
Generally, the crude oligonucleotide sample contains unwanted products,
including incomplete extended sequences and residual protecting groups. Therefore,
purification by FPLC is necessary to get a pure oligonucleotide for further experiments.
The crude oligonucleotides (0.3-0.4 µmol) were dissolved in deionized (DI) water (250
µL) and were purified by FPLC using a gradient of 70-30% buffer A (10 mM NaOH) and
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buffer B (30-70% 10 mM NaOH and 1 M NaCl) at a flow rate 6 mL/min on a Biorad
TSK gel DEAE-5PW preparative column (21.5 mm ID x 15 cm). The separation of the
oligonucleotides was monitored by UV detector at 260 nm and the mobile phase fractions
from the major peaks on the chromatogram were collected due to the likelihood that the
desirable DNA sequence is often the major product which gives the highest absorbance.
The fractions collected from FPLC have high salt concentration. Thus, a C18 Sep
Pak was used to desalt the oligonucleotide sample. A solid phase extraction started by
using a syringe to purge methanol (3 x 2ml) and water (3 x 2 ml) through the C18
cartridge respectively. The product fraction from FPLC was then slowly infused through
the cartridge. At this point, the oligonucleotide would adsorb to the C18 matrices while
the salt will pass through with solvent. Water (4 x 2mL) was later used to wash the
remaining salts out of the cartridge. The oligonucleotide was collected from the cartridge
after eluting with aqueous methanol (60% methanol, 4 x 1.5 mL). The solvent was
removed in a SpeedVac to yield a pure oligonucleotide sample.
To confirm that the purity of oligonucleotide after chromatography and desalting,
the sample has been analyzed using FPLC. The oligonucleotides sample (approximately
10 µM in DI water) was run with FPLC using a gradient of 70-30% buffer A (10 mM
NaOH) and buffer B (30-70% 10 mM NaOH and 1 M NaCl) at a flow rate 1 mL/min on a
Biorad TSK gel DEAE-5PW analytical column (5.0 mm ID x 5 cm). To eliminate the
false result that a single peak is composed of more than one product, which may occur
due to the binding of single-stranded oligonucleotides, the sample was heated at 90°C for
30 min to denature all DNA into single strand. The chromatogram obtained at 260 nm,
that displayed a single peak, indicates that the sample contained only one oligonucleotide
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which was successfully purified. The observed retention time of CG8CPh, CG8MMPh, and
CG8HMPh is 21.9, 17.7, and 25.3 min respectively as shown in the chromatograms in
Figure 3.1, 3.2, and 3.3.

Figure 3.1 FPLC chromatogram of CG8CPh

Figure 3.2 FPLC chromatogram of CG8MMPh

Figure 3.3 FPLC chromatogram of CG8HMPh
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3.2.4 ESI-MS Analysis
The purified CG decamers were examined by ESI-MS in negative ion mode to
confirm that we have obtained the desired modified oligonucleotides based on their MW.
The oligonucleotide sample (10 µM in DI water) was analyzed on a Finnigan LCQ deca
using direct injection through a syringe pump. Due to the nature of oligonucleotides that
have negatively charged phosphate backbones at physiological pH, the m/z of
oligonucleotides are best detected when operating in the negative ion mode. The series of
m/z peaks, based on charge state (e.g., M6-, M5-, M4-, and M3-) of the oligonucleotides
with different number of sodium adducts are, generally observed. The observed m/z of
CG8CPh, CG8MMPh, and CG8HMPh were in agreement with the calculated m/z of the DNA as
shown in Table 3.1. The result from ESI-MS indicates that the synthesized DNA have
been successfully made and ready for structural and conformational analysis. The mass
spectra of CG8CPh, CG8MMPh, and CG8HMPh can be found in Appendix C.

Table 3.1 ESI-MS analysis for the synthesized oligonucleotides
DNA

MW (g/mol)

Calculated m/z

Found m/z

CG8CPh

3150

CG8MMPh

3150

524.0, 629.0, 786.5, 1049.0

524.0, 629.2, 786.8, 1049.1

CG8HMPh

3136

521.7, 626.2, 783.0, 1044.3

626.5, 783.4, 1044.5

524.0a, 629.0b, 786.5c, 1049.0d 524.7, 629.8, 786.9, 1049.3

a

Charge state M6Charge state M5c
Charge state M4d
Charge state M3b

The C8-carboxyphenyl, methoxymethylphenyl, and TBS protected
hydroxymethylphenyl dG phosphoramidites have been made and characterized by NMR,
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ESI-MS, and UV analysis. The Suzuki cross coupling was proven to be a convenient and
efficient method to make C8-arylguanine adducts. The general protocol for making
phosphoramidites that was developed for preparing the C8-phenyl and C8-tolyl modified
dG seems to be generally applicable for other derivatives with minor alterations due to
the small distinctions in physicochemical properties of the modified dG when different
para-substituents were presented. For instance, the coupling between 8-BrdG and a
relatively hydrophobic TBS protected 4-HMPBA required more content of ACN in
Suzuki coupling solvent system compares to the syntheses of other aryl modified dG in
this study. Use lower ACN content results in a precipitation of (3) and a very low
production of the coupling product.
The N2 protection has been shown to be a straight forward step and gives
excellent yields (70-90%) for all derivatives without the need for further purification, The
5′-OH protection step has usually resulted in lower yields and requires a purification step.
Normal phase column chromatography (Al2O3, gradient 0-7% methanol in
dichloromethane) were used to separate 5′-OH protection products with the exception of
the C8-carboxyphenyl derivative, compound (10), which was found to be difficult to
separate with the chromatographic conditions successfully used with compounds (11) and
(12). Crystallization in dichloromethane seems to be a more practical alternative to purify
compound (10), although the product yield was low.
The phosphoramidites were made successfully and the modified DNA, CG8CPh,
CG8MMPh, and CG8HMPh, have been synthesized. As with phosphoramidites of the C8phenyl and tolyl, the phosphoramidites prepared here form gels shortly after dissolving in
ACN. This property necessitates manual addition of the modified base. We do not know

75

the exact nature of the gels formed though G-quartet formation is a reasonable
possibilitity. After FPLC purification, ESI-MS was used to identify the oligonucleotides
based on their MW. The result from ESI-MS indicates the success of CG8CPh, CG8MMPh,
and CG8HMPh syntheses.
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CHAPTER 4
EXPERIMENTAL PROCEDURES AND RESULTS PART II: CD AND NMR
ANALYSES OF CG DECAMERS CONTAINING C8-ARYL MODIFIED
GUANINE

In previous work we demonstrated that the incorporation of a C8-phenylguanine
adduct in a CG sequence stabilizes the Z DNA form and/or destabilizes the B-DNA
form22. Additional C8-arylguanine adducts had also been examined by molecular
modeling and free energy calculations99. The results of the computational methods were
in agreement with the experimental results that were available (e.g., unmodified and C8phenyl adduct). However, the computational results and predictions for some aryl
hydrazine related C8-adducts were not consistent with the proposed theory that Z DNA is
involved in aryl hydrazine carcinogenesis (e.g., C8-hydroxymethylphenyl adduct).
Therefore, to determine whether the results from prior computational studies, were
correct, the CG decamers, CG8Tol, CG8CPh, CG8MMPh and CG8HMPh, were prepared and
analyzed by CD and NMR
Circular dichroism is a useful tool for the study of B and Z DNA as the spectra
can be used to demonstrate the presence of these forms of DNA both qualitatively and
quantitatively. Here, we have used CD data to determine the molar fractions of B-DNA,
Z-DNA, and ssDNA of C8-arylguanine modified oligonucleotides as a function of
temperature and salt concentration. These data permit the comparison of the effects of the
selected aryl adducts on Z-DNA stabilization/B-DNA destabilization in a quantitative
fashion and provides insight in the nature and extent of the Z-DNA stabilization/B-DNA
destabilization aryl adducts produce. Ultimately, the goal is to determine, how the aryl
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adducts facilitate B-Z conversion, how they stabilize the Z DNA form and/or how they
destabilize the B form. In addition, the carcinogenic profiles and B-Z-DNA transition
effects of the selected aryl hydrazines can be correlated and evaluated, hence the potential
role of the Z form in carcinogenesis can be assessed.
All CG sequences used in this study have been examined with CD and NMR
analysis. The conformation of CG decamers can be assumed from CD spectra, while the
B-Z conversion can be observed by the change in pattern of the spectra. The proton NMR
experiments provide useful pieces of information regarding DNA conformation that have
proven to be useful to identify DNA conformation and support CD data.

4.1 CD Analysis and Molar Fraction Calculation of CG Decamers Containing C8Aryl Modified Guanine
4.1.1 General
The oligonucleotide samples (50 µM of CG, CG8Ph, CG8Tol, CG8CPh, CG8MMPh or
CG8HMPh in 10 mM phosphate buffer, pH 7.4, 300 µL) with various sodium chloride
concentrations (0, 25, 50, 100, 200, 500, 1000, 2000, and 4000 mM) were prepared in a
centrifuge tube. Prior to acquiring CD spectra, oligonucleotide samples were annealed by
heating at 90°C for 30 min, slowly cooling down to room temperature, and then further
cooled to 4°C for and additional 15 min. A sample was transferred to cuvette and CD
spectra were obtained using a Jasco J-810 spectropolarimeter (Easton, MD).
From the CD results, the molar fractions of B, Z and ssDNA, over the temperature
range 10-90°C and with NaCl concentrations from 0-4000 mM, were calculated as
described previously in Section 2.4.2
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4.1.2 CD Measurment
The CD spectra of each modified CG decamer sample was recorded from 220 to
350 nm at 10, 20, 30, 37, 50, 60, 70, 80, and 90°C using the instruments
temperature/wavelength scan mode with the temperature ramp rate of 1°C/min and a scan
rate of 50 nm/min. The data reported are the averages of two duplicate experiments.
The tertiary structure of DNA such as B and Z-DNA can be distinguished by CD.
The CD signal of B DNA shows positive ellipticity at approximately 280 nm and 220 nm
and a negative ellipticity at approximately 250 nm. In contrast, the CD spectrum Z-DNA
shows negative ellipticity at approximately 295 nm. The CD spectra of CG and aryl
modified CG, as a function of NaCl concentrations from 0-4000 mM at 37°C, are shown
in Figure 4.1-4.6. Generally, at low salt concentration, the alternating CG sequences
adopt a B-DNA conformation, while under high salt conditions a conformational
conversion for B to Z can be observed. The conversion of B to Z-DNA can be monitored
by the change in CD spectra. The negative ellipticipy observed at 295 nm increases in
intensity while, simultaneously, the negative ellipticity at 250 nm decreases in intensity
as the B-DNA converts to Z-DNA.
In agreement with previous studies of CG oligomers82, the unmodified CG
decamer predominantly adopts the B conformation at salt concentrations below 2 M, as
indicated by the positive ellipticity at 280 nm and negative ellipticity at approximately
250 nm (Figure 4.1). At 2 M NaCl, there is only a small amount of the Z form observed
and as the salt concentration is further increase to 4 M, the Z-DNA becomes predominant
(i.e., the positive ellipticity at 280 nm is replaced by negative ellipticity peak at 295 nm).
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Figure 4.1 CD spectra of CG with NaCl 0-4000 mM at 37°C
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Figure 4.2 CD spectra of CG8Ph with NaCl 0-4000 mM at 37°C
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Figure 4.3 CD spectra of CG8Tol with NaCl 0-4000 mM at 37°C
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Figure 4.4 CD spectra of CG8CPh with NaCl 0-4000 mM at 37°C
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Figure 4.5 CD spectra of CG8MMPh with NaCl 0-4000 mM at 37°C
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Figure 4.6 CD spectra of CG8HMPh with NaCl 0-4000 mM at 37°C
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The CD spectra of CG8Ph (Figure 4.2), CG8MMPh (Figure 4.5), and CG8HMPh (Figure 4.6),
show that the Z form is predominant (B-Z conversion greater than 50%) in samples that
have salt concentration of approximately 500 mM, considerably less than the 2 M salt
concentration required for the unmodified oligonucleotide. The modified CG decamers
are approximately 100% in the Z conformation at 1 M salt concentrations as indicated by
CD spectra. Based on the lower concentration of sodium chloride needed to stabilize the
Z comformation of CG8Ph, CG8MMPh, and CG8HMPh as compared to the unmodified CG,
indicates Z-DNA stabilization and/or B-DNA destabilization effects of C8-phenyl,
methoxymethylphenyl, hydroxymethylphenyl guanine adducts.
The effect of C8-tolyl guanine adduct on Z-DNA formation seem to be lower
since CG8Tol (Figure 4.3) requires 500 mM to 1 M salt to facilitate B-Z conversion and
requires approximately 2 M NaCl to make the Z-DNA form predominant. On the other
hand, the C8-carboxyphenyl guanine adduct seems to have the greatest effect on Z-DNA
formation, due to the fact that the B-Z conversion of CG8CPh (Figure 4.4) is observed at
very low salt concentration (25- 50 mM) and the oligonucleotide requires only 200 mM
salt to entirely adopt in Z conformation.
Generally, the C8-arylguanine modified CG decamers principally adopt the Z
form at salt concentrations below 1 M, much lower that what is needed for the
unmodified CG, indicating the Z-DNA stabilization and/or B-DNA destabilization effects
of the aryl adducts on CG decamer sequences. Among the aryl adducts, p-carboxyphenyl
has the greatest effect while tolyl has the lowest compare with phenyl, pmethoxymethylphenyl, and p-hydroxymethylphenyl which have comparable effects on ZDNA stabilization. To compare the effect of each aryl adduct on Z-DNA formation, the
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molar fraction of Z-DNA in each sample has been determined as described in the next
part.
4.1.3 Molar Fraction Calculation
CD spectra were analyzed assuming that there is equilibrium among three
conformation of DNA (B, Z, and ssDNA) in solution. Therefore, at each temperature

Δє295 = ΔєB295*fB + ΔєZ295*fZ + Δєss295*fss

Equation 3.1

1 = fB + fZ + fss

Equation 3.2

While f is the molar fraction of each DNA conformation, Δє of each conformation
was estimated from CD at 295 nm. At 270 nm, the isosbestic point of dsDNA forms and
where Δε of B and Z are equal, fss was determined from the Equations 3.3 and 3.4. The fB
and fZ then were solved from the calculated fss, Equation 3.1, and 3.2.

Δε270 = Δεds270*fds + Δεss270*fss

Equation 3.3

1 = fds + fss

Equation 3.4

Generally, for each oligonucleotide, Δεds270 was obtained and averaged from UV
absorbance at 270 nm from all samples at 10°C where DNA denaturation is minimized,
while Δεss270 was obtained the same way but at 90°C assuming that all DNA are in single
strand form. Molar ellipticities of B-DNA, Z-DNA and ssDNA are estimated from CD at
295 nm under conditions such that only one conformation of DNA is predominant. At
30°C, without or with low salt ΔєB295, was obtained, while at 10°C with high salt

87

concentration ΔєZ295 was calculated. The Δєss295 was estimated from CD295 of the DNA
samples at 90°C.
The fB, fZ, and fss of CG, CG8Ph, CG8Tol, CG8CPh, CG8MMPh and CG8HMPh were
approximated and are shown in Tables 4.1 through 4.6, respectively. From the calculated
data, the conformation diagrams, that represent the molar fractions of each DNA
conformation as a function of temperatures and sodium chloride concentration, have been
plotted and are shown in Figures 4.7- 4.12 for CG, CG8Ph, CG8Tol, CG8CPh, CG8MMPh and
CG8HMPh, respectively. The diagrams are consistent with the known behavior of DNA
where B-DNA predominates at low salt concentration or higher temperatures and Z-DNA
formation is favored at lower temperatures and higher salt concentrations. Raising the
temperature too high, of course, causes DNA denaturation and results in the formation of
ssDNA.
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Table 4.1 Molar fractions of B-DNA, Z-DNA, and ssDNA of CG with salt 0-4000 mM at
temperature 10-90°C
NaCl
(mM)
0
25
50
100
200
500
1000
2000
4000
NaCl
(mM)
0
25
50
100
200
500
1000
2000
4000
NaCl
(mM)
0
25
50
100
200
500
1000
2000
4000

10
0.99
0.98
0.98
0.99
0.98
0.97
0.96
0.72
0.00

10
0.01
0.02
0.02
0.01
0.02
0.03
0.04
0.28
1.00

10
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00

20
0.96
0.99
0.98
0.97
0.99
0.98
0.96
0.80
0.07

20
0.00
0.01
0.01
0.00
0.01
0.02
0.03
0.18
0.89

20
0.04
0.00
0.00
0.03
0.00
0.00
0.01
0.02
0.04

30
0.93
0.99
0.98
0.95
0.99
0.99
0.96
0.86
0.16

fB at Temperature (°C)
37
50
60
0.90
0.74
0.52
0.98
0.92
0.78
0.96
0.92
0.83
0.94
0.90
0.83
0.98
0.96
0.90
0.99
0.96
0.91
0.95
0.91
0.84
0.88
0.88
0.79
0.22
0.34
0.40

70
0.24
0.44
0.54
0.60
0.69
0.73
0.67
0.64
0.34

80
0.12
0.16
0.20
0.22
0.28
0.34
0.31
0.24
0.13

90
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00

30
0.00
0.00
0.00
0.00
0.00
0.01
0.02
0.12
0.77

fZ at Temperature (°C)
37
50
60
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.01
0.00
0.00
0.09
0.05
0.01
0.68
0.51
0.36

70
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.17

80
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.03

90
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00

30
0.07
0.01
0.02
0.05
0.01
0.00
0.03
0.02
0.07

fss at Temperature (°C)
37
50
60
0.10
0.26
0.48
0.02
0.08
0.22
0.04
0.08
0.17
0.06
0.10
0.17
0.02
0.04
0.10
0.01
0.04
0.09
0.04
0.09
0.16
0.03
0.08
0.20
0.10
0.15
0.24

70
0.76
0.56
0.46
0.40
0.31
0.27
0.33
0.36
0.49

80
0.88
0.84
0.80
0.78
0.72
0.66
0.69
0.76
0.84

90
1.00
1.00
1.00
1.00
1.00
1.00
1.00
1.00
1.00
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Figure 4.7 Plots of the molar fractions of B-DNA, Z-DNA, and ssDNA of CG over
the temperature range 10-90°C. The oligonucleotide samples were in 10 mM sodium
phosphate buffer, pH 7.4 and 0 mM (a), 25 mM (b), 50 mM (c), 100 mM (d), 200 mM
(e), 500 mM (f), 1000 mM (g), 2000 mM (h), and 4000 mM (i) NaCl.
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Table 4.2 Molar fractions of B-DNA, Z-DNA, and ssDNA of CG8Ph with salt 0-4000
mM at temperature 10-90°C
NaCl
(mM)
0
25
50
100
200
500
1000
2000
4000

10
0.98
0.77
0.85
0.65
0.32
0.01
0.00
0.00
0.04

20
0.96
0.85
0.90
0.68
0.36
0.06
0.01
0.04
0.11

NaCl
(mM)
0
25
50
100
200
500
1000
2000
4000

10
0.02
0.23
0.15
0.35
0.68
0.99
1.00
1.00
0.96

20
0.00
0.05
0.10
0.32
0.64
0.89
0.98
0.96
0.89

NaCl
(mM)
0
25
50
100
200
500
1000
2000
4000

10
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00

20
0.04
0.10
0.00
0.01
0.00
0.05
0.01
0.00
0.00

30
0.96
0.89
0.97
0.85
0.65
0.24
0.10
0.09
0.16

fB at Temperature (°C)
37
50
60
0.96
0.92
0.79
0.88
0.85
0.75
0.96
0.94
0.84
0.88
0.83
0.73
0.77
0.76
0.69
0.38
0.59
0.58
0.19
0.41
0.49
0.14
0.25
0.35
0.19
0.24
0.26

70
0.54
0.54
0.61
0.53
0.48
0.42
0.38
0.29
0.20

80
0.25
0.27
0.30
0.25
0.23
0.21
0.17
0.12
0.08

90
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00

30
0.00
0.00
0.01
0.05
0.24
0.63
0.85
0.90
0.83

fZ at Temperature (°C)
37
50
60
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.08
0.00
0.00
0.42
0.07
0.00
0.72
0.35
0.09
0.84
0.65
0.38
0.79
0.69
0.54

70
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.10
0.27

80
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.02
0.06

90
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00

30
0.04
0.11
0.02
0.11
0.10
0.13
0.04
0.01
0.02

fss at Temperature (°C)
37
50
60
0.04
0.08
0.21
0.12
0.15
0.25
0.04
0.06
0.16
0.12
0.17
0.27
0.15
0.24
0.31
0.20
0.33
0.42
0.08
0.24
0.42
0.02
0.11
0.27
0.02
0.07
0.20

70
0.46
0.46
0.39
0.47
0.52
0.58
0.62
0.61
0.53

80
0.75
0.73
0.69
0.75
0.77
0.79
0.82
0.86
0.86

90
1.00
1.00
1.00
1.00
1.00
1.00
1.00
1.00
1.00
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Figure 4.8 Plots of the molar fractions of B-DNA, Z-DNA, and ssDNA of CG8Ph over
the temperature range 10-90°C. The oligonucleotide samples were in 10 mM sodium
phosphate buffer, pH 7.4 and 0 mM (a), 25 mM (b), 50 mM (c), 100 mM (d), 200 mM
(e), 500 mM (f), 1000 mM (g), 2000 mM (h), and 4000 mM (i) NaCl.
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Table 4.3 Molar fractions of B-DNA, Z-DNA, and ssDNA of CG8Tol with salt 0-4000
mM at temperature 10-90°C
NaCl
(mM)
0
25
50
100
200
500
1000
2000
4000

10
0.98
0.94
0.71
0.37
0.16
0.04
0.00
0.00
0.00

20
0.95
0.97
0.84
0.67
0.46
0.18
0.03
0.02
0.04

NaCl
(mM)
0
25
50
100
200
500
1000
2000
4000

10
0.02
0.06
0.29
0.63
0.84
0.96
1.00
1.00
1.00

20
0.00
0.01
0.04
0.16
0.38
0.75
0.93
0.96
0.94

NaCl
(mM)
0
25
50
100
200
500
1000
2000
4000

10
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00

20
0.05
0.01
0.12
0.17
0.16
0.07
0.04
0.03
0.02

30
0.94
0.92
0.87
0.76
0.71
0.44
0.20
0.09
0.10

fB at Temperature (°C)
37
50
60
0.93
0.81
0.67
0.81
0.62
0.43
0.89
0.86
0.78
0.75
0.66
0.70
0.75
0.75
0.68
0.59
0.67
0.61
0.34
0.55
0.56
0.16
0.33
0.41
0.14
0.20
0.24

70
0.42
0.34
0.58
0.53
0.53
0.46
0.42
0.33
0.20

80
0.22
0.24
0.30
0.27
0.26
0.22
0.20
0.15
0.09

90
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00

30
0.00
0.00
0.00
0.00
0.04
0.36
0.70
0.86
0.87

fZ at Temperature (°C)
37
50
60
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.14
0.00
0.00
0.49
0.12
0.00
0.76
0.47
0.19
0.82
0.67
0.46

70
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.03
0.18

80
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.02
0.05

90
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00

30
0.06
0.08
0.13
0.24
0.26
0.20
0.10
0.05
0.02

fss at Temperature (°C)
37
50
60
0.07
0.19
0.33
0.19
0.38
0.57
0.11
0.14
0.22
0.25
0.34
0.30
0.25
0.25
0.32
0.27
0.33
0.39
0.17
0.33
0.44
0.08
0.20
0.41
0.04
0.13
0.30

70
0.58
0.66
0.42
0.47
0.47
0.54
0.58
0.64
0.62

80
0.78
0.76
0.70
0.73
0.74
0.78
0.80
0.83
0.86

90
1.00
1.00
1.00
1.00
1.00
1.00
1.00
1.00
1.00
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Figure 4.9 Plots of the molar fractions of B-DNA, Z-DNA, and ssDNA of CG8Tol over
the temperature range 10-90°C. The oligonucleotide samples were in 10 mM sodium
phosphate buffer, pH 7.4 and 0 mM (a), 25 mM (b), 50 mM (c), 100 mM (d), 200 mM
(e), 500 mM (f), 1000 mM (g), 2000 mM (h), and 4000 mM (i) NaCl.
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Table 4.4 Molar fractions of B-DNA, Z-DNA, and ssDNA of CG8CPh with salt 0-4000
mM at temperature 10-90°C
NaCl
(mM)
0
25
50
100
200
500
1000
2000
4000

10
0.32
0.24
0.11
0.00
0.01
0.00
0.00
0.06
0.09

20
0.45
0.31
0.16
0.05
0.04
0.02
0.02
0.07
0.12

NaCl
(mM)
0
25
50
100
200
500
1000
2000
4000

10
0.68
0.76
0.89
1.00
0.99
1.00
1.00
0.94
0.91

20
0.43
0.69
0.79
0.89
0.92
0.94
0.94
0.87
0.83

NaCl
(mM)
0
25
50
100
200
500
1000
2000
4000

10
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00

20
0.12
0.00
0.06
0.07
0.04
0.04
0.05
0.06
0.05

30
0.71
0.62
0.39
0.21
0.12
0.06
0.05
0.09
0.14

fB at Temperature (°C)
37
50
60
0.71
0.61
0.44
0.70
0.61
0.47
0.53
0.56
0.44
0.35
0.51
0.42
0.20
0.40
0.44
0.10
0.22
0.31
0.08
0.14
0.21
0.11
0.15
0.17
0.16
0.18
0.19

70
0.23
0.25
0.26
0.25
0.30
0.27
0.21
0.16
0.16

80
0.08
0.09
0.11
0.11
0.13
0.13
0.12
0.09
0.07

90
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00

30
0.00
0.22
0.39
0.61
0.77
0.85
0.86
0.81
0.76

fZ at Temperature (°C)
37
50
60
0.00
0.00
0.00
0.05
0.00
0.00
0.16
0.00
0.00
0.39
0.04
0.00
0.63
0.24
0.03
0.79
0.54
0.25
0.81
0.65
0.42
0.77
0.66
0.51
0.71
0.63
0.54

70
0.00
0.00
0.00
0.00
0.00
0.04
0.14
0.25
0.35

80
0.00
0.01
0.00
0.00
0.00
0.01
0.03
0.05
0.10

90
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00

30
0.29
0.16
0.22
0.18
0.11
0.09
0.09
0.11
0.10

fss at Temperature (°C)
37
50
60
0.29
0.39
0.56
0.25
0.39
0.53
0.31
0.44
0.56
0.27
0.46
0.58
0.17
0.35
0.53
0.12
0.24
0.45
0.11
0.20
0.37
0.12
0.19
0.32
0.12
0.19
0.27

70
0.77
0.75
0.74
0.75
0.70
0.69
0.65
0.59
0.49

80
0.92
0.90
0.89
0.89
0.86
0.85
0.85
0.86
0.82

90
1.00
1.00
1.00
1.00
1.00
1.00
1.00
1.00
1.00
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Figure 4.10 Plots of the molar fractions of B-DNA, Z-DNA, and ssDNA of CG8CPh
over the temperature range 10-90°C. The oligonucleotide samples were in 10 mM
sodium phosphate buffer, pH 7.4 and 0 mM (a), 25 mM (b), 50 mM (c), 100 mM (d),
200 mM (e), 500 mM (f), 1000 mM (g), 2000 mM (h), and 4000 mM (i) NaCl.
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Table 4.5 Molar fractions of B-DNA, Z-DNA, and ssDNA of CG8MMPh with salt 0-4000
mM at temperature 10-90°C
NaCl
(mM)
0
25
50
100
200
500
1000
2000
4000

10
0.96
0.96
0.78
0.31
0.24
0.04
0.00
0.00
0.01

20
0.93
0.93
0.86
0.55
0.37
0.10
0.01
0.03
0.07

NaCl
(mM)
0
25
50
100
200
500
1000
2000
4000

10
0.04
0.04
0.22
0.69
0.76
0.96
1.00
1.00
0.99

20
0.00
0.02
0.09
0.33
0.58
0.87
0.96
0.95
0.90

NaCl
(mM)
0
25
50
100
200
500
1000
2000
4000

10
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00

20
0.07
0.05
0.05
0.11
0.06
0.03
0.03
0.02
0.03

30
0.94
0.91
0.91
0.77
0.65
0.30
0.11
0.08
0.11

fB at Temperature (°C)
37
50
60
0.95
0.92
0.80
0.97
0.95
0.84
0.92
0.90
0.81
0.79
0.77
0.66
0.74
0.75
0.67
0.45
0.64
0.62
0.21
0.45
0.50
0.12
0.25
0.32
0.14
0.17
0.20

70
0.56
0.61
0.60
0.50
0.49
0.45
0.39
0.30
0.17

80
0.25
0.29
0.30
0.24
0.25
0.22
0.18
0.14
0.07

90
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00

30
0.00
0.00
0.00
0.02
0.17
0.58
0.81
0.88
0.83

fZ at Temperature (°C)
37
50
60
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.04
0.00
0.00
0.36
0.05
0.00
0.67
0.31
0.07
0.80
0.60
0.33
0.77
0.66
0.51

70
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.09
0.26

80
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.03
0.07

90
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00

30
0.06
0.09
0.09
0.21
0.18
0.12
0.08
0.04
0.05

fss at Temperature (°C)
37
50
60
0.05
0.08
0.20
0.03
0.05
0.16
0.08
0.10
0.19
0.21
0.23
0.34
0.22
0.25
0.33
0.18
0.31
0.38
0.12
0.24
0.43
0.07
0.16
0.36
0.09
0.17
0.29

70
0.44
0.39
0.40
0.50
0.51
0.55
0.61
0.61
0.57

80
0.75
0.71
0.70
0.76
0.75
0.78
0.82
0.84
0.86

90
1.00
1.00
1.00
1.00
1.00
1.00
1.00
1.00
1.00
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Figure 4.11 Plots of the molar fractions of B-DNA, Z-DNA, and ssDNA of CG8MMPh
over the temperature range 10-90°C. The oligonucleotide samples were in 10 mM
sodium phosphate buffer, pH 7.4 and 0 mM (a), 25 mM (b), 50 mM (c), 100 mM (d),
200 mM (e), 500 mM (f), 1000 mM (g), 2000 mM (h), and 4000 mM (i) NaCl.
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Table 4.6 Molar fractions of B-DNA, Z-DNA, and ssDNA of CG8HMPh with salt 0-4000
mM at temperature 10-90°C
NaCl
(mM)
0
25
50
100
200
500
1000
2000
4000

10
1.00
0.94
0.91
0.65
0.28
0.02
0.00
0.00
0.04

20
0.97
0.94
0.92
0.71
0.35
0.09
0.02
0.02
0.10

NaCl
(mM)
0
25
50
100
200
500
1000
2000
4000

10
0.00
0.06
0.09
0.35
0.72
0.98
1.00
1.00
0.96

20
0.00
0.03
0.05
0.25
0.55
0.90
0.97
0.95
0.90

NaCl
(mM)
0
25
50
100
200
500
1000
2000
4000

10
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00

20
0.03
0.03
0.03
0.04
0.10
0.01
0.00
0.03
0.00

30
0.96
0.94
0.91
0.82
0.59
0.30
0.13
0.05
0.15

fB at Temperature (°C)
37
50
60
0.94
0.85
0.74
0.93
0.85
0.70
0.91
0.83
0.71
0.86
0.72
0.58
0.61
0.56
0.49
0.41
0.49
0.41
0.23
0.47
0.48
0.11
0.21
0.31
0.18
0.23
0.24

70
0.51
0.48
0.47
0.37
0.36
0.38
0.36
0.28
0.21

80
0.23
0.20
0.23
0.12
0.15
0.21
0.18
0.12
0.08

90
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00

30
0.00
0.00
0.00
0.02
0.12
0.58
0.82
0.88
0.84

fZ at Temperature (°C)
37
50
60
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.02
0.00
0.00
0.34
0.03
0.00
0.67
0.27
0.06
0.80
0.60
0.33
0.80
0.68
0.52

70
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.09
0.24

80
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.02
0.06

90
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00

30
0.04
0.06
0.09
0.15
0.29
0.12
0.05
0.07
0.01

fss at Temperature (°C)
37
50
60
0.06
0.15
0.26
0.07
0.15
0.30
0.09
0.17
0.29
0.14
0.28
0.42
0.37
0.44
0.51
0.26
0.48
0.59
0.10
0.25
0.45
0.09
0.19
0.36
0.02
0.08
0.24

70
0.49
0.52
0.53
0.63
0.64
0.62
0.64
0.63
0.55

80
0.77
0.80
0.77
0.88
0.85
0.79
0.82
0.85
0.86

90
1.00
1.00
1.00
1.00
1.00
1.00
1.00
1.00
1.00
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Figure 4.12 Plots of the molar fractions of B-DNA, Z-DNA, and ssDNA of CG8HMPh
over the temperature range 10-90°C. The oligonucleotide samples were in 10 mM
sodium phosphate buffer, pH 7.4 and 0 mM (a), 25 mM (b), 50 mM (c), 100 mM (d),
200 mM (e), 500 mM (f), 1000 mM (g), 2000 mM (h), and 4000 mM (i) NaCl.
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The CD spectra of the unmodified and modified CG decamers indicate that the
aryl adducts formed from carcinogenic aryl hydrazines stabilize Z-DNA conformation
and/or destabilize B-DNA relative to the unmodified oligonucleotide.
To quantitatively compare the B-Z transition effect among aryl adducts, the molar
fraction of Z-DNA in various salt concentrations at different temperatures have been
calculated from the CD data and are plotted in Figure 4.13, fZ of CG, CG8Ph, CG8Tol,
CG8CPh, CG8MMPh and CG8HMPh as a function of salt concentration at 37°C. By
extrapolating from the plot, to obtain 50% Z-DNA, the unmodified CG needs 3400 mM
salt while CG8Ph, CG8Tol, CG8CPh, CG8MMPh and CG8HMPh require 606 mM, 1000 mM, 131
mM, 669 mM, and 694 mM sodium chloride respectively. Based on these data, the B-Z
transition effect of aryl adduct is ranked in the order of p-carboxyphenyl >> phenyl > pmethoxymethylphenyl > p-hydroxymethylphenyl >> p-tolyl >> unmodified
As can be seen, the mole fractions of B forms (Figure 4.14) roughly mirror the Z
forms. B-DNA is predominant at lower salt concentration, while the main conformation
in high salt sample is Z-DNA. Interestingly, at lower salt concentrations spikes of
ssDNA formation (Figure 4.15) are seen for the modified oligonucleotides. The intensity
of spikes is varied depending on the substituents on aryl adduct. This suggests that, in
addition to stabilizing Z-DNA at higher salt concentration, the aryl adduct destabilizes
the B form at salt concentrations less than that at which the spike occurs. This study
indicates the dual effect of aryl adduct on B and Z-DNA which drives B-Z conversion.
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Figure 4.13 Molar fractions of Z-DNA of the unmodified and aryl modified CG
decamers at 37°C as a function of NaCl concentration from 0 to 4000 mM

Figure 4.14 Molar fractions of B-DNA of the unmodified and aryl modified CG
decamers at 37°C as a function of NaCl concentration from 0 to 4000 mM
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Figure 4.15 Molar fractions of ssDNA of the unmodified and aryl modified CG
decamers at 37°C as a function of NaCl concentration from 0 to 4000 mM

4.2 NMR Analysis of CG Decamers Containing C8-Aryl Modified Guanine
CD is a powerful method for determining and monitoring the global
conformational of DNA but can not provide information regarding the finer details of
local conformation (e.g., of base-pairs). Information regarding local conformation can be
obtained from NMR studies. NMR has been extensively used to study and determine the
conformation(s) of nucleic acids and has relied upon two-dimensional correlation
spectroscopic techniques. Overall, the technique requires the assignment of nonexchangeable proton of the synthesized oligonucleotides which is possible with the
combined data from COSY and NOESY experiments as described by Scheek R.M. et al.
and Orbons L.P.M. et al. In prior studies, we successfully used the assignment procedure
to assign the non-exchangeable protons of CG in B form and CG8Ph in Z form22. Though
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there are potential difficulties - suitable spectra of the Z form of CG cannot not be
obtained due to line-broadening cause by the high salt concentration or due to spectral
complexity caused by the presence of multiple forms of DNA - the method has been
shown to be sufficient to characterize the B and Z conformations of nucleic acids and we
have applied it to determine the conformation of CG8CPh, CG8HMPh, and CG8MMPh.

4.2.1 General
Deuterated phosphate buffer for NMR was prepared by drying down a known
volume of phosphate buffer (10 mM, pH 7.4, 500 µL) in vacuo (SpeedVac) and then
adding back an equal volume of deuterium oxide (D2O, 99.996%, 500 µL). The resulting
solution was then evaporated and this process repeated three times. The solid deuterated
buffer salt was kept dry in cool place and was reconstituted in D2O just prior to use.
The oligonucleotide sample (0.8 mM of CG8CPh, CG8MMPh or CG8HMPh) was
prepared in deuterated phosphate buffer (10 mM, pD 7.4, 500 µL) with or without NaCl
(500 mM) and the sample solution was transferred into Shigemi NMR tube. High salt
concentration was used to ensure that the Z conformation of the CG decamer was
predominant in a sample. From CD data of CG8CPh, CG8MMPh or CG8HMPh with 500 mM
NaCl recorded at 30°C, the amount of Z conformation of each oligonucleotide was more
than 60% which would greatly simplify the proton assignment of Z-DNA. Without NaCl,
oligonucleotides are generally in B form.
All NMR spectra were measured on a Varian Unity 600 MHz spectrometer at
28°C. The 1H NMR spectra of the oligonucleotides were obtained with solvent (D2O)
suppression. Sample concentrations were approximately 0.8 mM (10 mM, pD 7.4, 500
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µL, Shigemi NMR tube was used to improve S/N) and required approximately 16
transients to obtain spectra with sufficiently high signal-to-noise. The 1H-1H COSY
spectra were collected with 512 t1 increments and 2048 t2 complex points, each the sum of
16 transients. The proton nOe correlation spectra (NOESY) of the non-exchangeable
protons were collected with a mixing time of 600 ms. The data were collected with 512 t1
increments and 2048 t2 complex points, each with the sum of 16 transients. Spectral
assignments were made as described in the following sections for the B and Z DNA
forms of CG8CPh, CG8MMPh or CG8HMPh.

4.2.2 B-DNA Non-exchangeable Proton Assignment
In order to assign the non-exchangeable protons of the modified CG decamer
duplexes in the B form, several types of NMR experiments are required including 1H
NMR, COSY, and NOESY. Basically, the 1-D proton spectrum gives a general idea of
whether ss or ds DNA is present and may also provide some information regarding the
DNA form (i.e., B or Z DNA). The non-exchangeable protons of DNA are typically
observed in the range of 0-9 ppm. The downfield region contains base protons including
H8 (δ 8.0-8.3 ppm) of guanines, H6 (δ 7.4-7.6 ppm), and H5 (δ 5.5-6.0 ppm) of cytosines
are usually seperate well for CG at low salt concentration. In the present case, the aryl
adduct protons (δ 6.3-7.3 ppm) are also included in this region. The sugar protons are
upfield of the base protons and, for a given type of sugar proton, generally exhibit poor
dispersion resulting in several clusters of unresolved peaks. Thus, to make specific
assignments requires 2-D NMR techniques.
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COSY data is used for the assignment of both base and sugar protons. In the case
of the base protons, only the cytosine H5/H6 protons can be assigned as no other base
bears protons that are adjacent to one another. Here, the COSY spectra also can be used
to assign the protons of the C8-aryl group (the protons that are ortho- and meta- to the
carbon attached to the modified guanine G6). In addition, the H-1′/H-2′/2′′ cross peaks
are fairly easy to assign by COSY, mainly because they often have a relatively broad
chemical shift range. However, the assignment of the base or sugar protons to specific
residues in an oligonucleotide can not be achieved using 1-D or COSY data alone and
requires inclusion of NOESY spectra.
The connection between base protons and sugar protons in the same nucleoside
residue can be determined from NOESY spectra due to close spatial proximities between
the proton nuclei. The nOe cross peaks of Aryl/H-1′, Aryl/H-2′/2′′, H8/H-1′, H8/H-2′/2′′,
H6/H5, H6/H-1′, and H6/H-2′/2′′ in the same nucleotide subunit are usually observed in
the spectra. To assign protons in and to successive bases, the connections between
adjacent bases are first located. As described in the proton assignment for d(CGC)2 in the
B form by Orbons L.P.M. et al.95, nOe cross peaks between H8 of G(n) and H6, H-1′, or
H2′/2′′ of C(n-1) were observed as well as nOes between H8, H-1′, or H2′/2′′ of G(n) and
H6 or H5 of C(n+1). Thus, by locating these nOe correlations they can be used as
connecting points and, in turn, for assignment of protons to specific bases.
Figure 4.16 shows a diagram that schematically shows the nOe correlations that
are generally used for protons assignment for oligonucleotides in the B-DNA
conformation and, in particular, for a B-DNA of CG decamer. The C1 residue can often
be used as the starting point because of its distinct H6 chemical shift that is the furthest
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downfield as compared to the remaining cytosines (due to base-pair fraying). Then, given
this assignment, the NOESY spectrum is used to identify H8 of G2 (C1-H-1′ and/or H2′/2′′ correlation with G2-H8) and, in turn, G2-H-2′/H2′′ (G2-H8 correlation with G2-H1′/2′/2′′). With G2-H-1′/2′/2′′ assigned, C3-H6, and in turn C3-H-1′/2′/2′′ can be assigned.
Continuing this process leads to assignment of all G-H8 and C-H6 protons and the H1′/2′/2′′ of the attached deoxyribose. The protons of modified G6 are also quite easy to
assign due to correlations with the unique aryl protons present in the DNA adduct.
Finally, the H-3′, H-4′, and H5′/5′′ assignments of each base are possible by following the
nOes and J-correlation cross peaks in NOESY and COSY spectra from the H-2′/2′′
protons.

Figure 4.16 Diagram shows proton assignment strategy for B-form of CG decamers
based on nOe correlations observed in NOESY spectra
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To demonstrate the assignment procedure, the assignment of the nonexchangeable protons of CG8HMPh will be described. The analysis begins with
examination of 1H NMR spectrum from δ5.4-8.3 ppm, shown in Figure 4.17. The four
furthest downfield singlets were assigned to the H8 protons of the four unique guanines
(δ8.33, 8.093, 8.089, and 8.05 ppm). Next, the cluster of neighboring upfield doublets
should be the proton resonances for the five unique cytosine H6 protons (δ7.75, 7.62,
7.52, 7.50, and 6.53 ppm). The doublets at 7.09 and 6.37 were assigned to the aryl
protons of G6 adduct based on their chemical shifts, and integration of about two protons
which distinguishes these doublets from H6 of cytosine.

Figure 4.17 1H NMR spectrum of B-CG8HMPh (downfield region). The resonances
corresponding to H8, H6, and aryl adduct protons are noted below the frequency axis.

The COSY spectra support our assignment on the chemical shifts of H8, H6, and
aryl protons. The 8.33, 8.093, 8.089, and 8.05 ppm peaks (Figure 4.18a) do not have any
cross peaks with any other protons, confirming that these peaks were G-H8 protons. The
peaks at 7.75, 7.62, 7.52, 7.50, and 6.53 ppm correlated to peaks at 6.03, 5.56, 5.50, 5.54,
and 5.58 ppm, respectively, and arise from the J correlations between H6 and H5 (Figure
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4.18b). As expected, the doublet at 7.09 ppm has a correltion with the peak at 6.37 ppm
(Figure 4.18c) verifying that they are adjacent protons on the aryl adduct. In addition, H1′/H-2′/2′′ correlations were observed as shown in Figure 4.18d. Between 5.6 and 6.5
ppm, ten H-1′ peaks (δ5.72, 5.89, 5.91, 5.97, 6.03, 6.13, 6.19, 6.26, 6.27, and 6.43 ppm)
were identified based on the criteria that these peaks had at least one correlation with
peak in the region below 3 ppm which usually is the region of H-2′/2′′. Most chemical
shifts of H-2′/2′′ were identified from H-1′/H-2′/2′′ cross peaks. Next step were to assign
H-1′/2′/2′′ to their corresponding H8, H6/H5, or aryl protons in sequential order.

Figure 4.18 COSY of B-CG8HMPh The boxed areas show a) H8, b) H6/H5, c) Ar/Ar,
and d) H-1′/H-2′/2′′ cross peaks.
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Due to the close spatial proximity (generally from 3-5 Å based on molecular
modeling) between H-1′ and H8, H6, or aryl protons in the same nucleotide residue, the
nOe cross peaks of H8/H-1′, H6/H-1′, and aryl/H-1′ can be observed in NOESY spectra.
Therefore, H-1′ chemical shifts can be matched up with H8 or H6 from the same bases in
NOESY as shown in Figure 4.19. The assignment of H-2′/2′′ from COSY can be
confirmed using NOESY in similar way to H-1′ since these protons usually are close
enough to have nOes with H8 or H6 in the same residue. As a result, the correlations of
H8, H6, or aryl Æ H-1′ Æ H-2′/2′′ were obtained including 6.53 Æ 5.97 Æ 2.20, 0.57
ppm, 7.09/6.37 Æ 5.72 Æ 3.68, 2.40 ppm, 7.50 Æ 5.89 Æ 2.43, 2.07 ppm, 7.52 Æ 6.43
Æ 2.25, 1.59 ppm, 7.62 Æ 6.27 Æ 2.69 ppm, 7.75 Æ 5.91 Æ 2.53, 2.11 ppm, 8.05 Æ
6.26 Æ 2.72, 2.46 ppm, 8.089 Æ 6.19 Æ 2.73 ppm, 8.093 Æ 6.13 Æ 2.95, 2.78 ppm, and
8.33 Æ 6.03 Æ 2.88, 2.75 ppm.

Figure 4.19 NOESY of B-CG8HMPh. The areas shows a) H8/H-1′, b) H6/H-1′, c) and
Ar/H-1′ correlations.
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To assign the chemical shifts in sequential order, we began with the peak at 7.75
ppm which was assigned to C1-H6 due to its most downfield position among H6. The
C1-H-2′/2′′ (2.53, 2.11 ppm) were then used to assign G2-H8 (8.093 ppm) based on the
observed nOe correlations. Likewise, G2-H-2′/2′′ (2.95, 2.78 ppm) were correlated with
C3-H6 (7.62 ppm). In addition, G2-H-1′ (6.13 ppm) was also correlated with C3-H6.
Although C3-H-2′/2′′ (2.69 ppm) was not correlated with any H8, C3 can be linked to G4
with a weak nOe from C3-H5 and G4-H8 (8.089 ppm) which allowed the further
assignments of C5-H6 (6.52 ppm) through nOe with G4-H-1′/H-2′/2′′ (6.19 and 2.73
ppm). The C5-H5 (5.50 ppm) has found to be correlated with aryl protons (6.37 ppm) of
G6 adduct. Both G6-Ar and G6-H-1′ then correlated with C7-H6 (7.52 ppm). The nOe
correlations between base(n)-H2′/2′′ and base(n-1)-H8 or H6 simply allowed the
assignments of G8-H8 (8.33 ppm), C9-H6 (7.50 ppm), G10-H8 (8.05 ppm) and their
corresponding H-1′ and H-2′/H-2′′. The uninterrupted assignment validated a previous
assumption that the chemical shift of C1-H6 was 7.75 ppm. If the assignment was
incorrect, an uninterrupted path would not have been observed. The NOESY in Figure
4.20 (left) shows nOe cross peaks that used for the proton assignment which are
schematically shown in the diagram on the right.
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Figure 4.20 NOESY (left) of B-CG8HMPh shows nOe correlations (right, a-q) that used
in sequential proton assignment.

Because H-2′/2′′ of each base has been identified, the H-3′ protons can be
assigned based mainly on the COSY data and with a little help from the NOESY data.
Due to their three bond separation, J-correlation between H-2′/2′′ and H-3′ were observed
in the COSY spectrum (Figure 4.21) and used to assign H-3′ of C1 through G10 (4.81,
5.11, 5.08, 5.27, 4.73, 4.94, 5.01, 5.10, 4.95, and 4.78 ppm, respectively).
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Figure 4.21 COSY of B-CG8HMPh. The cross peaks between H-3′ and H-2′/2′′ of C1
through G10 are marked.

Once H-3′ were assigned, H-4′ and H-5′/5′′ can be obtained by simultaneous use
of the NOESY and COSY spectra in the spectral regions shown in Figure 4.22. Based on
the NOESY data, H-4′ and H-5′/5′′ were determined from their intra-nucleotide cross
peaks with H-3′, Note that nOes between H-4′ or H-5′/5′′ and H-3′ of a neighboring base
is insignificant or can be ruled out because of their weaker cross peak intensities (more
spatial separation between nuclei) compared to the nOes of H-4′ and H-5′/5′′ to H-3′ in
the same base. The cross peaks found in COSY were only from H-3′/H-4′ but not from
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H-3′/H-5′/5′′, therefore, one can distinguish H-4′ and H5′/5′′ found in NOESY spectra. By
following this procedure H-4′ of C1, G2, C3, C5, G8, C9, and G10 (4.16, 4.46, 4.25,
4.11, 4.58, 4.22, and 4.26 ppm) were assigned. An alternate method was used to assign
G6-H-4′ and C7-H-4′, since their H-3′/H-4′ cross peaks could not be indentified in COSY
spectrum. Because H-4′ is close enough to have nOe with H8 or H6, G6-H-4′ (4.55 ppm)
and C7-H-4′ (4.40 ppm) were identified based on the appearance of their H-4′/H8 and H4′/H6 nOe cross peaks. G4-H-4′ and H-5′/5′′ could not be unequivocally assigned.

Figure 4.22 NOESY (left) of B-CG8HMPh displays nOe correlation between H-3′ and
H-4′/5′/5′′ of all bases. On the right, COSY shows H-3′/H-4′ cross peaks of C1, G2,
C3, C5, G8, C9, and G10.

By following the assignment strategy, the non-exchangeable protons of BCG8HMPh were assigned (see Table 4.7 for full chemical shift assignment). According to
1

H NMR, COSY, and NOESY, the patterns of spectra have verified that CG8HMPh was in

B conformation which is in agreement with the data from CD experiment. The nonexchangeable proton assignment of B-CG8MMPh was conducted in the same way as B-

114

CG8HMPh and is reported in Table 4.8. Unfortunately, the assignment of B-CG8CPh protons
was problematic due to a fairly high content of Z-CG8CPh even in low salt concentration
as supported by the CD data. The inability to obtain mainly B-DNA in the NMR sample
significantly increases the difficulty of the NMR analysis and prevents us from
successfully assigning the non-exchangeable protons for B-CG8CPh. Full 1H NMR,
COSY, and NOESY spectra of B-CG8CPh, B-CG8HMPh, and B-CG8MMPh can be found in
Appendix C.

Table 4.7 Non-exchangeable protons assignment of B-CG8HMPh
Base

a

C1
G2
C3
G4
C5
G6b
C7
G8
C9
G10

Non-exchangeable 1H Chemical Shifts (ppm) of CG8HMPh in B Conformationa
H6/H8/Ar
7.75
8.09
7.62
8.09
6.53
7.09, 6.37
7.52
8.33
7.50
8.05

H5
6.03
N/A
5.56
N/A
5.50
N/A
5.54
N/A
5.58
N/A

H1'
5.91
6.13
6.27
6.19
5.97
5.72
6.43
6.03
5.89
6.26

H2'
2.53
2.95
2.69
2.73
2.20
3.68
2.25
2.88
2.43
2.72

H2''
2.11
2.78
N/D
N/D
0.57
2.40
1.59
2.75
2.07
2.46

H3'
4.81
5.11
5.08
5.27
4.73
4.94
5.01
5.10
4.95
4.78

N/A – not applicable, N/D – not determined.
Chemical shift of p-substituent on the aryl adduct; 4.58 (–CH2)

b
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H4'
4.16
4.46
4.25
4.54
4.11
4.55
4.40
4.58
4.22
4.26

H5'/H5''
3.81
4.20, 4.09
4.37, 4.30
4.28, 4.20
4.19
4.30, 4.09
4.17
4.28, 4.20
4.18
4.15

Table 4.8 Non-exchangeable protons assignment of B-CG8MMPh
Base

a

C1
G2
C3
G4
C5
G6b
C7
G8
C9
G10

Non-exchangeable 1H Chemical Shifts (ppm) of CG8MMPh in B Conformation
H6/H8/Ar
7.75
8.10
7.62
8.09
6.52
7.08, 6.38
7.48
8.33
7.50
8.05

H5
6.04
N/A
5.56
N/A
5.49
N/A
5.49
N/A
5.57
N/A

H1'
5.91
6.13
6.28
6.19
5.96
5.72
6.44
6.03
5.88
6.27

H2'
2.54
2.95
2.69
2.72
2.19
3.70
2.24
2.88
2.44
2.71

H2''
2.10
2.81
N/D
N/D
0.58
2.42
1.63
2.74
2.08
2.48

H3'
4.82
5.11
5.08
5.27
4.73
4.94
5.03
5.11
4.95
4.77

H4'
4.16
4.47
4.26
4.54
4.11
4.54
4.40
4.58
4.21
4.28

H5'/H5''
3.82
4.20
4.38, 4.31
4.28, 4.21
4.19
4.30, 4.10
4.48, 4.17
4.20
4.48, 4.16
4.16

N/A – not applicable, N/D – not determined.
Chemical shift of p-substituent on the aryl adduct; 4.59 (–CH2) and 3.41 (–OCH3)

b

4.2.3 Z-DNA Non-exchangeable Proton Assignment
The same basic approach as used to assign the proton resonances for the B forms
of the C8-arylguanine modified oligonucleotides is used to assign resonances in the Z
form. Thus, the same data set needs to be acquired, including 1H NMR, COSY, and
NOESY. As in the case of the B form, the 1D proton spectrum gives provides
information as to whether B, Z or single-stranded DNA is present. The chemical shift
ranges for the base and sugar protons are roughly the same and the peaks for H8 (δ 7.87.9 ppm) of guanines, aryl adduct protons (δ 7.7-8.1 ppm), H6 (δ 7.4-7.5 ppm) and H5 (δ
5.2-5.3 ppm) of cytosines can be seen. However, as can be seen, the resolution is not as
good as for the B DNA spectra. This is due to the line broadening caused by higher salt
concentration, required for the oligonucleotide to adopt the Z conformation. The J
correlations of H6/H5 can be observed from COSY spectra as well as the correlation
between the aryl protons that are ortho- and meta- to the guanine C8 carbon of the aryl
adduct on G6. In addition, the correlation peaks between H-1′ and H-2′/2′′ are also shown
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in COSY. Based on the well defined regions on 1D 1H NMR and 2D COSY spectra, the
chemical shifts of aryl, H8, H5, H6, H-1′, H-2′, and H-2′′ protons can be obtained. To
proceed on the proton assignment, the connection between base protons and sugar
protons in the same nucleoside residue are observed from NOESY spectra due to close
spatial proximities between the proton nuclei. The nOe cross peaks of Aryl/H-1′, Aryl/H2′/2′′, H8/H-1′, H8/H-2′/2′′, H8/H-3′, H8/H-4′, H8/H-5′/5′′, H6/H5, H6/H-1′, and H6/H2′/2′′ in the same nucleotide subunit are generally observed in the spectra and can be used
to assign some of sugar protons for each base. Strong nOes cross peaks of H8/H-1′
indicate that dG are in syn conformation which associate with structural feature of ZDNA20,97. To sequentially assign protons, the connections between adjacent bases are
required. Instead of weak nOe correlations between H8 of G(n) and both H6 of C(n-1)
and C(n+1) observed in B form, NOESY of Z form shows relatively strong nOe cross
peaks only between H8 of G(n) and H6 of C(n-1) which would quickly help lining up
G(n) and C(n-1). To completely assign the base positions in CG decamer sequence,
C(n+1) can be linked to G(n) through nOes cross peaks between H-4′ or H-5′/5′′ of C(n1) and H8 of G(n) as described in a Z-DNA protons assignment reported by Orbons
L.P.M. et al95.
As was the case for the assignment of protons for the oligonucleotides in the B
form, the C1 base serves as the starting point because of its distinct H5 and H6 chemical
shifts that are most downfield compares to the rest of cytosines due to C1 position in the
sequence. Figure 4.23 shows a diagram described nOe correlations that generally used for
Z-DNA assignment of CG decamer. The protons of modified G6 are also quite simple to
assign due to its correlation with unique aryl protons from the DNA adduct. The H-3′, H-
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4′, and H5′/5′′ assignments of each base are possible by following nOes and J-correlation
cross peaks in NOESY and COSY spectra.

Figure 4.23 Diagram shows proton assignment strategy for Z-form of CG decamers
based on nOe correlations observed in NOESY spectra

To demonstrate the assignment of the non-exchangeable protons of the modified
CG decamer in Z conformation, the proton assignment of Z-CG8CPh will be used as an
example. The NMR spectra analysis was started on an expansion of 1H NMR spectrum
from δ7.0-8.3 ppm (Figure 4.24) where peaks of H8, H6, and aryl protons generally
locate. The two doublets at 8.16 and 7.81 ppm were expected to be aryl protons of G6
adduct based on their chemical shifts, and integration of about two protons. The next four
singlet peaks were suggested to be H8 of guanines (δ7.91, 7.88, 7.87, and 7.85 ppm),
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while the cluster of peaks around 7.4-7.5 ppm are assigned to the cytosine H6 protons.
Because the resolution of spectrum was fairly poor due to the high salt concentration in
NMR sample, the H6 cytosine protons could not be clearly assigned at this point.

Figure 4.24 1H NMR spectrum of Z-CG8CPh. The peaks corresponding to H8, H6, and
aryl adduct protons are indicated below the frequency axis.

The COSY spectra (Figure 4.25a) support our suggestion on the chemical shifts of
H8 (Figure 4.25a) and aryl protons (Figure 4.25c). The peaks at 7.91, 7.88, 7.87, and 7.85
ppm did not have cross peaks with any others which suggests that these peaks are the of
H8 protons. As expected, the doublet at 8.16 ppm is correlated with the doublet at 7.81
ppm (Figure 4.25b) verifying that they were protons of the aryl group. Because of
mesomeric effect, the downfield doublet at 8.16 ppm was assigned to the aryl protons
located ortho to the electron withdrawing p-carboxy substituent, while the upfield doublet
at 7.81 ppm was assigned to the protons ortho to the guanine C-8 carbon. Five pairs of
H6/H5 correlations (δ7.51/5.29, 7.50/5.83, 7.49/5.29, 7.46/5.19, and 7.44/5.20 ppm) were
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seen in the COSY (Figure 4.25b) spectrum and were used to assign H6 and H5 of
cytosines. In addition, several H-1′/H-2′/2′′ correlations can be observed in COSY as
shown in Figure 4.25d. Between 5.7 and 6.4 ppm, six H-1′ peaks (δ5.81, 5.87, 5.94, 6.30,
6.33, and 6.34 ppm) were identified based on the criteria that these peaks had at least one
correlation with peak in the region upfield of 3 ppm which usually is the region where the
H-2′/2′′ (Z DNA) protons are observed. Some of the chemical shifts for H-2′/2′′ were
identified from H-1′/H-2′/2′′ cross peaks. The assignment of H-1′/2′/2′′ to their
corresponding H8, H6/H5, or aryl protons were conducted in the next step followed by
sorting protons in CG decamer sequence.

Figure 4.25 COSY of Z-CG8CPh. The boxed regions show the a) H8, b) H6/H5, c)
Ar/Ar, and d) H-1′/H-2′/2′′ crosspeaks.
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Due to the close spatial proximity between H-1′ and H8, H6, or aryl protons in the
same nucleotide residue, nOes cross peaks of Ar/H-1′ (Figure 4.26a), H8/H-1′ (Figure
4.26b), and H6/H-1′ (Figure 4.26c) can be observed in NOESY spectra. It should be
noted that H8/H-1′ nOes have relatively intense cross peaks because G residues were in
syn-conformation which make H8 closer to H-1′ (2-3 Å) relative to the anti-conformation
that all bases adopt in B form. The intense H8/H-1′ nOe was the strongest evidence
indicating that the CG8CPh oligonucleotide was in Z form. From COSY (Figure 4.25d)
and NOESY (Figure 4.26d) spectra, H8, H6, or the aryl adduct protons were matched
with their corresponding H-1′ and H2′/2′′ (H8, H6, or aryl Æ H-1′ Æ H-2′/2′′: 7.44 Æ
5.81 Æ 2.69, 1.77 ppm, 7.46 Æ5.81 Æ 2.69, 1.77 ppm, 7.49 Æ 5.81 Æ 2.69, 1.77 ppm,
7.50 Æ 5.87 Æ 2.51, 1.71 ppm, 7.51 Æ 5.94 Æ 2.73, 1.82 ppm, 7.85 Æ 6.30 Æ 2.83,
2.66 ppm, 7.87 Æ 6.33 Æ 3.28, 2.51 ppm, 7.88 Æ 6.30 Æ 2.81, 2.67 ppm, 7.91 Æ 6.34
Æ 2.88, 2.66 ppm, 8.16/7.81 Æ 6.33 Æ 2.94, 2.77 ppm).
Based on the computational model of Z-CG8CPh, the distances between C(n-1)-H6
and G(n)-H8 are generally greater than 6 Å while the distances between C(n+1)-H6 and
G(n)-H8 are below 6 Å. Therefore, only nOes of C(n+1)-H6 and G(n)-H8 are observed
in the NOESY spectrum while none of C(n-1)-H6/G(n)-H8 cross peaks are observed,
unlike the case of B conformation where the nOes of C(n-1)-H6/G(n)-H8 and C(n+1)H6/G(n)-H8 may be seen. Therefore G(n) and C(n+1) can be unambiguously assigned
which was a result from nOes of C(n-1)-H6/G(n)-H8. Four H8/H6 nOes cross peaks
(7.85 Æ 7.44 ppm, 7.88 Æ 7.46 ppm, 7.91 Æ 7.51 ppm, and 8.16/7.81 (G6-Ar) Æ 7.49
(C7-H6) ppm, Figure 4.26e) were observed which allow the assignment of C1-H6 (7.50
ppm) and G10-H8 (7.87 ppm).
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Figure 4.26 NOESY of Z-CG8CPh. The boxed regions show the nOe correlations of a)
Ar/H-1′, b) H8/H-1′, c) H6/H-1′, d) Ar/H-2′/2′′, H8/H-2′/2′′, or H6/H-2′/2′′, and e)
G(n):H8/C(n-1):H6.

The chemical shift of C1-H-3′ (4.67 ppm) was assigned from COSY (cross peaks
of C1-H-2′/2′′ and C1-H-3′) and NOESY (C1-H6 and C1-H-3′) which allow further
assignment of C1-H-5′/5′′ (3.17 ppm). The C1-H-5′/5′′ then correlated with G2-H8 (7.85
ppm) as shown in Figure 4.27 which allowed an assignment of C3-H6 (7.44 ppm) since
the nOe cross peak of G2-H8/C3-H6 has been previously found. Similarly, C3 can be
connected to G4 through the cross peak between C3-H-5′/5′′ (3.85 ppm) and G4-H8 (7.88
ppm) followed by an assignment of C5-H6 (7.46 ppm). The only unassigned pair of
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H8/H6 has been assigned to G8-H8/C9-H6 (7.91/7.51 ppm). The H5, H-1′, and H-2′/2′′
were assigned, accordingly, to match with H8, H6, and Ar assignments.

Figure 4.27 NOESY of Z-CG8CPh showing the nOe correlations of a) C1:H5′/5′′/G2:H8 and b) C3:H-5′/5′′/G4:H8.

Because the J-correlation of H-3′ and H-2′/2′′ were barely observed in high salt
samples, the assignment of H-3′ was made based on nOes of H8/H-3′ and H6/H-3′ given
the chemical shifts of H-3′ were expected to be in range of 4.8-5.1 ppm. Unlike in BCG8HMPh, the assignment of H-4′ and H-5′/5′′ was more problematic because of the
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overlapping H-3′ peaks. Therefore, the chemical shifts of H-4′ and H-5′/5′′ were made
based on the correlation of H-4′ and H-5′/5′′ with intranucleotide Ar, H8 or H6 in
NOESY and are not unequivocal.
By following the assignment strategy, the non-exchangeable protons of Z-CG8CPh,
Z-CG8HMPh, and Z-CG8MMPh were assigned (see Table 4.9 to 4.11 for chemical shift
assignment). According to 1H NMR, COSY, and NOESY, the patterns of spectra have
verified that the aryl modified CG decamers were in Z conformation which is in
agreement with the data from CD experiment. Full 1H NMR, COSY, and NOESY spectra
of Z-CG8CPh, Z-CG8HMPh, and Z-CG8MMPh can be found in Appendix C.

Table 4.9 Non-exchangeable protons assignment of Z-CG8CPh
Base

a

C1
G2
C3
G4
C5
G6
C7
G8
C9
G10

Non-exchangeable 1H Chemical Shifts (ppm) of CG8CPh in Z Conformation
H6/H8/Ar
H5
H1'
H2'
H2''
H3'
H4'
H5'/H5''
7.50
5.83
5.87
2.51
1.71
4.67
3.74
3.17
7.85
N/A
6.30
2.83
N/D
5.08
4.26
4.20
7.44
5.20
5.81
2.69
1.77
4.88
4.48
3.85
7.88
N/A
6.30
2.81
N/D
5.08
4.24
N/D
7.46
5.19
5.81
2.69
1.77
4.89
4.24
3.89
8.16, 7.81
N/A
6.33
2.94
2.77
5.05
4.19
3.99
7.49
5.29
5.81
2.69
1.77
4.89
4.48
3.87
7.91
N/A
6.34
2.88
N/D
5.09
4.28
N/D
7.51
5.29
5.94
2.73
1.82
4.90
4.48
4.29, 3.89
7.87
N/A
6.33
3.28
2.51
4.90
4.38
3.99

N/A – not applicable, N/D – not determined.
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Table 4.10 Non-exchangeable protons assignment of Z-CG8HMPh
Base

a

C1
G2
C3
G4
C5
G6b
C7
G8
C9
G10

Non-exchangeable 1H Chemical Shifts (ppm) of CG8HMPh in Z Conformation
H6/H8/Ar
7.52
7.85
7.44
7.88
7.46
7.76, 7.73
7.48
7.91
7.52
7.89

H5
5.85
N/A
5.20
N/A
5.19
N/A
5.29
N/A
5.30
N/A

H1'
5.86
6.30
5.81
6.30
5.81
6.30
5.81
6.33
5.95
6.33

H2'
2.50
2.82
2.67
2.82
2.68
2.94
2.68
2.85
2.72
3.28

H2''
1.71
N/D
1.77
N/D
1.78
2.76
1.77
N/D
1.83
2.53

H3'
4.67
5.08
4.88
5.06
4.89
5.05
4.89
5.06
4.90
4.90

H4'
3.75
4.46
4.26
4.46
4.25
4.46
4.21
4.47
4.28
4.39

H5'/H5''
3.18, 2.84
4.19, 3.74
3.85, 2.83
4.21, 3.97
3.87, 2.82
4.19, 3.98
3.86
3.76
3.85, 2.78
4.20, 3.99

N/A – not applicable, N/D – not determined.
Chemical shift of p-substituent on the aryl adduct; 4.50 (–CH2)

b

Table 4.11 Non-exchangeable protons assignment of Z-CG8MMPh
Base

a
b

C1
G2
C3
G4
C5
G6b
C7
G8
C9
G10

Non-exchangeable 1H Chemical Shifts (ppm) of CG8MMPh in Z Conformation
H6/H8/Ar
7.51
7.85
7.44
7.89
7.46
7.77, 7.74
7.48
7.91
7.51
7.87

H5
5.83
N/A
5.20
N/A
5.19
N/A
5.29
N/A
5.29
N/A

H1'
5.87
6.30
5.81
6.30
5.81
6.30
5.82
6.33
5.94
6.32

H2'
2.50
2.82
2.68
2.81
2.68
2.94
2.68
2.84
2.71
3.29

H2''
1.71
N/D
1.77
N/D
1.77
2.76
1.78
N/D
1.84
2.51

H3'
4.67
5.07
4.88
5.08
4.88
5.04
4.88
5.09
4.90
4.90

H4'
3.74
4.47
4.26
4.47
4.25
4.47
4.25
4.47
4.27
4.38

H5'/H5''
3.17
3.72
3.85, 2.83
3.99
3.87, 2.82
4.19, 3.98
3.87
3.98, 3.77
3.88, 2.84
4.19, 3.99

N/A – not applicable, N/D – not determined.
Chemical shift of p-substituent on the aryl adduct; 4.49 (–CH2) and 3.60 (–OCH3)
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The results obtained from NMR analysis support the CD data that indicates the
predominant of Z form of the modified CG decamers at 500 mM NaCl, where the
unmodified CG could not well adopt the left handed conformation. An increase in
intensity of intranucleotide H8/H-1′ nOe cross peaks when high salt concentration was
introduced to the oligonucleotide samples suggests the change in conformation of dG in
CG decamer sequence from anti to syn conformation which suggests the conversion of B
to Z form.
The B-Z transition promoted by C8-arylguanine adducts have been confirmed by
NMR and CD analysis. The p-substituents on the aryl adducts have significant impact on
their effect on B- and Z-DNA stability, as the result has shown that different psubstituents give diverse degrees of Z-DNA formation. What could be gleaned from the
current dara set is that B-Z conversion is dependent upon more than a local steric effect
of C8-aryl adduct that would destabilize B-DNA. Additional forces that override an
unfavorable electronic interaction of Z-DNA may be necessary. The interplay of several
factors, including hydrophobic, electronic, steric interaction, and H-bonding that helps
stabilize Z-DNA and/or destabilize B-DNA are relevant in B-Z conversion process.
Molecular modeling and free energy calculation of the B and Z-forms of CG decamers
were conducted to help understanding the effect of aryl adduct on DNA conformation.
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CHAPTER 5
MOLECULAR MODELING OF THE B AND Z DNA FORMS OF CG
DECAMERS CONTAINING C8-ARYL MODIFIED GUANINE

Molecular modeling has become a significant tool to model and study biological
macromolecules. Modeling studies can provide information regarding the molecular
conformation of macromolecules, such as oligonucleotides, through the application of
molecular mechanical (MM) and molecular dynamical (MD) methods. More recently,
molecular modeling methods have been utilized to predict the stability of
macromolecules by the use of free energy perturbation (FEP) calculations. Here, we have
applied both molecular modeling and FEP methods to the C8-aryl modified guanine
containing oligonucleotides that were studied by CD and NMR. The aim of these studies
is two-fold. First, molecular models obtained by MM/MD methods are useful for
interpreting the experimental data. This is especially true for NMR NOESY data where
correlations (appearance and intensity) are distance dependent. Second, computational
methods allow deconvolution of the various contributors to the overall macromolecule
conformation and, therefore, determination of the important factors that drive it.
Analysis of the results of MM/MD calculations of the modified and unmodified
oligonucleotides studied by CD and NMR, in both the B and Z conformations is
necessary because base modifications often affect and distort a regular structure of DNA.
Topology, helical symmetry, and base paring of DNA all can be altered and to various
degrees as a result of the modification. Therefore, the changes in helicoidal and base
pairing parameters are typically used to elucidate and to explain how the C8-arylguanine
adduct affects the conformation of the CG decamer locally and globally. Figure 5.1
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shows diagrams of these helicoidal parameters100 including inter-base pair, intra-base
pair, and base pair-axis parameters that are considered as a part of this analysis.

Figure 5.1 Diagrams showing the helicoidal parameters that describe the movement of
base pairs and local and global conformation.
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Free energy calculations of the B and Z DNA forms of the oligonucleotides result
in a prediction of which form, B or Z DNA, is more favorable for a given modification.
In addition to this prediction, the free energy calculations, extracted from the MD
trajectories, provide a breakdown of the contributions from van der Waals interactions,
electrostatics, etc., and may be used to estimate how the aryl adduct affects each
component of the free energy. In turn, this may help elucidate how the aryl adducts
facilitate B-Z transition, by destabilizing the B form, and/or stabilizing the Z form. It
should be noted, however, that the methods used here (MM_PBSA and sietraj) are
designed for protein-substrate while they binding and have been used with B-DNAs with
limited success, they have not been used with Z DNAs.
The computational studies described below are a continuation of work on the 10mers of unmodified CG, CG8Ph, CG8Tol, and CG8HMPh conducted by Heavner99,101 and
some of these results are reproduced here for comparison purposes. The new studies refer
to the CG8CPh and CG8MMPh derivatives. We also note that in Heavner’s work, the CD and
NMR work was either incomplete or not conducted for CG8Tol and CG8HMPh and this body
of work completes Heavner’s research.

5.1 General
The computational studies on CG8CPh and CG8MMPh generally following the
protocol established by Heavner and applied to the CG, CG8Ph, CG8Tol, and CG8HMPh
decamers. The basic steps were as follows. First, parameters not provided in the
parm99.dat force field that is provided with the Amber suite of programs are developed.
These parameters were generated using Gaussian (g03), to calculate the natural bond
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lengths and stretching constants, bond angles and bending constants, the preferential
torsion angles and the atom charges. The resulting parameters were processed by
antechamber to create a prep file that modifies the Gaussian output by modifying the
atom names and charges to be consistent with the parm99.dat force field as well as
modifications needed by the Amber (version 8102, if not noted otherwise) modules xLEaP
and sander. Subsquently, this file is examined by parmchk to screen for any remaining
parameters that may be needed. The modified oligonucleotide is then built, suitable input
files written for the MM calculations. MM was then run using the sander module of
Amber to initially relax the oligonucleotide, solvent molecules that were added, or the
entire system. MD simulations, also using sander, were then run and the resulting
trajectories analyzed using utility programs contained within the Amber suite (e.g., ptraj,
nmode, MM_PBSA) or other programs including Dials & Windows103, CURVES104
(version 5.2) , X3DNA105, Moil-View106 and sietraj107,108.

5.2 Force Field Development
The structure of the C8-aryl modified dG (either CG8CPh or CG8MMPh) was built in
Gaussview109, then the electrostatic potentials associated with atoms in the structure were
calculated using Gaussian (g03). Antechamber was then applied to parameterize C8-aryl
modified dG to provide the prepi file and a pdb file. Atom types were consistent with the
parm99.dat force field. The frcmod file was created by parmchk, using the prepi file as
input. The pdb, prepi and frcmod files were loaded into xLEaP and a library file of the
modified base generated and saved for later use. Note that in case of the C8-
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carboxyphenyl dG derivative, the carboxylic proton was removed and thus was prepared
as the carboxylate since this is the form it is present as under physiological conditions.

5.3 Initial Oligonucleotide Structure Building
The starting point for the B DNA forms of the two structures built here was the
structure of B-CG8HMPh from our previous study which was used as a template for the BDNA form of CG8CPh. The pdb file of B-CG8HMPh was loaded into xLEaP using the
library file for the C8-hydroxymethylphenyl dG. The aryl residue was edited, replacing
the p-hydroxymethyl group with the p-carboxylate (p-COO-) substituent and the
structure was then saved as a pdb of B-CG8CPh. The text editor was then used to correct
the atom types, atom numbers, and assignment base of the modified dG residues (G6 and
G16) in a pdb of B-CG8CPh in order to comply with frcmod and lib files of C8carboxyphenyl dG that has written previously, renaming them as CPG. The resulting pdb
of B-CG8CPh was an initial structure of B-CG8CPh, in the deprotonated form (since it is
assumed that the carboxylic group is ionized under physiological conditions) and was
used as the starting structure for the MM and MD calculations. The initial structure of ZCG8CPh, B-CG8MMPh, and Z-CG8MMPh were constructed in the same way as described for
the B-DNA form of CG8CPh.

5.4 MM and MD Simulations
MM and MD were performed using the sander module of Amber and the
parm99.dat version of the Cornell force field. The pdb structure was loaded into xLEaP
and a water box (TIP3) was added. Charges were then neutralized by the addition of 18
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(19 for CG8CPh) sodium counter ions. A 10 Ǻ buffer zone between the box wall and
solute, containing solvent, was used. The pdb, topology (top), and coordinate (crd) files
of CG decamers including the solvent box and sodium ions were then saved and used in
the simulations.
The simulation protocol started with a MM to minimize the energy of the whole
system with the DNA fixed with 500 kcal/mol Ǻ positional restraints on all solute atoms
for 1000 steps of steepest descent and then 1500 steps of conjugated gradient
minimization. Then, the entire system was energy minimized (i.e. positional restraints on
DNA removed) with 500 steps steepest descent and 2000 steps conjugated gradient
minimization. The next step, was a 25 ps MD with the DNA fixed, was performed to
equilibrate water and counter ions followed by the isothermal-isobaric ensemble (300 K°,
1 atm) 25 ps MD with the SHAKE algorithm on and a 9 Ǻ cutoff. An additional 3 ps MD
with DNA fixed was performed in order to relax water and ions around the solute.
Another 600 steps MM was conducted to equilibrate solvent box with 5 kcal/mol Ǻ
positional restraints on all DNA atoms. Subsequently, the production MD with constant
temperature and pressure (300 K°, 1 atm) was performed over 2 ns (4 ns for CG8MMPh).

5.5 Most Representative Structure
The most representative structure is the structure that has the lowest average root
mean square derivation (RMSD) to all other member of the MD trajectory. This structure
is used in this work as the input into the CURVES and X3DNA routines that determine
helicoidal parameters. MOIL-view was used to select the most representative structure
from each of the four production trajectories. Due to the size limitations imposed by
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MOIL-view, trajectories were divided into 250 ps frame pieces. Each piece of trajectory
was analyzed using the cluster analysis feature in MOIL-view (2 Å cut-off distance) to
select the crd set of the most representative structure for each of the 250 ps frame pieces.
All of these files were then merged into a new trajectory using ptraj and the analysis
repeated on this new trajectory (typically comprised of 8-16 coordinate sets). The most
representative structure of the production run was generated by cluster analysis of this
newly written trajectory. The pdb of most representative structure was made using
ambpdb (Amber suite program) using the appropriate topology file and the coordinate set
that was determined by MOIL-view to be the most representative.
In addition to using this file for determination of the helicoidal parameters, it also
provides a representative model that can assist with the NMR assignment of nonexchangeable proton. The average distances between non-exchangeable protons obtained
from the structure were most useful for NMR assignment in NOESY spectra. The most
representative structures of all studied oligonucleotides in B forms are shown in Figure
5.2 and Z forms are shown in Figure 5.3. By inspection of the most representative
structures it is obvious that the B forms were distorted by the aryl adducts. The rise and
incline of base pairs in the middle of sequence, where the modified base presented, were
most notable. As far as we can see by mere visual inspection of the Z forms, the aryl
adducts have little effect on structure with the exception of CG8CPh and CG8MMPh but a
more quantitative evaluation is necessary to ascertain the extent of the effect.
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Figure 5.2 The most representative structures of a) CG, b) CG8Ph, c) CG8Tol, d)
CG8CPh, e) CG8MMPh, and f) CG8HMPh in the B-DNA conformation.
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Figure 5.3 The most representative structures of a) CG, b) CG8Ph, c) CG8Tol, d)
CG8CPh, e) CG8MMPh, and f) CG8HMPh in the Z-DNA conformation.
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5.6 Structural Analysis
5.6.1 B-DNA Oligonucleotides
Dials & Windows was used to examine the trajectories over the course of
production run to determine the helicoidal parameters of the oligonucleotides that vary
the most over time and with respect to the unmodified derivative. This analysis gives an
excellent presentation of the variation in these parameters as the system evolves over the
course of the MD. The analysis also guides the analysis of the helicoidal parameters of
the most representative structure using CURVES.
Figures 5.4, 5.5, and 5.6 show intra-base pair, inter-base pair, and base pair-axis
parameters obtained from Dials & Windows of the unmodified and modified CG decamer
in the B form over 2 ns trajectories (except for CG8MMPh that has a 4 ns trajectory),
respectively, for the CG, CG8Ph, CG8Tol, CG8HMPh, CG8CPh and CG8MMPh oligonucleotides.
There was no significant deviation of the intra base pair parameters of C8-aryl modified
CG decamer observed when compared to the unmodified DNA with the possible
exception of STG and BKL (these are low energy processes). Minor perturbations in
these two parameters were seen for CG8Ph, CG8Tol and perhaps CG8MMPh at or near the
modified base.
In the case of inter-base pair parameters (Figure 5.5), RIS and SLD of G6:C15
base pairs were altered. Both showed significant changes for CG8Ph, CG8Tol, and
CG8HMPh, while mainly RIS was different for CG8CPh and CG8MMPh containing
oligonucleotides in the B-DNA form. The increase in rise parameter and the change in
slide to negative value were likely driven by the tendency toward stacking of the aryl
adduct of G6 and pyrimidine C5. Paralleling these differences is the effect of the C8-
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Figure 5.4 Intra-base pair parameters for all base pairs obtained from Dials &
Windows analysis of the production trajectories of the unmodified and modified CG
decamers in the B-DNA form.
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Figure 5.5 Inter-base pair parameters of all base pairs obtained from Dials &
Windows analysis of the production trajectories of the unmodified and modified CG
decamers in the B-DNA form.
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Figure 5.6 Base pair-axis parameters of base pairs obtained from Dials & Windows
analysis of the production trajectories of the unmodified and modified CG decamers in
the B-DNA form.
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substituent on YDP and INC (and to a lesser extent, TIP) as seen in Figure 5.6. Thus, the
oligonucleotides that displayed significant effects on both SLD and TLT display large
changes in YDP and INC and had little effect on SLD or TLT, only YDP was altered
(e.g., CG8CPh and CG8MMPh).
To put the changes pointed by Dials & Windows on a more quantitiative analysis,
the helicoidal parameters were obtained utilizing the most representative structure.
CURVES was used for this purpose with the results being compiled in Tables 5.1 and
5.2. Inspection of Table 5.1 indicates that STG and BKL are, as suggested by Dials &
Windows, significantly affected by the C8-aryl adduct. It should be noted, however, that
STG and BKL are not energetically costly motions and are more likely in response to
other conformational changes.
As suggested by Dials & Windows, the inter-base parameters SLD and RIS are
significantly different from the unmodified oligonucleotide. In all cases, SLD is nearly 1
Å more negative than the unmodified oligonucleotide. RIS varied from a modest increase
of 0.57 Å for CG8CPh to 3.12 Å for CG8Tol. To a lesser extent, changes in SHF and TWS
are seen. In the case of SHF, the change was smallest for the CG8Ph (-0.49 Å) and largest
for CG8MMPh (-1.08 Å). The changes in TWS also range from showing a modest decrease
for CG8MMPh (3.15o) to very large decrease for CG8Tol (12.14o) indicating the C8arylguanine modification produces local unwinding of the helix.
Based on values for the helicoidal parameters obtained from CURVES, the
amount of rise (RIS), slide (SLD), and shift (SHF) were all significantly altered by the
presence of the C8-arylguanine base. The only difference between the aryl groups,
however, is the p-substituent. Furthermore, the observed changes in RIS, SLD, and SHF
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Table 5.1 Helical parameters of the unmodified and modified CG decamers determined
by CURVES analysis of the most representative structures in the B-DNA form.a
Intra-Base Pair
CG

CG8Ph

CG8Tol

CG8CPh

CG8MMPh

CG8HMPh

G6/G16

G6/G16

G6/G16

G6/G16

G6/G16

G6/G16

SHR
STR

-0.12 (-0.10)
-0.03 (0.00)

-0.04 (-0.06)
-0.20 (0.16)

0.01 (-0.27)
-0.17 (0.10)

-0.08 (0.09)
0.23 (0.18)

0.40 (-0.30)
0.04 (-0.25)

0.00 (0.20)
-0.06 (0.06)

STG

0.53 (0.10)

-0.48 (-0.13)

-0.67 (-0.20)

-0.11 (0.09)

-0.30 (-0.51)

-0.33 (-0.08)

BKL

9.80 (1.10)

-0.93 (-3.27)

3.60 (-3.50)

-4.57 (-0.36)

-5.00 (-3.01)

-15.6 (-2.89)

PRP

-12.1 (-12.0)

-9.50 (-9.57)

-6.71 (-10.5)

-11.39 (-12.92)

-9.85 (-8.15)

-9.50 (-11.2)

OPN

-2.47 (-1.83)

4.90 (1.17)

-2.12 (4.43)

-0.04 (-2.31)

0.54 (-1.55)

2.09 (2.10)

CG8MMPh

CG8HMPh

Inter-Base Pair
CG

8Ph

CG

CG8Tol

CG8CPh

C5:G6

C5:G6

C5:G6

C5:G6

C5:G6

C5:G6

SHF

0.81 (0.06)

0.32 (0.00)

0.36 (0.07)

-0.08 (-0.01)

-0.27 (-0.13)

-0.22 (-0.05)

SLD

-0.44 (-0.14)

-1.76 (-0.06)

-1.69 (0.11)

-1.27 (-0.01)

-1.26 (-0.06)

-1.63 (-0.04)

RIS

3.00 (3.18)

5.55 (3.58)

6.12 (3.83)

3.57 (3.38)

3.95 (3.89)

4.74 (3.64)

TLT

-5.60 (-1.70)

-0.65 (1.97)

-10.3 (1.40)

3.24 (0.00)

7.53 (6.75)

5.30 (0.11)

ROL

7.97 (5.04)

0.28 (7.24)

-6.00 (7.09)

8.62 (2.26)

5.14 (1.50)

6.86 (7.79)

TWS

32.2 (31.45)

21.5 (30.1)

20.6 (30.4)

33.05 (34.33)

29.05 (35.0)

22.0 (30.4)

CG8MMPh

CG8HMPh

Base Pair-Axis
CG

a

8Ph

CG

CG8Tol

CG8CPh

G6/G16

G6/G16

G6/G16

G6/G16

G6/G16

G6/G16

XDP

-2.22 (-2.06)

-1.32 (-1.34)

-0.75 (-0.71)

-1.06 (-0.97)

-0.79 (-0.61)

-0.08 (0.08)

YDP

0.31 (-0.17)

-0.43 (-0.42)

-0.36 (-0.37)

-0.31 (-0.28)

-1.40 (-1.57)

-0.10 (-0.02)

INC

1.65 (3.98)

-11.5 (-4.97)

-17.9 (-8.50)

-1.57 (0.55)

-2.35 (-1.06)

-15.8 (-7.30)

TIP

-2.00 (-2.72)

1.00 (1.52)

2.50 (3.06)

2.29 (1.92)

11.99 (11.08)

1.61 (1.03)

Values in parenthesis are for the average over all bases

all effect the extent to which the C8-aryl group of the modified base stacks over the 5′cytosine. The CG8Ph displays the most negative slide (-1.76) (the effect being augmented
by STR (-0.20)) and gives rise to a significant stacking interaction between phenyl adduct
and pyrimidine on the 5′ side. To accommodate these changes and relieve steric
interactions, an increase in local rise (5.55 Å) occurs. The latter increase is responsible
for the observed decrease in TWS. Note that while the observed changes result in the
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stacking interaction and though similar SHF and SLD values are observed for the CG8Tol
derivative, the unusually large negative roll (-6.00) and increase in rise prevent the p-tolyl
from stacking well over the 5′ pyrimidine.
The stacking interaction of CG8CPh, CG8MMPh, and CG8HMPh were expected to be
lower than CG8Ph based on rise, slide, shift, and stretch parameters and is what is
suggested by the most representative structures (Figure 5.2). In case of CG8HMPh, there is
a possibility that hydroxyl proton of p-CH2OH H-bonding with nearby phosphate oxygen
and this, in turn shifts slide back toward the unmodified oligonucleotide at the G6:C15
base pair. If stacking arrangement observed computationally (and experimentally) for the
CG8Ph, was adopted by CG8HMPh, it would disrupt the optimum distance (2.4 Å) between
hydroxyl proton and phosphate oxygen and diminish the chance of H-bonding.
The unfavorable electrostatic interaction between the negatively charge phosphate
backbone of the oligonucleotide and the p-COO- substituent in CG8CPh appears to be the
main reason for the decreased stacking in this oligonucleotide as the more interaction
there is between the C5 pyrimidine and the aryl group of CG8CPh the more the carboxylate
group interacts with the negatively charged oxygens on the backbone. In addition, this
oligonucleotide shows a fair amount of SHF, which further decreases stacking
interactions.
The steric effect of the p-CH2OCH3 (with the phosphate backbone) is likely to be
the cause of the decrease in stacking for CG8MMPh as it will decrease the amount of SLD
relative to the unmodified oligonucleotide. Furthermore, the near zero values for
inclination, a base pair-axis parameter, of G6:C15 of CG8CPh (-1.57) and CG8MMPh (-2.35)
probably occurs to avoid unfavorable interactions between the p-substituents and the
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backbone. Having the same degree of inclination like CG8Ph (-11.5) would put p-COOand p-CH2OCH3 very close to the phosphate group of C5.
In addition to the effect of aryl adducts on base pair parameters that may
contribute to B-DNA destabilization, groove parameters also affected by the presence of
aryl adducts. The minor groove widths obtained from the CURVES analysis of the most
representative structures are shown in Table 5.2. The C8-aryl adducts on G6 generally
reduce the minor groove width which may result in increasing the electrostatic repulsion
caused by bringing the phosphates close together. Although the trend of minor groove
reduction and the B-Z conversion were not well correlated, the effect likely plays a role
in reducing the stability of the B-DNA form of the C8-arylguanine modified
oligonucleotides.

Table 5.2 Major and minor groove widths of the unmodified and modified CG decamers
determined by CURVES analysis of the most representative structures in the B-DNA
form.
Major Groove Width (A°)
CG

CG8Tol

CG8CPh

CG8MMPh

CG8HMPh

12.20

16.80

21.94

12.14

13.21

15.96

11.85

17.50

23.72

12.06

13.09

16.67

6

11.36

17.55

23.90

13.14

11.18

15.45

7

15.38

15.72

15.87

12.33

12.67

13.20

Average

12.70

16.89

21.36

12.42

12.54

15.32

Base No.

CG

4
5

8Ph

Minor Groove Width (A°)
CG8Tol

CG8CPh

CG8MMPh

CG8HMPh

7.22

5.00

6.60

5.73

6.83

4.32

4.81

4.65

6.51

6.38

7.00

5.99

5.41

7.01

5.47

7.74

7

7.77

7.58

8.80

9.40

5.74

7.13

Average

7.77

6.28

6.01

6.92

5.86

7.02

Base No.

CG

4

7.91

5

8.40

6

8Ph

CG
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5.6.2 Z-DNA Oligonucleotides
The intra-base pair, inter-base pair, and base pair-axis parameters obtained by
Dials & Windows analysis of the unmodified and modified CG decamers in Z form over
2-4 ns production runs are shown in Figure 5.7, 5.8, and 5.9. There was no significant
difference observed between the unmodified and modified oligonucletides when the
intra-base parameters (Figure 5.7) are considered except in the case of the CG8MMPh
derivative where greater variation in STR and STG are observed, suggesting greater
mobility of this base and therefore decreased stability of the base-pair. Much the same
can be said for the inter-base parameters (Figure 5.8). The alteration seen in SLD, RIS,
ROL, and TWS are due to the alteration of the glycosidic bond of the pyrimidines (anti)
and the purines (syn) in Z DNA. The main outlier is the SLD and RIS values for the C6G15 base pair. In most cases, SLD becomes more positive while RIS becomes more
negative while in the case of the CG8CPh and CG8MMPh, just the opposite is observed.
Finally, no real differences are observed for the base pair-axis parameters. The different
scales used for the last two panels corresponding to CG8CPh and CG8MMPh seem to suggest
a difference but this is only a scaling effect.
The helical parameters from the CURVES analysis of the most representative ZDNA structures are shown in Table 5.3. Since the C8-aryl group of the modified guanine
lies largely outside of the DNA helix in the Z-form, the aryl group should have little
effect on DNA conformation (constraining the view to just the Z-DNA form). For the
most part, and as expected from the most representative structures of CG8Ph, CG8Tol, and
CG8HMPh in Z-DNA form shown in Figure 5.3, there were not many differences between
the modified and unmodified CG oligonucleotides. The most notable differences seen in
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the intra-base pair parameters are 1) the value for STR of CG8MMPh, which is quite
negative, 2) PRP for both CG8CPh and CG8MMPh, both of which departed considerably
from the unmodified oligonucleotide, albeit in opposite directions and 3) OPN for the
CG8MMPh oligonucleotide.
Differences were also observed in inter-base pair helical parameters. The overall
trends are that the CG8CPh and CG8MMPh modified oligos alter inter-base parameters
typically in the opposite direction as compared to the CG8Ph, CG8Tol or CG8HMPh
oligonucleotides (with the unmodified oligo as reference). The deviations from the
unmodified oligonucleotide can be quite large (selected values of RIS, TLT, and ROL).
In the case of Z-CG8CPh, an obvious outcome (see Figure 5.3) is that the aryl
adduct is almost planar to purine ring of G6 unlike the rest of modified CG decamers in
which the aryl group is approximately perpendicular to purine. It is not clear what the
source of this unique structural feature of Z-CG8CPh is though the carboxylate group is
very electron donating and therefore there may be a resonance effect with the relatively
electron deficient guanine base. Such an effect would also reduce the base pair strength
and increase base mobility (in turn, increasing BKL, PRP, OPN, etc.). This proposal is
partially supported by the Dials & Windows results that showed considerable variation of
helical parameters in the MD trajectories of CG8MMPh, especially in the middle of
sequence at the site of modification.
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Figure 5.7 Intra-base pair parameters for all base pairs obtained from Dials &
Windows analysis of the production trajectories of the unmodified and modified CG
decamers in the Z form.
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Figure 5.8 Inter-base pair parameters for all base pairs obtained from Dials &
Windows analysis of the production trajectories of the unmodified and modified CG
decamers in the Z form.
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Figure 5.9 Base base-axis parameters for all base pairs obtained from Dials &
Windows analysis of the production trajectories of the unmodified and modified CG
decamers in the Z form.
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With the exception of CG8CPh and CG8MMPh with structures seemed to be
relatively less sound, the modified CG decamers in Z-form look more rigid and the aryl
adducts did not appear to interfere with the conformation, in general, based on helical
parameters. Interestingly, minor groove widths in Z-DNA were wider in case of the
modified CG decamers except for CG8HMPh. This effect is the reverse of what is observed
for the B forms and could be one of the factors that stabilize Z form because increasing
the minor groove width decreases the unfavorable electrostatic interaction.
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Table 5.3 Helical parameters of the unmodified and modified CG decamers determined
by CURVES analysis of the most representative structures in the Z-DNA form.a
Intra-Base Pair

SHR
STR

CG

CG8Ph

CG8Tol

CG8CPh

CG8MMPh

CG8HMPh

G6/G16

G6/G16

G6/G16

G6/G16

G6/G16

G6/G16

-0.25 (-0.30)
0.03 (0.09)

0.03 (-0.02)
0.24 (0.10)

0.00 (-0.09)
-0.04 (0.08)

-0.18 (-0.01)
0.17 (0.04)

-0.09 (0.04)
-0.75 (-0.06)

-0.04 (-0.09)
0.22 (0.08)

STG

0.42 (0.00)

0.20 (0.20)

0.10 (0.11)

-0.02 (0.14)

0.94 (0.29)

-0.20 (0.02)

BKL

-3.50 (-2.30)

-8.60 (1.07)

-2.50 (0.80)

9.09 (1.32)

14.18 (1.53)

-9.30 (-6.10)

PRP

-5.40 (0.56)

-2.00 (-2.70)

4.20 (4.00)

-25.28 (-11.37)

-34.74 (-13.11)

3.10 (1.20)

OPN

1.15 (-0.70)

0.45 (0.04)

0.44 (0.06)

4.01 (-0.38)

-19.60 (-2.34)

1.26 (-0.21)

CG8Tol

CG8CPh

CG8MMPh

CG8HMPh
C5:G6/ G6:C7

Inter-Base Pair
CG

SHF
SLD
RIS
TLT
ROL
TWS

8Ph

CG

C5:G6/ G6:C7

C5:G6/ G6:C7

C5:G6/ G6:C7

C5:G6/ G6:C7

C5:G6/ G6:C7

(C:G)

0.19 (0.03)

0.44 (0.35)

0.27 (0.28)

-0.53 (0.06)

-0.39 (0.27)

0.21 (0.14)

(G:C)

-0.44 (-0.93)

-0.49 (-0.42)

-0.22 (-0.19)

0.17 (0.07)

0.28 (-0.32)

-0.53 (-0.12)

(C:G)

4.09 (4.26)

4.37 (4.27)

4.00 (4.22)

1.84 (3.65)

1.57 (3.93)

4.35 (4.31)

(G:C)

-4.48 (-4.17)

-4.67 (4.15)

-3.81 (-4.00)

-4.32 (-3.56)

-3.99 (-3.88)

-4.42 (-4.27)
4.15 (3.71)

(C:G)

3.91 (4.26)

3.57 (4.34)

3.92 (4.46)

4.81 (5.17)

2.88 (4.36)

(G:C)

3.03 (2.86)

2.98 (2.88)

2.81 (2.77)

3.08 (2.71)

6.08 (3.79)

2.88 (3.35)

(C:G)

4.90 (-3.58)

8.53 (-2.78)

2.04 (-2.49)

-5.38 (3.19)

-1.78 (-1.86)

-8.28 (2.31)

(G:C)

3.22 (4.55)

0.45 (2.65)

1.50 (0.18)

3.27 (-0.31)

13.60 (-0.55)

-3.63 (-1.37)

(C:G)

-1.90 (1.67)

7.07 (1.97)

11.47 (6.79)

-26.47 (-5.51)

11.61 (-0.62)

4.01 (4.18)

(G:C)

3.73 (4.32)

-8.74 (0.55)

-2.76 (3.70)

3.41 (10.80)

-4.04 (4.99)

-7.90 (-2.28)

(C:G)

-8.49 (-10.7)

-10.6 (-8.78)

-10.70 (-13.4)

-4.99 (-9.73)

13.46 (-5.76)

-12.3 (-10.8)

(G:C)

-44.7 (-45.3)

-44.4 (-44.9)

-38.6 (-41.6)

-35.75 (-41.11)

-39.29 (-42.90)

-48.1 (-43.2)

CG

CG8Ph

CG8CPh

CG8MMPh

CG8HMPh

Base Pair-Axis

a

CG8Tol

G6/G16

G6/G16

G6/G16

G6/G16

G6/G16

G6/G16

XDP
(C:G)
YDP
(G:C)

-2.15 (-2.18)

-2.00 (-2.03)

-1.55 (-1.55)

-0.21 (-0.47)

-1.72 (-1.64)

2.15 (-2.15)

-2.17 (-2.07)

-1.86 (-1.80)

-1.79 (-1.83)

-1.68 (-2.14)

-0.92 (-1.26)

-2.15 (-2.10)

2.05 (2.18)

2.41 (2.35)

2.30 (2.34)

1.29 (1.47)

2.20 (2.71)

2.11 (2.11)

INC

6.28 (7.78)

5.80 (6.76)

11.0 (10.5)

11.66 (16.44)

-1.10 (7.42)

7.47 (6.33)

TIP

179 (178)

180 (181)

182 (18.2)

1 (35.6)

-171 (-139)

179 (179)

Values in parenthesis are for the average over all bases
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Table 5.4 Major and minor groove widths of the unmodified and modified CG decamers
determined by CURVES analysis of the most representative structures in the Z-DNA
form.
Major Groove Width (A°)
CG

CG8Tol

CG8CPh

CG8MMPh

CG8HMPh

12.28

10.92

13.27

14.48

22.91

12.92

14.41

14.36

15.01

15.70

20.69

15.60

6

10.50

12.40

11.76

15.29

19.42

11.15

7

N/A

N/A

15.31

N/A

N/A

N/A

Average

12.40

12.56

13.84

15.16

21.01

13.22

Base No.

CG

4
5

8Ph

Minor Groove Width (A°)
CG8Tol

CG8CPh

CG8MMPh

CG8HMPh

1.49
4.79

1.91
4.79

4.87
7.03

5.04
5.14

2.23
4.29

4.13

3.75

4.22

5.38

5.07

2.63

4.13

4.98

4.13

4.99

5.08

4.27

3.59

3.75

3.76

5.57

5.08

3.36

Base No.

CG

4
5

1.93
4.15

6
7
Average

8Ph

CG

5.7 Free Energy Calculation
The MM_PBSA module of Amber was used to calculate the absolute free
energies of the modified DNAs in solution from Amber trajectories. The following set of
equations show the breakdown of the components of the free energies obtained with
MM_PBSA.

GAS = ELE + VDW + INT

Equation 5.1

PBSOL = PBSUR + PBCAL

Equation 5.2

PBELE = PBCAL + ELE

Equation 5.3

PBTOT = PBSOL + GAS

Equation 5.4

TSTOT = TSTRA + TSROT + TSVIB

Equation 5.5

ΔG_PB = PBTOT - TSTOT
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Equation 5.6

From Equation 5.4 - 5.6, the free energy of the system (ΔG_PB) is calculated as
the summation of the molecular mechanic energy (GAS), the solvation free energy
(PBSOL), and the total entropy multiplied by the temperature (TSTOT). Sander was used
to determine the GAS term (Equation 5.1), which represents electrostatic interaction
(ELE), van der Waals (VDW), and internal energy (INT). Poisson-Boltzman (PB)
approach using Delphi102 was applied to calculate the hydrophobic contribution to
solvation free energy (PBSUR) and the reaction field energy (PBCAL) which are
summed to give PBSOL (Equation 5.2). The total entropy (TSTOT), composed of
translational (TSTRA), rotational (TSROT), and vibrational (TSVIB) entropies, were
calculated using the nmode module in Amber
The production trajectories from frame 500 to 1950 ps were used in the
MM_PBSA calculation after water and ions were stripped out. To insure the MM_PBSA
results for CG8CPh and CG8MMPh were consistent and comparable with the previous data
set for CG, CG8Ph, CG8Tol, and CG8HMPh, MM_PBSA in Amber version 7110 was used.
Free energy calculations were performed on both the B and Z forms and by subtracting
the free energy of B-DNA (ΔG_PB_B) from the free energy of Z-DNA (ΔG_PB_Z),
ΔΔG_PB_ZB was obtained. This value was then used to compare the effect of aryl
adducts on B-Z conversion and determine the relative stability of the two forms. A
negative value for ΔΔG_PB_ZB indicates that the transition from B to Z is energetically
favorable. The free energies of the modified and unmodified CG decamers in B and Z
form calculated by MM_PBSA method are reported in Table 5.5.
Sietraj was used as an alternative method to MM_PBSA to calculate the free
energy from molecular dynamic trajectory of CG decamers. Rather than setting DNA as a
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single molecule in the system and calculating the absolute free energy, as we did in
MM_PBSA calculation, a DNA duplex was considered to be two molecules binding, one
a receptor and the second a ligand, though these two parts are identical. The binding free
energy (ΔG) was then calculated as the difference in free energies between the isolated
palindrome strands that comprise the duplex and the duplex itself. Generally, sietraj uses
a similar approach as MM_PBSA to obtained ΔG with the following exceptions: sietraj
neglects the vibration entropy, a different surface generation method is used107, and
sietraj uses an internal Poisson solver111,112. As with the MM_PBSA calculations, a
ΔG_ZB was calculated. The binding free energies of the modified and unmodified CG
decamers in both B and Z form are reported in Table 5.6 as is ΔG_ZB negative values
indicate the Z-DNA form is preferred.
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Table 5.5 The free energies of the unmodified and modified CG decamers calculated with the MM_PBSA method
Energy
(kcal/mol)
ELE
VDW
INT
GAS
PBSUR
PBCAL
PBSOL
PBELE
PBTOT
TSTRA
TSROT
TSVIB
TSTOT
ΔG_PB
ΔΔG_PB_ZB

CG

CG8Ph

CG8Tol

CG8HMPh

CG8CPh

CG8MMPh

B
Z
-817.40
-63.41
-164.30
-196.20
939.70
953.50
-42.00
693.89
17.63
16.43
-4858.00
-5604.00
-4841.00
-5587.00
-5676.00
-5667.00
-4883.00
-4893.11
15.57
15.57
15.18
15.20
490.30
478.70
521.05
509.47
-5404.05
-5402.58
1.47

B
Z
-821.80
-65.69
-169.60
-194.20
968.40
975.80
-23.00
715.91
17.90
17.14
-4839.00
-5593.00
-4821.00
-5576.00
-5661.00
-5659.00
-4844.00
-4860.09
15.59
15.59
15.22
15.23
497.30
493.30
528.11
524.12
-5372.11
-5384.21
-12.10

B
Z
-698.30
53.67
-171.80
-195.20
975.20
981.00
105.10
839.47
17.99
17.35
-4977.00
-5729.00
-4959.00
-5712.00
-5676.00
-5675.00
-4853.90
-4872.53
15.60
15.60
15.23
15.24
501.70
499.30
532.53
530.14
-5386.43
-5402.67
-16.24

B
Z
-812.71
-24.78
-171.10
-196.50
955.90
983.50
-27.91
762.22
17.89
17.43
-4838.00
-5625.00
-4820.00
-5607.00
-5651.00
-5649.00
-4847.91
-4844.78
15.60
15.60
15.21
15.25
500.30
503.00
531.11
533.85
-5379.02
-5378.63
0.39

B
Z
-765.59
-360.68
-177.38
-161.64
1111.28
1161.11
168.31
638.79
18.37
17.48
-4635.08
-5030.51
-4616.72
-5013.03
-5400.67
-5391.19
-4448.41
-4374.24
15.61
15.61
15.19
15.29
526.67
521.01
557.47
551.91
-5005.88
-4926.15
79.73

B
Z
-730.40
-470.84
-153.52
-147.59
1150.98
1244.11
267.06
625.68
30.80
30.72
-4778.74
-5036.44
-4747.94
-5005.72
5509.13
-5507.29
-4480.88
-4380.04
15.61
15.61
15.24
15.32
533.88
533.15
564.73
564.08
-5045.61
-4944.12
101.49

Table 5.6 The free energies of the unmodified and modified CG decamers calculated with the sietraj method.

B

ΔG

673.71

ΔΔG_ZB

CG8Ph

CG

Energy
(kcal/mol)

Z

B

649.39

676.46

-24.32

CG8Tol
Z

B

646.85

663.48

-29.61

CG8HMPh
Z

B

649.40

656.04

-14.08
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CG8CPh
Z

B

634.13

851.66

-21.91

CG8MMPh
Z

B

782.18

780.43

-69.48

Z
740.72

-39.71

The experimental results obtained by CD and NMR have shown that the order of
Z-DNA preference is CG8CPh, followed by CG8Ph, CG8MMPh, CG8HMPh, then CG8Tol, and
finally CG based on the required salt concentration to obtain 50% of Z-DNA form. The
free energy analysis study has been conducted in order to try to elucidate the factors
underlying these results and therefore be able to explain the effect of selected aryl
adducts on both B and Z-DNA stability and help us understand how the aryl adducts
cause the conformational change.
The destabilization effect of aryl adduct on the B-DNA conformation was
expected. This is based on the well known effect of the steric interaction that occurs
between the the C8-arylguanine and the H-2′ proton which can be avoided if the
nucleoside adopts a syn conformation. However, for base pair formation, the C8arylguanine base must adopt the anti in B-DNA. From the structural analysis of the
computational data, B-DNA destabilization effect of C8-arylguanine adducts can be
inferred from the helicoidal parameters that show the modified oligonucleotides are
distorted from the unmodified oligonucleotide when in the B-DNA form. Besides steric
effects, structure analysis on different p-substituent derivatives has suggested that an
electronic effect may also be important in the B-DNA destabilization as seen in case of
CG8CPh. The dual interactions, steric and electronic, of p-carboxyphenyl adduct may
explain its remarkable effect on B-Z conversion.
A more interesting question is how the aryl adducts affect Z-DNA stability.
Because the aryl adducts can drive B to Z form without significantly increasing
denaturation, which could be a reasonable alternative to B-Z conversion, one would
expect that the C8-aryl adducts should stabilize Z form or at least would not destabilize it.
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Structural analysis has shown the similarity of helical parameters among the unmodified
CG, CG8Ph, CG8Tol, and CG8HMPh suggesting that phenyl, p-tolyl, and phydroxymethylphenyl did not alter the conformation in any significant extent. On the
other hand, p-carboxyphenyl and p-methoxymethylphenyl have distorted the Z form of
CG decamer in the way that would destabilize Z form which would contradict to our
initial idea toward these two adducts. In contrast, since, in the Z-DNA form, the purines
adopt a syn conformation and substituents located on the C8-guanine position lie outside
of the DNA helix, little effect upon the stability of the Z-DNA forms is expected. This
may be modulated some by the substituents attached to the phenyl ring. Groups that are
hydrophobic will tend to destabilize the Z-DNA form while just the opposite is expected
from hydrophilic substituents.
The free energy analysis of the models, then, should help verify the proposed
effects and also determine the relative weights of steric and electronic interactions.
MM_PBSA and sietraj were used to calculate the free energies of the unmodified and
modified CG decamers in both B and Z form. As seen in Table 5.5, MM_PBSA
calculation predicts that B-Z conversion would be favorable if CG decamer is modified
with a phenyl or tolyl adduct. Based on ΔG_PB_ZB, the remaining adducts should prefer
to adopt the B-DNA form, opposite from what we have observed experimentally. The
results from sietraj are different than the MM_PBSA and predict that Z-DNA should be
preferred for all of the CG decamers. It could be that the ‘zero’ point needs to be
calibrated (e.g., set the free energy of the unmodified decamer to favor the B form).
However, the predicted stability trend is also out of order based on the experimental
results.
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While the overall free energy values do not correlate with the experimental trends,
the trends of the individual components, in many cases, make some sense. Shown in
Figure 5.10 are plots of GAS and PBSOL. The unmodified and the modified
oligonucleotides are arranged along the X-axis with respect to the salt concentration at
which the fZ is 0.5. The Y-axis is the indicated value calculated by MM_PBSA. The plot
for GAS shows a slight downward trend in the stability of the B forms with the
methoxymethyl and carboxy derivative calculated to be least stable ones. The B forms of
CG8HMPh and CG8Ph are less destabilized than might be predicted assuming a linear
relationship, but the previously discussed hydrogen bonding interactions form p-CH2OH
and stacking interactions for phenyl must attenuate the unfavorable steric interactions. In
contrast, relative to the unmodified oligonucleotide, the modified base can either
destabilize the Z form (CG8Tol), have little effect (CG8HMPh or CG8Ph), or stabilize it
(CG8CPh or CG8MMPh). The effect may, in part, be due to the
hydrophobicity/hydrophilicity of the aryl group. For example, the tolyl group is the most
hydrophobic and the carboxy the most hydrophilic which parallels the Z destabilization
or stabilization caused by these groups relative to the unmodified derivative.
The plot for PBSOL, for the B form is fairly consistent with the expections.
Ingoring the values for the CG8CPh (these are the ones that are at 100 mM on the X-axis),
there is little variation in PBSOL. PBSOL is the sum of PBSUR and PBCAL (the
reaction field term) and is dominated by the latter. The specific values PBSOL for CG8CPh
(B or Z forms) suggest it is destabilized. As previously discuss, we expect the pcarboxylate group to destabilize the B-DNA form and may also destabilizing the Z-DNA
form due to the increase in negative charge, the factor that most destabilizes the Z form
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of DNA. Then, if the numbers that are used to calculate ΔG generally make sense, then
why aren’t the computational results better correlated with the experimental results? In
part the problem is that the numbers being used to calculate the difference in free energy
between the B and Z forms are both large but the difference is small. Thus, small errors
in the free energy calculation for the B form or Z form are much less significant than
when the difference is calculated.

Figure 5.10 Plots of a) GAS or b) PBSOL vs NaCl concentration required to have
50% Z conformation of CG (3600 mM), CG8Tol (1000 mM), CG8HMPh (694 mM),
CG8MMPh (669 mM), and CG8CPh (131 mM).

The current data from the free energy calculations from both methods are
inconclusive and cannot be used to accurately predict preferred conformational stabilities
(B or Z). However, this does not appear to be due to a fundamental problem with the
approach rather it more like is a problem with the accuracy of the method used.
Refinement of the methods, may in time, allow more accurate predictions.
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CHAPTER 6
DISCUSSION AND CONCLUSIONS

Aryl hydrazines and related compounds are known for their carcinogenicity4. The
mechanism of carcinogenesis is believed to initiate from metabolic activation5,6 of aryl
hydrazines which lead to the formation of harmful reactive intermediates,
arenediazonium ions and aryl radicals. Consequently, DNA adducts can form from the
reactive aryl hydrazine metabolites and these have been suggested to be the cause of
genetic alterations which eventually lead to carcinogenesis. Among several potential
hypotheses, carcinogenesis through Z-DNA stabilization by the DNA aryl adduct has
particularly caught our attention and has been one of our major research questions.
To evaluate the relevant of Z-DNA stability in aryl hydrazine carcinogenesis, the
effect of various C8-aryl adducts on B-Z conversion has been investigated using both
experimental and computational methods. We have reported on the CG decamers that
contain a C8-phenylguanine modified base22. The modification forms from
arenediazonium ions or aryl radicals generated during the metabolism of phenyl
hydrazine and may be involved in the mutagenicity of phenyl hydrazine. The resulting
adduct causes a shift in the B/Z-DNA equilibrium toward the Z-conformation. In this
study, additional examples of CG decamers that contain C8-arylguanine adducts is
described. The adducts selected for study form by metabolism of known carcinogenic
aryl hydrazines. The correlation between aryl hydrazine carcinogenicity and the shift in
B/Z-DNA equilibrium were expected, if Z-DNA stabilization or/and B-DNA
destabilization is the only major factor involved in aryl hydrazine carcinogenesis.
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The aryl modified dG phosphoramidites have been synthesized in order to prepare
the modified CG decamers through automated DNA synthesis. CD and NMR analysis
have been extensively used in this study to examine the effect of selected aryl adducts on
Z-DNA stability. The experimental results have shown there is a remarkable effect
caused by the C8-arylguanine adduct on B-Z equilibrium which is partially supported by
the computational study. The results from both methods will be discussed in this chapter.
The connection between aryl hydrazine carcinogenesis and Z-DNA stabilization/ B-DNA
destabilization will also be addressed.

6.1 Modified Oligonucleotide Synthesis
Generally speaking, the preparation of the phosphoramidites used to prepare the
C8-arylguanine modified oligonucleotides was the same as previously reported22. The
syntheses utilized a Suzuki coupling to introduce the aryl residue, and the subsequent
steps used to introduce the protecting groups, are standard. Nevertheless, a few
adaptations were made, particularly for the preparation of the p-hydroxymethylphenyl
derivative, which requires TBS protection of the benzyl alcohol group.
Using intermediates that contained the unprotected p-hydroxymethyl substituent
was found to be problematic. The nucleophilic nature of the free hydroxyl group was
expected to interfere with reactions that mechanistically required nucleophilic
substitution. However, due to the success we had making the CG8CPh oligonucleotide
without using a protected p-carboxyphenyl dG phosphoramidite, the synthesis of
CG8HMPh without p-hydroxymethyl protection was attempted. Although, the free phydroxymethyl substituent did not hinder Suzuki coupling or N2 protection, 5′OH
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protection was affected. Similar to 5′OH, the p-hydroxymethyl substituent seemed to also
be reactive toward DMTr-Cl. Thus, we obtained a bis-tritylated product. This product
was isolated and used to prepare the phosphoramidite. However, the use of this material
for automated DNA synthesis failed to provide the desired oligonucleotide, CG8HMPh.
Failure to make the desirable oligonucleotide confirmed that protection of the phydroxymethyl substituent would be necessary.
The TBS group, which has commonly been used to protect the 2′-OH hydroxyl
group of the ribose sugar in automated RNA synthesis68, was selected to serve as the
protecting group for p-hydroxymethyl substituent since it is known to survive automated
synthesis and can be removed with the same reagent as used to remove other protecting
groups following automated synthesis. Initially, 4-(TBS-O-methyl)-phenyl boronate
pinacol ester was made (Scheme 6.1) and used in the in Suzuki coupling to make
compound (6). Likely due to the hydrophobicities of the TBS and pinacol protecting
groups, the reaction was found to proceed very slowly with a very low yield of the
desired product. A suspension formed during the reaction, performed in aqueous ACN,
and the TBS protected starting material precipitated and therefore was present as a
suspension. The reaction conditions, including the amount, ratio, or type of organic
solvent (ACN, THF, DME), palladium ligands (TPPTS, TXPTS), and reaction
temperature, were varied in an attempt to cope with solubility problems and improve
reactivity and hence the overall yield but all modifications explored were found to be
ineffective.
Substitution of 4-(TBS-O-methyl)-phenyl boronic acid (compound (3)) in this
reaction scheme (Scheme 6.1) combined with increasing the ACN content in the coupling
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was found to alleviate the solubility problem and lead to acceptable yields of the desired
product (Table 6.1). Without pinacol protection, the hydrophobicity had been reduced. In
addition, by increasing the organic content of the solvent (using 1:1 instead of 2:1
water:ACN), the solubility problem was completely eliminated.

Scheme 6.1 Synthesis of 4-(TBS-O-methyl)-phenylboronate pinacol ester

Other than the problem with solubility described above, the aqueous Suzuki
coupling between 8-BrdG and aryl boronic acids has been proven to be an effective
method to make C8-aryl modified dG. While the approach only provides medium to
moderately high product yields (Table 6.1), it is a very clean and simple synthetic
procedure and obviates the need for any intermediate protection or deprotection steps.
Workup only involves precipitating the coupling products by the addition of 10% HCl to
adjust the pH to between 6-7. This step is not always necessary as compound 6
precipitated as soon as the reaction mixture was diluted with water. In this particular case
we found that by washing the precipitate with ethyl acetate was all that was required to
remove excess starting material, compound 3. Generally, it was found that precipitation
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of the coupling products, without further purification, provided sufficiently pure material
as confirmed by NMR and ESI-MS analysis of the coupling products.
Table 6.1 Synthesis yields of C8-aryl modified dG and derivatives prepared by Suzuki
coupling.
p-Substituent
on Aryl Adduct
COOH
CH2OCH3
CH2OTBS

Percentage Yield (%)
Suzuki Coupling

N2 Protection

5'OH Protection

82.6
67.1
71.8

95.7
87.6
77.3

30.9
54.5
41.4

The protection reaction of the N2 amine of 2′-deoxyguanosine residue of the
modified base produced good yields of the desired product (typically > 75%, Table 6.1).
Based on 1H NMR analysis, the nucleoside precursor was completely consumed resulting
in only the production of N2 protected nucleoside and the by-product, DMF. We found
that by precipitation of N2 protection product by the addition of water was an effective
way to remove the DMF and thereby further purify the crude product, but this procedure
resulted in a loss of product in the case of compounds (8) and (9) likely because these
products were slightly water soluble. The product of p-carboxy derivative (compound
(7)) was quite water soluble and thus could not be precipitated. Since DMF does not
interfere with 5′OH tritylation, we did not typically remove it from a crude product prior
to conducting this step.
Unlike the previous two reactions, the 5′OH protection reaction required column
chromatography to isolate the trityl protected product. The yield was relatively low (3050 %, Table 6.1) probably because of several factors including, product degradation, side
reactions, and loss of sample during column chromatography. The glycosidic bond of C8-
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aryl modified dG is weaken relative to the unmodified nucleoside, and is very acid
sensitive. In addition, the DMTr protected 5′OH is, itself, an acid labile functional group
which is easily cleaved off, reverting back to the unprotected 5′OH in the presence of
protic acid. Based on TLC obtained during the reaction, the tritylation did not go to
completion after 12 hours. Using extended reaction times, longer than 4 hours, resulted in
the production of the undesired double tritylation product (tritylation of both 5′OH and
3′OH). Thus, in order to minimize by-product formation at the cost of product yield the
reaction was stopped after 4 hours. Finally, as with the previously synthesized C8arylguanosine derivatives, using acidic silica gel as a stationary phase causes degradation
of the trityl protected product. Therefore, neutral or basic Al2O3 gel has to be used to
minimize the degradation.
Among the three nucleosides prepared in this work, the yield of the
carboxyphenyl derivative (compound (10)) was the lowest yield (Table 6.1). This is due
to the purification process we had to use - precipitation instead of column
chromatography. Because the carboxylate substituent strongly bound to the Al2O3,
column chromatography purification was not possible. However, the carboxylate
derivative 10 displayed poor solubility in dichloromethane (the reaction solvent) was low
enough such that we were able to isolate it from crude product by precipitation. Although
this method’s effectiveness has appeared to be moderately low, it was more practical than
column chromatography.
In the case of the p-hydroxymethyl derivative, the instability of TBS protecting
group toward basic conditions may explain the low yield of (12). The basicity of pyridine
and TEA used in the reaction, to neutralize the HCl formed, may also have caused
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deprotection of TBS group in (12) or the starting material. As expected the pmethoxymethylphenyl derivative did not have any significant solubility or stability issue,
therefore, the product yield of (11) was, relatively higher.
The intermediates, especially after introduction of the aryl group, were prone to
decomposition via cleavage of the glycosidic bond. The intermediates leading up to the
phosphoramidite could be purified but, even with chromatography on basic alumina,
significant decomposition occurred. Purification of phosphoramidite resulted in
degradation of product and has shown to be unnecessary since crude phosphoramidites
were effectively used to make the modified oligonucleotides. 1H NMR analysis was used
as a quick method to screen a crude phosphoramidite used in DNA synthesis. This is
somewhat complicated by the fact that the chiral phosphoramidite group was introduced
on the 3′OH and significantly increased the the multiplicity of peaks, especially sugar
protons, as the number of diastereomers present doubled.
The phosphoramidites prepared as described were successfully used to make
oligonucleotides but exhibited an unfortunate behavior of aggregate formation and
precipitation in ACN, though this behavior was not seen with other solvents. Once
formed, this material was insoluble in most aprotic solvents. The aggregate was not
identified but we speculate that it may be related to the G-quartet. Guanosine and
derivatives are known to form gels though gel formation tends to require the presence of
a metal cation. While it is unknown what the constitution of the gel is, it is relevant to
note here as it directly affects oligonucleotides synthesis.
Gel formation is relatively fast, occurring over a few minutes and this may hinder
addition of the base for coupling during oligonucleotides synthesis by limiting the access
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of phosphoramidite solution to CPG surface where base coupling takes place. It is
unlikely that the manual addition procedure was directly responsible for the relatively
low yields obtained as manual addition of unmodified bases did not decrease yields.
Instead, the lower yield with the C8-arylmodified guanines was more likely due to the
acid sensitivity of the glycosidic bond. Each base addition cycle on an automated DNA
synthesizer exposes, albeit it briefly, the growing oligonucleotide to strong acid (TCA)
which may cause partial decomposition.
Because of the possibility of incomplete extension and decomposition of
oligonucleotides containing the C8-arylguanine modification during synthesis,
purification was necessary. FPLC chromatograms of the crude CG8CPh or CG8MMPh
oligonucleotides shows a series of minor peaks associated with incomplete sequences and
degraded products that appear before the major peak of the desired product. In the case of
CG8HMPh, two large peaks were observed in the chromatogram and we believe them to be
the peaks of TBS protected and unprotected CG8HMPh oligonucleotides, which was
subsequently proved to be true by ESI-MS analysis. The TBS protected CG8HMPh was
collected and re-reacted with NH4OH to give CG8HMPh.
As expected, the retention time of CG8MMPh was shorter than CG8HMPh because the
methoxy residue decreases the hydrophilicity and thus the affinity for anion exchange
resin relative to a hydroxyl group. CG8CPh was expected to elute more slowly than the
other two oligonucleotides due to the polar nature of the –COOH group and that, under
the FPLC conditions, it is negatively charged (the FPLC conditions used to separate
oligonucleotides based on charge and hydrophobicity). Interestingly, the results from the
FPLC have shown otherwise as it was found that CG8CPh eluted faster than CG8HMPh. It is
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possible that the conformation of the carboxy bearing oligonucletide is different that that
with the hydroxymethyl derivative, perhaps screening it from the stationary phase.
Overall, in this study, we have demonstrated that our previously used methods can
be considered a standard approach for the preparation of C8-aryl modified guanine
phosphoramidites. Further, these phosphoramidites can be used for the preparation of
oligonucleotides though the utilization of them requires manual addition. The possibility
that they are sensitive to acid should be noted as it may impact on decisions as to where
to place modified oligonucleotides in a sequence. Since automated DNA synthesis is
typically from the 3′ end, decomposition will be minimized if the modified base is nearer
the 5′ end, given that the option exists. According to FPLC and ESI-MS, the synthesized
oligonucleotides were pure enough to use in structural and conformational analysis by
CD and NMR.

6.2 CD Analysis and Molar Fraction Calculation
The global conformation of oligonucleotides can be determined from the shape of
the CD curves. Therefore, the transition of B form to Z form of CG decamers can be
observed as can the B/Z equilibrium constant using CD spectroscopy. The C8arylguanine adducts have been shown to effect the B-Z equilibrium, shifting it toward the
Z-DNA form. This can be demonstrated since the modified CG decamers required much
lower salt concentrations as compared to the unmodified CG decamer. With the
exception of C8-carboxyphenyl adduct, which is obviously the best at shifting the B-Z
equilibrium toward the Z-DNA form of the CG decamer, the remaining two aryl adduct
containing oligonucleotides were similar to the phenyl derivative. At the same time and
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as will be discussed below, the NMR data and modeling results suggested that the three
oligonucleotides studied here adopted conformations different from that adopted by the
phenyl derivative. Here, we sought to put the effect on a quantitative basis and determine
equilibrium constants and therefore thermodynamic parameters.
The molar fractions of three DNA conformations (random coil, B, and Z forms)
that may be present in sample solutions of our modified oligonucleotides have been
calculated from CD data. The effect of adducts on B-Z conversion has been determined
with comparisons made based on the salt concentrations that are required to obtain CG
decamers in 50 % in the Z form (fZ = 0.5, Figure 4.13). The lower the salt concentration
needed to achieve this indicates a greater effect on B-Z equilibrium. Based on the
response to salt concentrations, then, CG8CPh was found to be the most prone to form the
Z-DNA conformation followed by CG8Ph, CG8MMPh, CG8HMPh, and finally CG8Tol.
The effect is partially due to destabilization of B-DNA form, as suggested from
Figure 4.14, which illustrates the modified DNA have higher concentrations of the singlestranded DNA (ssDNA) forms under a given set of conditions (i.e., denaturation of the B
DNA is occurring) than the unmodified DNA, especially at lower salt concentrations,
conditions under which the B form should be predominant. To the extent that the ssDNA
and Z forms are in equilibrium and that increasing the concentration of the ssDNA form
will tend to drive the equilibrium toward the Z form, this may be one of the possible
factors that affect the B-Z equilibrium. The position of the B-Z equilibrium is one
measure of the effect of the aryl modification. However, it is a relative one and does not
directly address if the effect is one of destabilizing the B-DNA form, stabilizing the ZDNA form, or both. To explore this aspect, we used the melting temperature (Tm) data
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(Figure 6.1) and, in particular, selected the conditions under which molar fraction was fss
= 0.5. For the unmodified CG decamer, Tm continuously dropped as salt concentration
increased. Ignoring the effect of salt concentration on Tm (for a B DNA, increasing the
salt concentration tends to increase the Tm), the overall decline in Tm (e.g., above 500
mM NaCl) reflects the shift in the B-Z equilibrium toward the Z form, which
predominates at high salt concentration. Thus, based on Tm, the Z-DNA form is less
stable than the B-DNA form.

Figure 6.1 The Tm of the unmodified and modified CG decamers in phosphate buffer
pH 7.4 with NaCl concentration of a) 0-4000 mM. The expansion of 0-500 mM is
shown in plot b).
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Introduction of the aryl adduct clearly altered the stabilities of B and Z-DNA.
The effect was the most pronounced for the B form and the aryl group tended to
destabilize as can be seen by considering the decline of Tm at low salt concentration for
all modified CG decamers. The source of this destabilization, in part, is likely due to a
steric effect of C8-aryl as there is limited space around C8-position of an anti G6 in B
form of CG decamer. In this regard, the Tm of CG8CPh, CG8Tol and CG8HMPh are unique
and show a sharp and substantial decline, initially, as the salt concentration is increased
and this is not observed for the CG8Ph or CG8MMPh oligonucleotides. This behavior does
not seem to be consistent with being caused by only steric interactions to explain the Tm
results since p-CH3, p-COO- and p-CH2OH are all of similar size to the p-CH2OCH3
group. An electrostatic interaction may play an additional role to destabilize B form of
CG8CPh as, at pH 7.4, the carboxylic group will be negatively charged and may
unfavorably interact with the phosphate backbone. While not charged, and potentially Hbonding to the phosphate backbone, the p-CH2OH also bears lone-pairs and, if H-bonding
is occurring, will also be more negatively charged than an isolated alcohol oxygen. The
suggestion of electronic destabilization is supported by the molecular modeling results.
Based on the most representative structures of B-CG8CPh and B-CG8HMPh, the nearest
distance between negatively charged oxygens of p-COO- and C5 phosphate oxygen was
3.4 Å while the neutral oxygen of p-CH2OH was even closer to C5 phosphate oxygen
with the distance of 2.8 Å (Figure 6.2). The distances were far more than 10 Å in Z form
of both oligonucleotides, diminishing the electronic effect that may be existed in B form.
Note that the lack of negatively charge of p-CH2OCH3 and longer distance from C5
phosphate may explain why the Tm of CG8MMPh does not follow this trend (though it may
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and additional points near 0 mM NaCl need to be collected). The most representative
structure and helical parameters obtained from structure analysis in computational study
does support the idea of B-DNA destabilization. However, electrostatic interactions like
those described for B-CG8CPh and B-CG8HMPh clearly are not possible for CG8Tol and other
or additional factors must be involved.

Figure 6.2 Snapshot shows possible electrostatic interaction between C5 phosphate
and the p-substituents of aryl adducts on CG8HMPh (left) and CG8CPh (right).
Although the destabilization of B form can be extrapolated from the Tm data, the
effect of the aryl adduct on Z-DNA stability is more difficult to ascertain. This is because
as the temperature increases and the Tm approached, an ever increasing amount of the Z
DNA form converts to the B-DNA form prior to melting. Therefore, it is not necessarily
correct to compare the stability of Z-DNA based on the observed Tm only, even at higher
salt concentrations. Nevertheless, if it can be assumed that at 4000 mM NaCl, that most
of the modified oligonucleotides are in the Z-DNA conformation during melting, then
some comparisons can be made. In particular, if there is destabilization of the Z-form
then the order is CG8Tol > CG8MMPh > CG8HMPh > CG8Ph > CG8CPh.
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6.3 NMR Analysis
In addition to the global conformation of DNA that can be detected by CD, the
determination of local conformation can be obtained from NMR analysis. The results
from the NMR studies were mainly in agreement with the CD data. Thus, they confirm
that at low salt the modified CG decamers were in B form while Z form was a
predominant conformation in samples containing high salt concentrations. The latter is
demonstrated by the strong nOe cross peak of H8/H-1′ suggesting that the purines (dG)
were adopting the syn-conformation as they are in Z-DNA.
The chemical shifts of C8-aryl adduct of G6 (Table 6.2) have implications for
what is the local structure of G6 in the B and Z forms. The aryl adduct protons of the B
form were found to be upfield relative to these protons in the Z form. This indicates that,
in the B conformation, G6 may be positioned in such a way that the aryl ring of the
adducts are under an influence of the π system of the 5′ pyrimidine ring (C5). This would
produce a shielding effect on aryl adduct protons, shifting them upfield. This suggestion
is supported by the molecular modeling results that show partial stacking/overlapping
aryl ring of the C8-aryl adduct located at the G6 and the pyrimidine at C5 in B form of
modified CG decamers. Unlike B forms, the aryl adducts in Z forms are pointed away
from and are entirely outside of the helical axis and therefore cannot be shielded by
neighboring bases.
It is also key to note that there were five distinct chemical shifts observed for the
phenyl adduct in B form. This is not what was observed for the new adducts, rather the
protons located at both the ortho and meta protons relative to the p-substituent were
equivalent and displayed a the typical AA′XX′ pattern of a 1,4-disubstituted benzene ring
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and not four distinct resonances. One explanation for this is that there is free rotation
about the aryl-dG bond in the p-substituted aryl systems such that the two ortho or meta
protons can interconvert, but not in the phenyl substituted system. Based on structural
analysis in computational study, the helical parameter suggested more stacking between
phenyl adduct and pyrimidine of C5 which may constraint the phenyl adduct so that it
can not rotate as fast as other adducts.

Table 6.2 1H NMR assignment of C8-aryl G6 adduct in CG decamers.
DNA

Chemical shifts of aryl adducts protons (ppm)
B form

Z form

6.35 ,7.04 ,7.28 ,7.32 ,7.33

7.55, 7.65, 7.84

CG8Tol

6.28, 6.86

7.64, 7.69

8CPh

6.72, 7.79

7.81, 8.16

8MMPh

CG

6.38, 7.08

7.74, 7.77

CG8HMPh

6.37, 7.09

7.73, 7.76

8Ph

CG
CG

The assignment of non-exchangeable protons to each base in CG decamer
sequences has shown some interesting trends in chemical shifts that contain structural
implications. The aryl adducts have structurally affected their neighboring base as we
observed from the altered chemical shifts. In case of the unmodified B-CG (Figure 6.3a),
the chemical shifts for most of a given type of proton were fairly constant except at the
ends were fraying effects modulate shifts, and are consistent with well oriented base pairs
in a double helix. In contrast, the C8-aryl adduct on G6 of, for example, B-CG8MMPh
(Figure 6.3b), caused discontinuities in chemical shift of all protons of G6 and C5 (G15
and C16) suggestive of a local disruption in structure. This also supports the CD results
that show the aryl adduct destabilized B form.

173

Molecular modeling studies suggested the same idea and have been used to help
explain some of the abnormality in chemical shifts of the modified CG decamers. For
instance, in the model of the B-CG8MMPh, C5:H6 and C5:H-2′ are located right above the
aryl adduct on G6 which should position them such that they should be shielded and be
upfield shifted as observed. Likewise, the unusual downfield H-1′ of C7 could be a
consequence of a remarkably close distance (2 Å) between the H-1′ and G8:N7, which
were generally farther (5 Å) for other cytosines. All aryl adducts (except for pcarboxyphenyl due to unavailable NMR assignment of B-CG8CPh) have been show to
cause similar patterns in chemical shift plots of protons in oligonucleotides in B form.
The conformational transition of B to Z form requires rearrangement of the DNA
structure that is reflected in the change in proton chemical shift. By comparison of proton
chemical shift plots of the B-CG (Figure 6.3a) and Z-CG8CPh (Figure 6.4a) or Z-CG8MMPh
(Figure 6.4b), we can observe the differences in chemical shift between B and Z-DNA.
The most notable ones were including the downfield shifts of G:H-1′, C:H5, and the
upfield shift of C:H-2′. The key to these chemical shift changes is based on the transition
of anti-dG to syn-dG as occurs when B-DNA converts to the Z conformation. In B form,
dG bases are in the anti-conformation such that H-1′ of dG are positioned deep inside the
helix and are probably shielded by neighboring pyrimidines. Similarly, H5 of dC
experience a shielding effect caused by the purine of 5′ dG. Once the conformation of dG
reverses to syn, the shielding effects are no longer possible resulting in downfield
chemical shifts of G:H-1′ and C:H5. On the other hand, the syn conformation of dG
places H-2′ of dC closer to N2 amino group of 5′ dG causing C:H-2′ to be slightly
upfield.
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Figure 6.3 The plots of non-exchangeable proton chemical shifts of each base in a) BCG and b) B-CG8MMPh

Figure 6.4 The plots of non-exchangeable proton chemical shifts of each base in a) ZCG8CPh and b) Z-CG8MMPh
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As we can see from the continuity of plot of chemical shift in Z form, the aryl
adducts do not seem to disrupt the structure of Z form as they did in B form. This remark
is generally supported by the model of modified CG in the Z-DNA conformation with the
exception of Z-CG8CPh. In this case, the aryl adduct is pointed away from the helical axis
due to syn-glycosidic bond of G6 that position such that the steric interaction between H8
and H-2′/2′′ was reduced. Consequently, this would prevent the aryl adduct from
interacting and interfering with base pairing, unlike what occurs when this adduct adopts
the B-DNA form. NMR analysis has suggested additional structural information that the
aryl adducts favor Z over B conformation.

6.4 Computational study
The most representative structures and helical parameters have shown that the
aryl adducts, in general, distorted the B conformation. Based on general considerations,
the bulkiness of aryl adducts is the likely cause of the structural deformations. However,
the simulations of various aryl modified CG decamers have pointed toward the possibility
that other interactions may also play important roles with respect to the effect of them on
the B-DNA conformation, both locally and globally. A major factor is the occurrences of
stacking interactions between the C8-aryl adduct on G6 and pyrimidine ring of C5 was
found to be energetically possible, especially in the case of the phenyl adduct.
Structurally, this interaction requires, locally, increase rise and negative slide of the base
pair which, in turn, stretches the duplex. These changes decrease the overall contribution
of base-base stacking and destabilize the B-DNA conformation.
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There may also be electrostatic repulsion between the p-substituent that further
decreases the overall stability of the B-DNA. All of the aryl adducts have been shown to
cause compression of the minor groove (decreased width). Decreasing the minor groove
width causes the phosphate groups to be closer to one another causing an unfavorable
electrostatic interaction. In addition, depending upon the specific adduct, additional
unfavorable electrostatic factors may further destabilize the B-DNA form as in the case
of the p-COO- derivative in which the negatively charged carboxylate group is position
near the negatively charged phosphate backbone. This additional factor is the likely cause
of the low stability of B-CG8CPh that observed in Tm profile (Figure 6.1).
The simulations of the C8-arylguanine adducts in the Z-DNA conformation have
not elucidated the order of stability experimentally determined. Except for CG8CPh and
CG8MMPh, in which the aryl adducts seemed to have caused some effects on duplex
structure. Nevertheless, with current data from the structure analysis, the computational
studies have not fully explained how the aryl adducts are effecting Z-DNA stability.
The free energy calculation was conducted in an attempt to gain more information
regarding Z-DNA stability, but the free energy calculations based on MM_PBSA or
sietraj are not in agreement with the experimental results. There are several potential
reasons for this that were previously discussed and additional reasons, such as the effect
of the choice of sampling (i.e., which structures are used to calculate the free energy)
which has been shown to provide different free energy results. Also, it is possible that the
length of simulations were insufficient. This is particularly true for the Z-CG8MMPh as the
RMSd plot indicated that the structure was still drifting from the starting structure and
changing helicoidal parameters determined with Dials & Windows, even after 4 ns of
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MD. Revision or continuation of the simulation(s) of the Z-DNAs may be required to sort
out the problem with the computation and thereby resolve the differences observed
between the experimental and computational results.

6.5 Thermodynamic study
The B-DNA destabilization effect of the aryl adducts seems to be clear based on
the CD, NMR, and computational studies. The effect on the Z-DNA form is still
ambiguous. Thermodynamic studies may be able to aid in understanding what is driving
the shift in the B-Z equilibrium as a function of the aryl adducts. The van’t Hoff plot of
the B-Z equilibrium has been made to obtain thermodynamic parameters including ΔH,
ΔS, and ΔG20,21,85. The system equilibrium has been simplified to ease the calculation as
depicted in Figure 6.5, and assumes that B, Z, and ssDNA are the only species present
and simplifies the analysis by assuming that only the B and Z forms interconvert (KB-Z).
The alternative is that this is a three species equilibrium (i.e., B/ss followed by ss/Z rather
than B/Z) but is much more difficult to fit.

Figure 6.5 A diagram shows equilibrium between B-, Z-, and ssDNA
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The van’t Hoff equation was derived as following

ΔG = ΔH – TΔS

Equation 6.1

ΔG = -RTlnKB-Z

Equation 6.2

lnKB-Z = -ΔH/RT + ΔS/R

Equation 6.3

ln(fZ/fB) = -ΔH/RT + ΔS/R

Equation 6.4

ln(fB/fZ) = ΔH/RT - ΔS/R

Equation 6.5

Based on Equation 6.5, by plotting ln(fB /fZ) against 1/T, ΔH can be obtained from
slope (ΔH/R) and ΔS can be obtained from intercept (-ΔS/R), where R is the gas constant
(1.9872 cal mol-1K-1). The van’t Hoff plots of B-Z transition of the unmodified and
modified CG decamers are shown in Figure 6.6 and the thermodynamic parameter are
reported in Table 6.3. From the thermodynamic data, the B-Z conversion was mainly
enthalpy driven. The aryl adducts make the transition to the Z-form more favorably by
lowering energy of the Z-DNA form based on significant enthalpy change, even though
the B-Z conversion process of the modified oligonucleotides reduces the entropy of the
system. Although the negative ΔG of B-Z conversion indicates that the process was
energetically favorable (which is obvious), it does not elucidate the source of the
stabilization.
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Figure 6.6 The van’t Hoff plot of B-Z transition of the unmodified and modified CG
decamer in phosphate buffer pH 7.4 with 500 mM NaCl.

Table 6.3 Thermodynamic parameters for B-Z transition of the unmodified and modified
CG decamer in phosphate buffer pH 7.4 with 500 mM NaCl at 298°K (25°C).
DNA

Slope

Intercept

R2

CG
CG8Ph
CG8Tol
CG8CPh
CG8HMPh
CG8MMPh

-5.33
-16.30
-15.06
-10.85
-14.63
-13.30

22.52
52.65
49.98
33.04
47.74
43.39

0.95
0.99
1.00
0.99
0.99
0.98

ΔH
(cal mol-1)
-10594
-32389
-29933
-21553
-29071
-26426

ΔS
(cal mol-1 K°-1)
-44.75
-104.62
-99.33
-65.66
-94.86
-86.23

ΔG
(kcal mol-1)
2.74
-1.21
-0.33
-1.99
-0.80
-0.73

To further explore the idea that the aryl adducts stabilize the Z-DNA form and
thus work synergistically with their effect of destabilizating the B-form, ΔG of Z and BDNA duplex binding have been estimated using the same method as used for B-Z
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conversion. A decline in ΔG (i.e., more negative) would be expected if the duplex in the
Z-form was stabilized in the presence of an aryl adduct, since this means higher energy is
required to denature double strand DNA to single strand DNA. On the other hand,
increase in ΔG means CG decamer duplex was destabilized by an aryl adduct. The
thermodynamic parameter of B-DNA and Z-DNA duplex binding are shown in Table 6.4
and 6.5.
Table 6.4 Thermodynamic parameters for B-DNA duplex binding (ssÆB) of the
unmodified and modified CG decamer in phosphate buffer pH 7.4 with 500 mM NaCl at
298°K (25°C).
DNA

Slope

Intercept

R2

CG
CG8Ph
CG8Tol
CG8CPh
CG8HMPh
CG8MMPh

-21.22
-7.11
-6.65
-7.28
-7.88
-8.45

59.65
20.65
19.16
21.78
23.35
24.44

0.98
0.95
0.91
0.93
0.96
0.96

ΔH
(cal mol-1)
-42176
-14123
-13213
-14475
-15655
-16793

ΔS
(cal mol-1 K°-1)
-118.53
-41.03
-38.07
-43.28
-46.40
-48.58

ΔG
(kcal mol-1)
-6.85
-1.90
-1.87
-1.58
-1.83
-2.32

Table 6.5 Thermodynamic parameters for Z-DNA duplex binding (ssÆZ) of the
unmodified and modified CG decamer in phosphate buffer pH 7.4 with 1000a mM NaCl
at 298°K (25°C).
DNA

Slope

Intercept

R2

CG
CG8Ph
CG8Tol
CG8CPh
CG8HMPh
CG8MMPh

-16.94
-27.86
-20.19
-15.46
-27.55
-19.04

52.58
85.28
62.37
46.06
84.17
57.74

0.99
0.97
1.00
0.95
0.97
0.99

ΔH
(cal mol-1)
-33655
-55353
-40130
-30718
-54743
-37840

a

ΔS
(cal mol-1 K°-1)
-104.48
-169.46
-123.94
-91.52
-167.26
-114.74

ΔG
(kcal mol-1)
-2.52
-4.85
-3.20
-3.44
-4.90
-3.65

Data points at 1000 mM were used in van’t Hoff plot of Z-DNA Æ ssDNA instead of at 500
mM due to the fZ data of the unmodified CG that available only at higher salt concentration.
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By comparing ΔG of the modified CG decamers to the unmodified one, we have
again confirmed that the aryl adduct destabilized B form and by far B-CG8CPh was the
least stable one as expected from experimental and computational studies. More
importantly, we have finally demonstrated that the aryl adducts actually stabilized ZDNA as ΔG of Z-DNA binding were lower in case of the modified CG decamers.
The aryl adduct stabilizes the Z-DNA by reducing system enthalpy and suggests,
from the thermodynamic parameters obtained and shown in Table 6.5, except in the case
of the p-carboxyphenyl adduct. This unique behavior was actually observed in the most
representative structure in which the Z-CG8CPh seemed to bind relatively loose compared
to the rest of CG decamers.
Note that Z-DNA is known to be unusually rigid20,21 as compared to its
counterpart B conformation or other DNA conformations. The decrease in entropy of the
modified CG decamers compared with the unmodified one may suggest that the aryl
adducts have affected the structure of Z-DNA such that it is even more rigid than the
unmodified version. The computational study has shown us that the Z form of CG8CPh
seemed to be more flexible compared to the rest of modified CG decamers. This notion
corresponds to the free energy estimation that formation of Z-CG8CPh has the smallest
entropic penalty. The unique electronic effect of p-COO- is likely involved in driving
structural change in a way that lowered rigidity of Z form compared to other aryl adducts.
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6.6 Relevance of the B-Z Transition in Aryl Hydrazine Carcinogenesis
To evaluate the role of B-Z transition in aryl hydrazine carcinogenesis, we have
set out to make the modified CG decamers with selected C8-arylguanine adduct. By
linking the effect of the aryl adduct on Z-DNA stabilization/B-DNA destabilization and
carcinogenic profile of the aryl hydrazine that serves as the precursor to adduct
formation; we hoped to show the relevance of B-Z equilibrium in carcinogenesis will be
revealed. While it has been shown in our study that all studied carcinogenic aryl
hydrazines can generate aryl adducts that stabilized Z-DNA and/or destabilized B-DNA
and shift the B-Z equilibrium toward the Z-DNA form, we also hoped that a ranking of
the effect would correlate with the carcinogenicity of the aryl hydrazines.
There have been numerous studies of the mutagenicity and/or carcinogenicity of
aryl hydrazines and related chemicals. These studies have been conducted in a wide range
of several cell lines and animals4. Although the pool of carcinogenic data is large, a
consistent data set (e.g., same dose, species, etc.) in which the carcinogenicities of
various aryl hydrazines were compared under identical conditions is unavailable. Usually
different models or conditions were used for each study and a clear ranking is difficult to
create. The most comprehensive carcinogenic profile was from Lawson, T., et al., work
that was conducted in collaboration with our lab in 199546. In this study, the
mutagenicities of selected aryl hydrazine metabolites, including MBD, HMBD, MMBD,
and CBD, were measured in TA102 and V79 cells. The result on TA102 (Figure 6.7)
suggests that the mutagenic potency of arenediazonium ions was in order of MBD >
HMBD > MMBD > CBD, which turned out completely opposite to the trend the resulting
adducts derived from the benzenediazonium ions have on the B-Z equilibrium found in
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this study. Note that MBD gives p-tolyl adduct while HMBD, MMBD, and CBD give phydroxymethylphenyl, p-methoxymethylphenyl, and p-carboxyphenyl adducts
respectively.

Figure 6.7 Mutagenicity of arenediazonium ions in TA102 cells

Considering that the known mechanism of mutagenesis in TA102 model was
based on the frame shift caused by mutation specifically at a ‘hot spot’ comprised of five
consecutive A-T base pairs113, the data seemed to be less relevant and may not be directly
applicable to our work that used CG decamer sequence as a testing model of B-Z
equilibrium.
The result obtained from the V79 assay, a more difficult but more relevant assay
(mammalian cells rather than bacteria). The assay itself is run in Chinese hamster ovarian
cells and is based on the mutation of the hypoxanthine-guanine phosphoribosyl
transferase (HGPRT)114,115. The mutagenicity of the arenediazonium ions based on this
mutational analysis are shown in Figure 6.8 and show a different pattern of mutagenicity
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in which MBD is now the weakest mutagen and the order of the remaining three
arenediazonium ions is as observed in the Ame’s assay.

Figure 6.8 Mutagenicity of arenediazonium ions in V79 cells.

The mutagenic trend of arenediazonium ions in the V79 assay was better
correlated with the results we had obtained regarding the Z-DNA stabilization effect
observed for the modified oligonucleotides we had examined (p-hydroxymethylphenyl >
p-methoxymethylphenyl > p-carboxyphenyl > p-tolyl) though the p-carboxyphenyl was
out of order depending upon whether the effect of salt or Tm was used for the
comparison. However, if the effect of the adducts on B-DNA stabilization is included, the
mutagenic trend seemed to be unrelated to the effect of the adducts on B-Z equilibrium.
The situation is further complicated if the stability of arenediazonium ions (tested in
aqueous solution) is taken into account. If this factor is included then a possible
correlation between mutagenicity and the B-Z equilibrium can be made. In particular,
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arenediazonium ions are highly electrophilic and decompose very fast in cells culture
media. The stability of arenediazonium in Williams medium E (WE) used in V79 study
decrease in the order HMBD > MBD > MMBD > CBD (29%, 26%, 20%, and 14%
remaining after 16 hrs in WE). The corresponding p-substituted phenols form as the
arenediazonium ions decomposed. The degradation of the tested chemical in WE could
greatly affect their mutagenicity and should be considered along with the reported data.
The adjusted trend (Figure 6.9) on mutagenicity of aryl hydrazines was generally
aligned with the trend observed for the effect of the aryl adducts on the B-Z equilibrium.
The tolyl adduct, which had the least effect on B-Z equilibrium forms from MBD, the
weakest mutagen in V79 study. In addition, the V79 mutagenicity of HMBD was
significantly higher than MMBD at a 10 µM dose, but the difference disappeared when
tested at higher concentrations (50 µM and 100 µM dose) as the p-hydroxymethylphenyl
and p-methoxymethylphenyl adduct have similar effect on B-Z conversion. Finally, as
seen in Figure 6.8, the mutagenicity of CBD was relatively low, but after the stability of
CBD in WE was considered, CBD was among the strongest mutagenic in the series and
correlates with the result that p-carboxyphenyl adduct was the best at promoting B-Z
transition.
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Figure 6.9 Mutagenicity in V79 cells factoring with arenediazonium ions stabilities.

An additional factor that needs to be considered is repair. While this is not an
issue in the Ame’s assay, in other settings, the rate of repair of damaged DNA (e.g.,
following adduct formation) is of considerable importance. A famous example of this is
the O6-methyl and N7-methyl guanine adducts that form from N,N-dimethylnitrosamine.
The latter is formed in vivo in amounts that are ten times that of the former116. However,
the N7-methyl adduct is rapidly repaired while the O6-methyl adduct persists117. In the
present case, the adducts all cause some degree of distortion of the DNA they are in. The
tolyl adduct causes the greatest amount of distortion and is likely to be ‘seen’ by repair
enzymes much more readily than the p-hydroxymethylphenyl adduct which produce only
minor distortion of the DNA. Thus, how long the adducts persist may also play a
significant role in the carcinogenicity of the parent aryl hydrazines.
Overall, it is unlikely that a simple correlation will be found between, for
example, the Ames’ Assay, V79 assay, repair assays, etc. Instead, all data, including the
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conformational effects of the adducts will need to be considered to ascertain the role the
B-Z equilibrium may play in aryl hydrazine mutagenesis and/or carcinogenesis. At the
same time, our data do suggest the possibility of a correlation between aryl hydrazine
carcinogenesis and B-Z equilibrium and therefore provides reasonable cause to continue
with studies in a more biological setting (cellular level or in vivo) to more clearly
determine the relationship between carcinogenicity and the effect of the aryl adducts on
B-Z equilibrium.

6.7 Conclusion
Aryl hydrazines and related compounds have been known to be carcinogens
several decades. Likewise, they have been extensively studied yet a mechanism or
mechanisms of carcinogenesis is still unclear. The DNA aryl purine adducts generated
from reactive metabolites of aryl hydrazines, including arenediazonium ions and aryl
radicals, are suspected to be involved in or the cause of carcinogenesis like other adducts
generate from non-hydrazine carcinogens (aminofluorene17, PAHs48, etc.). Several
possible effects of the aryl adduct on DNA that may lead to genetic alterations have been
suggested, among them the effect on the B-Z equilibrium as caused by aryl adducts has
caught our interest.
The biological relevance of Z-DNA has been extensively studied and debated
especially during the 1980’s, though the debate continues and the scientific community as
since largely ignored Z-DNA in a biological context. A similar history occurred for
triplex DNA as when if was first discovered in 1957 it was consider an anomaly and
nearly 30 years passed before a biological role was found. It was not until recently that Z-
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DNA regained biological interest as Z-DNA formation has been shown to be an
intermediate in activation process of CSF-137 which indicates possible biological role of
Z-DNA in gene transcription. In addition, the mutagenic potential of Z-DNA has been
proposed based on the result that links Z-DNA to DNA damage such as genetic deletions
in mammalian cells45. These studies have pointed out the possibility that unregulated ZDNA formation could consequently trigger genetic alteration and lead to carcinogenesis.
With the possibility that aryl adducts formed from aryl hydrazines may promote B-Z
transition like the well-known C8-bromo or C8-methyl guanine adducts, we have
proposed that aryl hydrazine carcinogenesis may occur through altering the B-Z
equilibrium facilitated, in the case of aryl hydrazines, by the aryl adduct. Therefore, we
have set out to investigate 1) the effect of aryl adducts formed from aryl hydrazines on BZ DNA equilibrium and 2) the relevancy between Z-DNA formation and aryl hydrazine
carcinogenesis.
To this end, the CG decamer has been selected as the model system to investigate
the effect of C8-arylguanine adducts on B-Z transition. The unmodified and modified CG
decamers, including CG8Ph, CG8Tol, CG8CPh, CG8MMPh, and CG8HMPh, were successfully
made through Suzuki coupling and phosphoramidite chemistry. Structural and
conformational analyses of the synthesized oligonucleotides, conducted by using CD and
NMR, indicates that C8-arylguanine adducts have facilitates Z-DNA formation. The
quantitated effect of adducts on B-Z transition estimated from salt concentration required
to have CG decamers in Z form at a level of 50% suggests the preference on Z-DNA
formation is in the order CG8CPh > CG8Ph > CG8MMPh > CG8HMPh > CG8Tol. The melting
temperature data shows that the adducts destabilize the B-DNA form. The
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thermodynamic studies have confirmed the B-DNA destabilizing effect and show a
simultaneous stabilizing effect on the Z-DNA form is caused by the C8-arylguanine
adducts.
Computational studies have been used to understand and explain the local and
global effects of the aryl adducts that drive B-Z conversion. The steric effect from C8arylguanine adduct related to the anti dG form and the stacking interaction observed
between the aryl adduct and C5 pyrimidine are most likely the main cause of the
observed distortion seen for the B-DNA form and indicate a destabilizing effect on this
conformation. Depending upon the adduct, there may be addition destabilizing effects.
For example, the carboxylate group of the CG8CPh oligonucleotide is also destabilized by
electrostatic repulsion between the p-COO- and the phosphate backbone and is likely the
explanation for its unique effects relative to the other adducts on B-DNA destabilization.
With current data, the Z-DNA stabilization effect of the aryl adducts can not be clearly
explained except that in general, the adducts do not seem to interfere with the Z-DNA
structure and therefore are not expected to decrease the stability of Z form like they do in
B form.
We expected to find a correlation between carcinogenic potential of an aryl
hydrazine and the effect on B-Z equilibrium. However, given the multitude of other
factors that may impinge on the carcinogenicity of aryl hydrazines discussed above and
additional factors such as absortion, distribution, etc., a perfect correlation is
unreasonable to expect. However, based on the consideration noted above, CBD can be
argued to be the most potent carcinogen followed by HMBD, MMBD, and MBD and this
trend generally correlated with the trend observed for the position of the B-Z equilibrium
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of CG8CPh, CG8HMPh, CG8MMPh, and CG8Tol. Based on the knowledge that all C8arylguanine adducts formed from carcinogenic aryl hydrazines and that these adducts
drive equilibrium toward the Z conformation, a better than expected correlation with
mutagenicity and perhaps carcinogenicity has been revealed. Thus, this study has shown
a potential connection between Z-DNA formation and aryl hydrazine carcinogenesis
opening the possibility to advance the investigation to the next level.

6.8 Future Direction
The current data from this study suggests a possible link between Z-DNA and
carcinogenesis by aryl hydrazines. Additional studies, however, will be required in order
to obtain sufficient data to strongly support the proposed hypothesis.
In vitro studies have shown that the aryl adducts affect the relative stability of B
and Z-DNA forms such that they shift the equilibrium toward the Z-DNA form. At the
same time, we can not be certain that the aryl adducts will have the same effect in vivo.
Although it may be true that some factors in the physiological environment such as ZDNA binding proteins and other cations could promote Z-DNA formation, several factors
may limit the formation of Z-DNA in physiological condition such as relatively low salt
concentration, abundance of Z-DNA forming sequences, etc. Therefore, investigation of
Z-DNA formation in vivo, as a result of adduct formation is needed. The presence of ZDNA in physiological system is generally transient which will make observing it in vivo
more difficult. No matter, it has been shown to be detectable by several methods
including Z-DNA specific antibody binding assay35,118-120, reaction with DEPC37,121, and
enzyme restriction of the B-Z junction45. In addition, detection of the binding to Z-DNA
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specific proteins such as ADAR142,98, DML198,122, or E3L123-125 would be a probable
alternative or at least a first step toward detection of Z-DNA in vivo.
Ultimately, a more relevant, comprehensive carcinogenic profile of aryl
hydrazines or arenediazonium ions from in vivo studies that incorporates the detection of
Z-DNA formation as an intermediate process will be necessary to establish the
correlation between Z-DNA and aryl hydrazines carcinogenesis.
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APPENDIX A
ABBREVIATIONS

Chemicals
8-BrdG, 8-bromo-2′deoxyguanosine
A, adenine
ACN, acetonitrile
BD, benzenediazonium ion
C, cytosine
CBD, pcarboxybenzenediazonium ion
CE-PA, cyanoethyl
phosphoramidites
CG, d(CGCGCGCGCG)2
CG8CPh, d(CGCGCG8CPhCGCG)2
CG8HMPh,
d(CGCGCG8HMPhCGCG)2
CG8MMPh,
d(CGCGCG8MMPhCGCG)2
CG8Ph, d(CGCGCG8PhCGCG)2
CG8Tol, d(CGCGCG8TolCGCG)2
D2O, deuterium oxide
DEME, diethylaminoethyl
dG, 2′-deoxyguanosine
DME, dimethylether
DMF, N’N-dimethylformamide
DMTr, dimethoxytrityl
dsDNA, double strand DNA
G, guanine
HMBD, phydroxymethylbenzenediazoniu
m ions
MBD, pmethylbenzenediazonium ions
MMBD, pmethoxymethylbenzenediazoniu
m ions
NBS, N-bromosuccinimide
Pd(OAc)2, palladium acetate
ssDNA, single strand DNA
T, thymine
TBS, t-butyldimethylsilyl
TCA, trichloroacetic acid

Experimentals
1D, one dimension
2D, two dimensions
COSY, correlation spectroscopy
Css, conc. of ssDNA (µM)
Cds, conc. of dsDNA (µM)
CB, conc. of B-DNA (µM)
CZ, conc. of Z-DNA (µM)
CD, circular dichroism
CD295, CD at 295 nm
CI, chemical ionization
CPG, controlled pore glass
CSF-1, colony stimulating
factor-1
EI, electron ionization
ESI, electrospray ionization
FEP, free energy perturbation
FPLC, fast protein liquid
chromatography
HETCOR, heteronuclear
correlation spectroscopy
HPLC, high pressure liquid
chromatography
M, molecular mass
MD, molecular dynamic
MM, molecular mechanic
MS, mass Spectrometry
MW, molecular weight
m/z, mass to charge ratio
NMR, nuclear magnetic
resonance
nOe, nuclear Overhauser
enhancement
NOESY, nuclear Overhauser
effect correlation spectroscopy
Nα, lower energy state nuclei
Nβ, higher energy state nuclei
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pD, apparent pD
R, gas constant
RF, radio frequency
RMSD, root mean square
derivation
RP-TLC, reverse phase thin
layer chromatography
SPE, solid phase extraction
TLC, thin layer chromatography
Tm, melting temperature
UV, ultraviolet
ΔE, energy gap
ΔG, free energy
ΔH, enthalpy
ΔS, entropy
A, absorbance
B0, magnetic field strength
b, path length
fss, molar fraction of ssDNA
fds, molar fraction of dsDNA
fB, molar fraction of B-DNA
fZ, molar fraction of Z-DNA
h, Plank’s constant
I, spin number
J, coupling constant
n, charge state of the molecule
(MS); number of adjacent
protons with the same coupling
constant (NMR)
v, applied radio frequency
veff, effective radio frequency
σ, shielding constant
δ, chemical shift
ε, molar absorptivity
є, total ellipticity
Δє, molar ellipticity
γ, gyromagnetic ratio

APPENDIX B
CHEMICAL STRUCTURES

1) 8-Bromo-2′-deoxyguanosine
2) 4-(TBS-O-methyl)-phenyl bromide
3) 4-(TBS-O-methyl)-phenyl boronic acid
4) 8-(4-Carboxyphenyl)-2′-deoxyguanosine
5) 8-(4-Methoxymethylphenyl)-2′-deoxyguanosine
6) 8-(4-(TBS-O-methyl)phenyl)-2′-deoxyguanosine
7) N2-(N,N-Dimethylformamidine)-8-(4-carboxyphenyl)-2′-deoxyguanosine
8) N2-(N,N-Dimethylformamidine)-8-(4-methoxymethylphenyl)-2′-deoxyguanosine
9) N2-(N,N-Dimethylformamidine)-8-(4-(TBS-O-methyl)phenyl)-2′-deoxyguanosine
10) 5′-O-(DMTr)-N2-(N,N-dimethylformamidine)-8-(4-carboxyphenyl)-2′deoxyguanosine
11) 5′-O-(DMTr)-N2-(N,N-dimethylformamidine)-8-(4-methoxymethylphenyl)-2′deoxyguanosine
12) 5′-O-(DMTr)-N2-(N,N-dimethylformamidine)-8-(4-(TBS-O-methyl)phenyl)-2′deoxyguanosine
13) 3′-O-[(2-Cyanoethoxy)(diisopropylamino)phosphino]-5′-O-(DMTr)-N2-(N,Ndimethylformamidine)-8-(4-carboxyphenyl)-2′-deoxyguanosine
14) 3′-O-[(2-Cyanoethoxy)(diisopropylamino)phosphino]-5′-O-(DMTr)-N2-(N,Ndimethylformamidine)-8-(4-methoxymethylaryl)-2′-deoxyguanosine
15) 3′-O-[(2-Cyanoethoxy)(diisopropylamino)phosphino]-5′-O-(DMTr)-N2-(N,Ndimethylformamidine)-8-(4-(TBS-O-methyl)aryl)-2′-deoxyguanosine
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Chemicals

216

Formular

MW

C10H12O4N5Br

346.14

C13H21OSiBr

301.30

C13H23O3BSi

266.22

Chemicals
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Formular

MW

C17H17O6N5

387.35

C18H21O5N5

387.40

C23H33O5N5Si

487.63

Chemicals
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Formular

MW

C20H22O6N6

442.43

C21H26O5N6

442.47

C26H38O5N6Si

542.71

Chemicals
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Formular

MW

C41H40O8N6

744.80

C42H44O7N6

744.85

C47H56O7N6Si

845.08

Chemicals
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Formular

MW

C50H57O9N8P

945.02

C51H61O8N8P

945.07

C56H73O8N8SiP

1045.30
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